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SUMMARY 
 
The microbiota of the gastro-intestinal tract plays an important role in human health. In addition 
to their metabolic interactions with dietary constituents, gut bacteria may also be involved in 
more complex host interactions, such as modulation of the immune system. Changes in the 
microbiota during an individual’s lifespan are accompanied by modifications in multiple health 
parameters, and such observations have prompted intense scientific efforts aiming to 
understand the complex interactions between the microbiota and its human host, as well as how 
this may be influenced by diet (Milani et al., 2016). To investigate the role of diet of the 
microbiota we performed three studies. In the first study we investigated the human gut 
microbiota composition in obese and normal-weight children; in the second project we studied 
the role of polysaccharide and fiber privation in wild type mice to gain more insight into the 
role of diet on gut microbiota. In the third study we analyzed the role of another important 
microbiota communities: the oral microbiota, in association with diet and release of the 
inflammatory marker IL-8 from gingival epithelial cells (GEC). 
An altered gut microbiota has been linked to obesity in adulthood, though little is known about 
childhood obesity. In this study we characterized the composition of the gut microbiota in a 
large cohort of obese (n=42) and normal-weight school-aged children (n=36). The obese group 
was characterized by a more elevated intake of kcal/die and macronutrients (g/die) respect to 
normal-weight. Body mass index (BMI) z-score was significantly associated with gut 
microbiota composition, as determined with 16S rRNA gene amplicon sequencing, as well as 
levels of bacterial fermentation products (short chain fatty acids [SCFAs]). Obesity was 
associated with an altered gut microbiota characterized by elevated levels of Firmicutes and 
depleted levels of Bacteroidetes. Members of the Bacteroidetes were generally better predictors 
of BMI z-score and obesity than Firmicutes, which was likely due to discordant responses of 
Firmicutes OTUs. 
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Correlation network analysis revealed that the gut microbiota of obese children also had 
increased correlation density and clustering of operational taxonomic units (OTUs). Moreover, 
we identified several bacterial taxa significantly associated with BMI z-score as well as SCFA 
levels. This suggests that alterations in the microbiota are linked to increased fermentation, 
which may play a role in promoting childhood obesity. 
To gain more insight into the role of diet on gut microbiota composition we studied the intestinal 
microbiota by using immunofluorescence images of fixed colon cross-sections for 
quantification and spatial organization of bacteria and laser capture microdissections (LCM) of 
specific areas from proximal to distal colon in wild-type mice. Subsequently, we sequenced 
LCM and stool samples by using 16S rRNA gene amplicon sequencing. We applied this 
protocol to three groups of mice with control diet (CON), fiber free (FF)  and polysaccharide 
free (PF) demonstrating that elimination of microbiota-accessible carbohydrates from the diet, 
resulted in a decrease of diversity, changes in microbial composition along colon compartments 
and in stool samples, in a thinner mucus layer and in a reduced biovolume fraction of goblet 
cells. This high-resolution system to capture and examine spatial organization of intestinal 
microbes demonstrated the strong impact of diet on gut microbiota community but even on 
mucus layer structure and goblet cells. 
In the third study we examined the oral microbiota community in healthy humans and its 
association with nutrition, oral hygiene habits, and the release of the inflammatory marker IL-
8 from GEC with and without stimulation with bacterial endotoxins to identify possible 
indicator operational taxonomic units (OTUs) for the initiation of oral diseases. GECs from 21 
healthy participants were incubated with/without addition of bacterial lipopolysaccharides 
(LPS), and the oral microbiota was profiled using 16S rRNA gene-targeted sequencing. 
Members of the oral microbiota were associated with basal IL-8 levels, the intake of meat, tea, 
white wine, sweets and the use of chewing gum, as well as flossing habits, allergies, gender and 
BMI. Interestingly, the stimulation with bacterial endotoxin revealed 11 indicator bacterial 
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OTUs, 9 of which were associated with high basal levels of IL-8 and an increase in IL-8 release 
after challenge with LPS and the other two with low level and high basal level of IL8 
irrespective of response to LPS challenge. The identification of indicator bacteria in healthy 
subjects with high levels of IL-8 release may be promising early-warning indicators for the 
possible onset of oral inflammations. 
In conclusion, in these three studies we demonstrated the importance of diet in the modulation 
of gut and oral microbiota in humans and wild-type mice and in health and disease, improving 
our understanding of host-microbes interactions.  
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1. The gut microbiota 
1.1 Definition of microbiota and microbiome 
The term microbiota was coined for the first time by Joshua Lederberg in 2001 to signify “the 
ecological community of commensal, symbiotic, and pathogenic microorganisms that literally share 
our body space and can be determinants of health and disease”. Specifically, the term “microbiota” 
represents the microbial taxa associated with human body and the term “microbiome” is the catalog 
of these microbes and their genes. The Human Microbiome Project and Metagenomics of the Human 
Intestinal Tract (MetaHIT) (www.metahit.eu/) project clearly demonstrated that gut microorganisms 
are not just passive residents, carrying out a range of biological functions that are important in 
nutrition and well-being of the individual (Dewhirst et al., 2010; The Human Microbiome Project 
Consortium, 2012).  
 
1.2 The evolution of the gut microbiota  
 
The first colonisation of the intestine is one of the most profound immunological exposures faced by 
the newborn and it is influenced by external and internal factors. The early composition of human 
microbiota could have long-lasting metabolic effects and the initial composition of human intestinal 
bacteria is also known to affect postnatal immune system development. Mode of delivery and feeding 
as an infant have a major role on the composition of intestinal microbiota in early infancy (Biasucci 
et al., 2010).  
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1.2.1 Mother–child symbiosis  
 
The mother–child symbiosis, tend to prepare a dynamic baseline on the newborn gut microbiota. An 
incorrect maternal behavior (smoking, weight gain in pregnancy), poor social condition and diseases 
during pregnancy can negatively influence the newborn gut microbiota composition (Figure 1.1 and 
1.2A) (Putignani et al., 2014). 
Theoretically, during its uterine life, the fetus develops in a sterile environment (Putignani et al., 
2014). Recent studies in animals have demonstrated that the association between the microbiome and 
fat deposition and resultant development of metabolic syndrome may begin as early as the prenatal 
period. Bacteria from pregnant mice gut have been demonstrated in mesenteric lymph nodes and are 
thought to possibly be transferred through the placenta into the fetus. Bacteria have been 
demonstrated even in meconium, which is the first stool passed by the fetus and thought to be sterile 
(Jiménez et al., 2008).  
The composition of the gut microbiota ecosystem is a complex but continuous process, affected by 
endogenous and exogenous determinants of variability, with an immediate effect at the time of birth 
that continue for several years during childhood through subsequent stages (Figure 1.2B). One of the 
major causes of onset and modulation of the newborn gut microbiota is the mode of delivery. Children 
born by natural delivery develop a microbiota similar to their mothers’ vaginal microbiota 
(Lactobacillus spp., Prevotella spp., Sneathia spp.), while children born by Caesarean section (CS) 
are characterized by microbiota similar to mother skin microbiota (Staphylococcus spp., 
Corynebacterium spp., Propionibacterium spp.). Babies born by CS, present a microbiota not 
necessarily mother induced, but often reflecting skin ecosystems of healthcare workers, surfaces, etc., 
which may come into contact with the baby during delivery. In addition, breastfeeding exposes infants 
predominantly to Bifidobacteria (90%), whereas formula-feeding is associated with a more diverse 
bacterial population, including Bacteroidetes and Clostridia species (Putignani et al., 2014). 
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This initial “bacterial imprinting” may later on differentially contribute to the onset of atopic diseases, 
allergies, asthma (Biasucci et al., 2010), and obesity described as more frequent in CS-born children 
rather than in those naturally delivered (Goldani et al., 2011; Mueller et al., 2015; Portela et al., 2015) 
 
1.2.2 From birth into adulthood 
In the pediatric age scale, 0–18 y (Figure 1.2B), feeding, environmental, social, biological, and 
genetic factors progressively influence the entire individual psychosomatic development, intimately 
connected to the gut microbiota onset and modulation. From 0 to 1 year infant gut interacts with 
mother and from 2 to 19 years child gut microbiota plays a crucial role in energy storage and 
metabolism, immune function, barrier integrity, epithelial cell proliferation, and intestinal motility. 
During toddlerhood, the intake of solid food and the maturation of immune system profoundly modify 
the gut microbiota profiles toward adult gut microbiota setting. During childhood and in teens, the 
maturation of hormonal and sexual development, social behavior, and adult-like diet and lifestyle 
changes continue to affect the gut microbiota shaping (Putignani et al.,2014).  
Information regarding the structure and function of the gut microbiota during childhood is limited. 
Although it has been suggested that the microbiota reaches a relatively stable adult-like state in the 
first three years of life, other evidence indicates that it continues to develop through adolescence. As 
such, childhood may provide unique opportunities for microbiota interventions to promote health or 
prevent disease. It is therefore vital to establish a baseline understanding of pediatric gut microbiota 
structure and function, as during this period the gastro-intestinal tract undergoes a transition from an 
immature to a mature state (Hollister et al., 2015). 
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Figure 1.1 Illustration of the main determinants of variability affecting the gut microbiota ecosystem. During early 
life, several external factors, such as delivery mode, feeding modality, environmental influences, antibiotic exposure, and 
functional food intake, can affect microbiota shaping and composition. Vaginally born babies acquire bacterial 
communities that resemble their mother’s vaginal microbiota, while Caesarean delivered babies harbor bacterial 
communities that are similar to the skin surface communities of the mothers. Additionally, breast-fed newborns show a 
more uniform and stable bacteria population compared with formula-fed newborns. Moreover, the environment during 
delivery, antibiotic treatment, and hygiene measures can influence the composition of the gut microbiota in neonates. 
Finally, the intake of functional foods, containing probiotic, prebiotic, or bioactive proteins (e.g., lactoferrin), modify the 
gut microbiota, reducing pathogen growth (Putignani et al., 2014). 
 
 
 
 
Figure 1.2 (A) Mother–child symbiosis elements affecting the onset and modulation of the newborn gut microbiota. (B) 
Physiological conditions of the gut microbiota during age of development from birth to adulthood (Putignani et al., 2014).  
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1.3 The gut microbiota composition 
 
The microorganisms that inhabit the human gastro-intestinal tract comprise a complex ecosystem 
with functions that significantly contribute to our systemic metabolism and have an impact on health 
and disease. The gastro-intestinal ecosystem constituting the microbiota can be represented as a 
“microbial organ” (named superorgan), located in the host organism (superorganism) and 
characterized by a dynamic interaction with food and host cells (Putignani et al.,2014). In line with 
its importance, the human gastro-intestinal microbiota has been extensively studied. Despite the fact 
that a significant part of the intestinal microorganisms has not yet been cultured, presently over 1000 
different microbial species that can reside in the human gastro-intestinal tract are composed by all 
three domains of life: Bacteria, Archaea, and Eukarya (Figure 1.3) (Rajilicˊ-Stojanovicˊ et al., 2014). 
 
 
 
 
Figure 1.3. Phylogenetic tree of the human gastro-intestinal microbiota. The numbers in parentheses indicate thenumber  
of cultured species given per phylum. The pie charts illustrate distribution between the number of species with full  
genome sequence genome (full sectors), the number of species with partial genomesequence (semi full sectors) and 
number of  species without any genome sequence (empty sectors) given for Archaea, Eukarya and per phylum for 
Bacteria. The color code of pies corresponds to the color code of the phylogenetic tree (Rajilicˊ-Stojanovi et al.,2014). 
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It is estimated that the human microbiota contains 1014 bacterial cells, a number that is 10 times 
greater than the number of human cells present in our bodies. The microbiota colonizes virtually 
every surface of the human body that is exposed to the external environment. Microbes are present 
on our skin and in the genitourinary, gastro-intestinal, and respiratory tracts. By far the most heavily 
colonized organ is the gastro-intestinal tract; the colon alone is estimated to contain over 70% of all 
the microbes in the human body.  Additionally, the gastro-intestinal tract is rich in molecules that can 
be used as nutrients by microbes, making it a preferred site for colonization (Sekirov et al., 2010).  
The intestinal microbiota is not homogeneous. The number of bacterial cells present in the 
mammalian gut shows a continuum that goes from 101 to 103 bacteria per gram of contents in the 
stomach and duodenum, progressing to 104 to 107 bacteria per gram in the jejunum and ileum and 
culminating in 1011 to 1012 cells per gram in the colon (Figure 1.4). Although there have been over 
50 bacterial phyla described to date, the human gut microbiota is dominated by only 2 of them: the 
Bacteroidetes and the Firmicutes, whereas Proteobacteria, Verrucomicrobia, Actinobacteria, 
Fusobacteria, and Cyanobacteria are present in minor proportions (Sekirov et al., 2010). The 
Firmicutes phylum comprises gram positive organisms from greater than 200 different genera 
including Catenibacterium, Clostridium, Eubacterium, Dorea, Faecalibacterium, Lactobacillus, 
Roseburia, Ruminococcus, and Veillonella while the Bacteroidetes phylum consists of gram negative 
bacteria from approximately 20 genera including Bacteroides, Odoribacter, Prevotella, and 
Tannerella (John and Mullin, 2016).  
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Figure 1.4. Spatial and temporal aspects of intestinal microbiota composition. (A) variations in microbial numbers and 
composition across the length of the gastro-intestinal tract. (B) longitudinal variations in microbial composition in the 
intestine (Sekirov et al., 2010).  
 
 
The mammalian lower gastro-intestinal tract contains a variety of distinct microbial habitats along 
the small intestine, caecum and large intestine (colon). Physiological variations along the lengths of 
the small intestine and colon include chemical and nutrient gradients, as well as compartimentalized 
host immune activity, all of which are known to influence bacterial community composition. The 
small intestine is more acidic, has a lower pH, lower transit time of complex polysaccharides, higher 
levels of oxygen and antimicrobials than the colon (Figure 1.5) (Donaldson et al., 2015; Swidsinski 
et al., 2007). Therefore, the microbial community of the small intestine is dominated by fast-growing 
facultative anaerobes that tolerate the combined effects of bile acids and antimicrobials while still 
effectively competing with both the host and other bacteria for the simple carbohydrates that are 
available in this region of the gastro-intestinal tract. Bile acids, secreted through the bile duct at the 
proximal end of the small intestine, are bactericidal to certain species owing to their surfactant 
properties and are known to broadly shape the composition of the microbiota, especially in the small 
intestine (Donaldson et al., 2015).  
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The bacteria in the small intestine are potentially competing with the host for nutrients, host-derived 
bile acids and antimicrobial peptides limit bacterial growth to low densities in proximal regions. Only 
at the distal end of the small intestine, in the terminal ileum, bacterial densities reach saturating levels 
similar to those found in the large intestine (Figure 1.5). The caecum and colon cultivate the most 
dense and diverse communities of all body habitats. In the caecum and colon, microorganisms are 
responsible for the breakdown of otherwise ‘resistant’ polysaccharides that are not metabolized 
during transit through the small intestine. Lower concentrations of antimicrobials, slower transit time 
and a lack of available simple carbon sources facilitate the growth of fermentative polysaccharide-
degrading anaerobes, notably the Bacteroidaceae and Clostridia (Donaldson et al., 2015).  
In the mouse, the caecum is enriched in species of the families Ruminococcaceae and 
Lachnospiraceae, whereas the colon is enriched in members of the families Bacteroidaceae and 
Prevotellaceae (Gu et al., 2013). Species from the family Rikenellaceae are prominent in both the 
caecum and the colon (Gu et al., 2013). As well as the variation in microbial community composition 
longitudinally within the gut, various host factors drive community differences over the cross-
sectional axis of the gut. The entire wall of the colon folds over itself, creating compartments between 
folds (inter-fold regions) that are distinct from the central lumenal compartment (Figure 1.5). In 
mouse studies that used laser capture microdissection to profile the composition of the microbial 
communities in discrete regions, significant differences were observed between the central lumenal 
compartment and the inter-fold regions (Nava et al., 2011; Pédron et al., 2012). Specifically, the 
Firmicutes families Lachnospiraceae and Ruminococcaceae were enriched between folds, whereas 
the Bacteroidetes families Prevotellaceae, Bacteroidaceae and Rikenellaceae were enriched in the 
digesta (Nava et al., 2011). Relative to the digesta, the inter-fold regions are likely to contain greater 
amounts of mucus, which can serve as a nutrient source for certain bacteria (Donaldson et al., 2015).  
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Figure 1.5. Microbial habitats in the human lower gastro-intestinal tract. The dominant bacterial phyla in the gut are 
Bacteroidetes, Firmicutes, Actinobacteria, Proteobacteria and Verrucomicrobia. The dominant bacterial families of the 
small intestine and colon reflect physiological differences along the length of the gut. For example, a gradient of oxygen, 
antimicrobial peptides (including bile acids, secreted by the bile duct) and pH limits the bacterial density in the small 
intestinal community, whereas the colon carries high bacterial loads. In the small intestine, the families Lactobacillaceae 
and Enterobacteriaceae dominate, whereas the colon is characterized by the presence of species from the families 
Bacteroidaceae, Prevotellaceae, Rikenellaceae, Lachnospiraceae and Ruminococcaceae (colours correspond with the 
relevant phyla). A cross-section of the colon shows the digesta, which is dominated by Bacteroidaceae, Prevotellaceae 
and Rikenellaceae, and the inter-fold regions of the lumen, which are dominated by Lachnospiraceae and 
Ruminococcaceae. cfu, colony-forming units (Donaldson et al., 2015). 
 
 
1.3.1 Paneth cells 
The large and small intestine are lined with a single layer of columnar epithelial cells that are linked 
via complexes of junctional proteins and desmosomes creating a sealed yet dynamic barrier. 
Enterocytes and enteroendocrine cells are found throughout the gastro-intestinal tract and are 
involved in nutrient and water absorption and hormone production (Bowcutt et al., 2014). The base 
of the crypts in the gastro-intestinal tract contain undifferentiated stem cells from which progenitor 
cells are derived and develop into any of one of four major differentiated epithelial cell types; 
enterocytes, Paneth cells, goblet cells, enteroendocrine cells (Bowcutt et al., 2014; Kim and Ho, 
2010).  
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Paneth cells, a specialized lineage of cells unique to the small intestine, are a major source of 
antimicrobial peptides (AMPs) including α-defensins, lysozyme, ribonucleases [such as angiogenin 
4 (ANG4)], secretory phospholipase A2 and C-type lectins [such as the regenerating islet derived 
protein (REG3) family]. AMPs are thought to act as mediators in host defence against pathogens and 
in shaping the microbiome composition for the maintenance of homeostasis. AMPs such as REG3γ 
and REG3β promote spatial segregation of microbial populations from the epithelial surface of the 
small intestine. AMPs also help shape microbial diversity and thus may contribute to the relatively 
low bacterial burden in the duodenum compared with the large intestine. In addition to the production 
of AMPs, Paneth cells may directly recognise pathogens via pattern recognition receptors enabling 
them to initiate innate immune responses (Bowcutt et al., 2014; Nakamura et al., 2016).  
 
1.3.2 Goblet cells and mucus layer: structure and composition 
Goblet cells exhibit a non-homogenous distribution along the intestinal epithelium. The proportion 
of goblet cells among epithelial cell types increases caudally from duodenum (4%) to distal colon 
(16%), similar to the increasing number of microbial organisms present in the proximal intestine to 
colon (Kim and Ho, 2010). They release a panel of bioactive compounds including mucins, AMPs 
such as resistin-like molecule β (Relmβ), ANG4, REG3γ, regenerating REG3β and trefoil peptides 
that further contribute to innate immune defence (Bowcutt et al., 2014).  
Another important role perfomed by goblet cells is mucus secretion forming a mucus layer of varying 
thickness that partially or fully covers the epithelium, creating a boundary between the gut lumen and 
the host tissue (Figure 1.6) (Donaldson et al., 2015; Kim and Ho, 2010).  
The small intestine harbours a single, tightly attached mucus layer (Figure 1.6A). In the colon, mucus 
is organized into two distinct layers: an inner, stratified mucus layer that is firmly adherent to the 
epithelial cells and approximately 50 μm thick in the mouse; and an outer, non attached layer that is 
usually approximately 100 μm thick as measured in mouse layers (Figure 1.6B) (Li et al., 2015; 
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Johansson et al, 2011). The inner mucus layer is dense and theoretically does not allow bacteria to 
penetrate, thus keeping the epithelial cell surface free from bacteria. Interestingly other evidence 
suggest that tightly adhering inner mucus layer and the crypts could be penetrated at low density by 
a more restricted community that includes Bacteroides fragilis and Acinetobacter spp. (Donaldson et 
al, 2015, Nava et al., 2011; Pédron et al., 2012). The mucus is continuously secreted and the inner 
mucus layer is converted into the outer layer, which is the habitat of the commensal microbiota. The 
outer mucus layer has an expanded volume due to proteolytic activities provided by the host but 
probably also caused by commensal bacterial proteases and glycosidases. In mice, a viscosity gradient 
of the gel-forming mucus increases from the proximal colon (which includes the caecum and the 
ascending and transverse colon) to distal colonic sites (which include the descending colon and the 
sigmoid colon connecting to the rectum). In addition to mucus density, itself serving as a physical 
obstacle for microorganisms, antimicrobial molecules and oxygen secreted from the epithelium 
accumulate at high local concentrations within the mucosa, especially in the small intestine, greatly 
restricting potential microbial inhabitants (Figure 1.6A). Therefore, the mucus layers of the gastro-
intestinal tract creates distinct environments for specific bacterial ecosystems that thrive in proximity 
to host tissue (Donaldson et al, 2015).  
Many diseases of the gastro-intestinal tract and extra-intestinal conditions are associated with 
intestinal barrier alterations. This includes both functionality (permeability) and immune or structural 
parameters of the barrier such as secretion of antimicrobial peptides and mucins, in which the 
microbiota can play a central role. Alterations in barrier function by bacteria has been associated in 
animal studies with increases in translocation of bacteria, uptake of microbial products and dietary 
antigens, and it has been proposed that this could promote a proinflammatory state. Clinically, small 
intestinal bacterial overgrowth is associated with changes in barrier function in humans, however 
mechanisms and bacterial culprits or constituents are unknown (McCarville et al., 2016).  
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Figure 1.6. The mucus layers of the small intestine and colon. Several factors limit the ability of gut bacteria to access 
host cells, such as the mucus layers in the small intestine and the colon; antimicrobial peptides (AMPs) in the small 
intestine, including those produced by Paneth cells at the base of the crypts; secreted immunoglobulin A (sIgA) in both 
the small intestine and colon; and a steep oxygen gradient that influences which bacteria are capable of surviving close 
to the epithelial surface. (A) The surface of the small intestine is shaped into villi and crypts and is colonized by certain 
adherent species, including segmented filamentous bacteria (SFB), Lactobacillaceae and Helicobacter spp. (B) The colon 
has two distinct mucus structures: the loose outer layer is colonized by mucin-degrading bacteria and is characterized by 
the presence of Bacteroides acidifaciens, Bacteroides fragilis, Bifidobacteriaceae and Akkermansia muciniphila; the 
tightly adhering inner mucus layer and the crypts are penetrated at low density by a more restricted community that 
includes Bacteroides fragilis and Acinetobacter spp. (Donaldson et al., 2015). 
 
1.3.3 MUC2 
Up to 20 different mucin genes have been identified, from MUC1 to MUC20 according to order of 
their discovery. Mucin genes are expressed in tissue and cell type-specific manner and are broadly 
classified into two types, secretory and membrane-associated. Gel-forming secretory mucins such as 
MUC2, MUC5AC, MUC5B, and MUC6 are localized on chromosome 11.5.5 as a cluster. In small 
and large intestine, MUC2 is the major secretory mucin synthesized and secreted by goblet cells, 
whereas goblet and absorptive cells express membrane-bound mucins, MUC1, MUC3, MUC4, 
MUC13, and/or MUC17, in the apical membrane. Secretory and membrane mucins have distinct 
structural features and biosynthetic pathways. MUC2 is the first human secretory mucin to be 
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identified and characterized (Kim and Ho, 2010) and typically the mucus is structurally built around 
the MUC2 mucin that after secretion from the goblet cell expands dramatically and forms sheets of 
MUC2 networks that stack and form the stratified mucus layer (Jakobsson et al, 2015). The MUC2 
mucin encodes a protein of approximately 5200 amino acids.  Its central part contains two so-called 
PTS domains which are rich in the amino acids proline (P), threonine (T) and serine (S). PTS domains 
are often highly repetitive (as in the second MUC2 domain) but lack sequence conservation between 
species. The abundant hydroxy amino acids act as attachment sites for the O-glycans. Once the mucin 
apoprotein reaches the Golgi apparatus, it is densely decorated by consecutive additions of 
monosaccharides. These highly glycosylated domains are called mucin domains and characterize all 
mucins. The O-glycans make the mucin domains highly protease resistant and give mucins their high 
waterbinding capacity (Swidsinski et al., 2007) (Figure  1.7).  
Commensal bacteria use these glycans as an important energy source. That commensal bacteria have 
the opportunity to degrade indigestible glycans has been crucial for the coevolution of host and its 
microbiota, because this increases the energy extraction from food significantly. The bacteria use its 
high number of glycan hydrolytic enzymes to degrade polysaccharides and other glycoconjugates that 
come to the colon from food via the small intestine. However, it is not only the extra energy that 
comes from the nondigestible food important, the bacterial degradation of the mucins and glycans 
also provide significant energy. This will allow the host to recover some of the energy spent to 
produce the protective mucus (Johansson et al, 2011). The numerous O-glycans on the MUC2 mucin 
not only serve as nutrients for the bacteria but also as attachment sites and, as such, probably 
contribute to the selection of the species-specific colonic microbiota (Johansson et al, 2011).  
The removal of microbiota accessible carbohydrates, which are typically abundant in dietary fiber 
and serve as primary metabolic input for the gut microbiota, shift the balance of the microbiota 
towards mucus-consuming bacteria (Earle et al, 2015). The mucosa-associated microbial composition 
differs from the luminal content and can be particularly important for nutrient exchange, 
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communication with the host, development of the immune system, and resistance against invading 
pathogens (Ouwerkerk et al, 2013). It has been demonstrated in mice that the mucosa-associated 
microbiota has adapted to the glycan rich environment by the production of mucus-degrading 
enzymes and mucus-binding extracellular proteins, and include mucus degrading specialists such as 
Akkermansia muciniphila, Bacteroides thetaiotaomicron (Ouwerkerk et al, 2013) and Bacteroides 
acidifaciens (Donaldson et al, 2015).   
 
 
Figure 1.7. Schematic outline of the MUC2 mucin and its formation of mucus in the small and large intestine. (A) 
Assembly of the MUC2 mucin (protein core red) into dimeric forms in the endoplasmic reticulum (ER), O-glycosylation 
(green) in the Golgi apparatus, formation of trimeric forms in the trans Golgi network (TGN) and a schematic picture of 
the secreted MUC2 polymer. (B) The MUC2 mucin is secreted from the goblet cells (black arrows) to form the mucus. 
Colon has a two layered mucus where the inner layer is converted (red arrows) to the outer mucus layer. The stomach has 
a mucus essentially as that of colon (not shown). Red dots symbolize bacteria (Swidsinski et al., 2007). 
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1.3.4 Mucosa-associated microbiota has distinct composition 
Within the mucus layer the Firmicutes are generally higher in abundance compared to the 
Bacteroidetes both in humans and rodents. The mucosa-associated microbiota in the ascending, 
transverse, and descending colon is highly similar within individuals (Ouwerkerk et al., 2013). 
Studies based on 16S RNA gene sequences in mice show an increased abundance of the following 
genera and species in the mucosa: Lachnospiraceae, Ruminococcaceae (Nava et al., 2011) and both 
Bifidobacterium bifidum and Bifidobacterium longum (Van den Abbeele et al., 2011). Bacteria 
belonging to Clostridium cluster XIVa have been associated in vitro with the colonization of a mucin 
rich environment, and include butyrate producers Retortamonas intestinalis and Eubacterium rectale 
(Van den Abbeele et al., 2012).  The Verrucomicrobia were found to be enriched in the mucus layer 
compared to the luminal content, implicating colonization of the only known Verrucomicrobia in the 
gut: the mucus degrading Akkermansia muciniphila (Derrien et al., 2004). Additional evidence comes 
from fluorescence in situ hybridization (FISH) based studies showing that mucosa-associated bacteria 
include the following family, genera and species in human: Lachnospiraceae, Enterobacteriaceae, 
Bacteroides, Eubacterium rectale, Faecalibacterium prausnitzii, Eubacterium cylindroides, 
Clostridium histolyticum, Clostridium lituseburense (Swidsinski et al., 2008). Not found but 
predicted to colonize close to the mucus layer are sulphate-reducing bacteria, methanogenic archaea 
and acetogenic bacteria, all hydrogenotrophic microbes that are associated with the colonic mucosa 
of healthy subjects (Nava et al., 2012; Ouwerkerk et al., 2013).  
 
1.3.5 Mucin-degrading specialists 
Mucus-degrading bacteria have an advantage in the mucosal niche that is rich in endogenous 
glycoproteins both from excreted mucin proteins and shed epithelial cells. However, these bacteria 
need several linkage specific enzymes to degrade the highly diverse glycans present in the mucus 
layer, such as glycosidases, sulphatases, and sialidases. After degradation there are several microbial 
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strategies to harvest the glycans, including the starch utilization system (Sus)-like system of the Gram 
negative Bacteroidetes and ABC transporters for carbohydrate uptake in Gram-positive bacteria 
(Koropatkin et al., 2012). Mucus-degrading specialists possess a variety of enzymes to degrade the 
mucus glycans, subsequently harvest the oligosaccharides for their own metabolism, and therefore 
have a colonization advantage competing for this niche. A second advantage is that their energy 
source is permanently present, because the production of endogenous mucins is not depending on the 
diet that may fluctuate. Mucin-degrading specialists are scattered among the microbiota-associated 
phyla and include the following species: Akkermansia muciniphila, Bacteroides thetaiotaomicron, 
Bifidobacterium bifidum, Bacteroides fragilis, Ruminococcus gnavus, and Ruminococcus torques. 
These specialists degrade the mucin protein, which possibly leads to the availability of 
oligosaccharides for other bacteria that do not harbour the correct enzymes for this process 
(Ouwerkerk et al., 2013).  
 
1.4 The role of the gut microbiota  
 
The gut microbiota is involved in the regulation of multiple host pathways and participates in 
metabolic and immune-inflammatory axes connecting the gut with the liver, muscle, and brain. 
(Nicholson et al., 2012). Compositional alterations that disturb the normal balance of the gut 
microbiota, a phenomenon referred as gut dysbiosis, may promote or cause the development of 
metabolic disorders such as obesity, as well as gut diseases such as inflammatory bowel disease and 
colon cancer (Figure 1.8).  
Gut microbes exert a wide variety of physiological functions that have an influential role in intestinal 
and extra-intestinal homeostasis (Fernandez et al., 2014). The gut microbiota has critical roles in the 
protection against pathogenic bacteria producing bacteriocins, blocking adhesion of pathogens and in 
the fermentation of indigestible plant polysaccharides (see paragraph below) and host-produced 
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glycans (e.g.mucin) (Milani et al., 2016). In particular, the microbiota is involved in the production 
of vitamin K, multiple B vitamins, H2, CO2, methane gas, lysine, and the conversion of urea to 
ammonia. It also metabolizes ingested foreign compounds (xenobiotics) and modulates the enter-
hepatic circulation of compounds detoxified by the liver and excreted in the bile.  
Commensal microorganisms have important roles in the development and in the modulation of the 
immune system and in the production of secretory IgA (Tsai et al., 2009). There is evidence that the 
gut microbiota exerts a key role in inducing immunoglobulin A production, as well as maintaining 
the homeostasis of several T cell populations in the gut, including regulatory T cells (Treg), T helper 
1 (Th1) and T helper 17 (Th17) cells and also mucosal-associated T cells (Milani et al.,2016). Certain 
microbiota components have been shown to promote Treg development (Bacteroides fragilis, 
Clostridium strains, Lactobacillus spp and Bifidobacterium spp), whereas others induce Th17 
development (Candidatus arthromitus). A balanced autochthonous microbiota is required to drive the 
normal development of both mucosa-associated lymphoid tissue and mucosally-induced tolerance 
mechanisms involving the generation of Treg cells (Milani et al., 2016) (Figure 1.8).  
 
 
 
 
Figure 1.8. Schematic representation of the functional roles of key members of the human gut microbiota in health 
and disease. IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; SCFA, short-chain fatty acid.(Milani et 
al., 2016). 
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1.4.1. Short chain fatty acids (SCFAs) 
 
One of the main activities of the gut microbiota is to breakdown substrates such as resistant starch 
and dietary fiber, which are incompletely hydrolyzed by host enzymes in the small intestine. The 
main fermentation products resulting from fiber degradation are the short chain fatty acids (SCFAs) 
acetate, propionate, and butyrate (Schwiertz et al., 2009). SCFAs concentration are highest in the 
large intestine, mainly because of greater carbohydrate availability. Studies using intestinal material 
obtained from human sudden death victims found that acetate:propionate:butyrate values were similar 
in different regions of the large intestine (about 57:22:21) (Macfarlane S and Macfarlane G, 2003).  
SCFAs play different roles in energy salvage: normal colonic epithelia derive 60–70% of their energy 
supply from SCFAs, particularly butyrate. Propionate is largely taken up by the liver and is a good 
precursor for gluconeogenesis, liponeogenesis and protein synthesis and acetate enters the peripheral 
circulation to be metabolized by peripheral tissues and is a substrate for lipid and cholesterol synthesis 
(Martins dos Santos et al., 2010). Moreover, intracellular butyrate and propionate (but not acetate) 
inhibit the activity of histone deacetylases (HDACs) in colonocytes and immune cells, which 
promotes the hyperacetylation of histones, in addition to some transcription factors and proteins that 
are involved in signal transduction. This has multiple consequences for gene expression and cellular 
differentiation, including the downregulation of pro-inflammatory cytokines, such as interleukin-6 
(IL-6) and IL-12 in colonic macrophages (Louis et al., 2014). 
 
1.4.2 Microbial production of SCFAs  
The production of microbial SCFAs is influenced by diet. Between 10% and 20% of ingested dietary 
carbohydrates are resistant to small intestinal digestion, increasing colonic fermentation, gut transit 
and stool output and decreasing the pH of the intestinal lumen. These non-digestible dietary 
carbohydrates include certain forms of starch that are resistant to amylase digestion (resistant starch: 
cereals, raw banana, potato) as well as non-starch polysaccharides (pectin, cellulose). Non-digestible 
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dietary carbohydrates enter the colon and are fermented by colonic bacteria to SCFA, lactate, and 
gases such as CO2, H2, and methane  (Ramakrishna et al., 2013). 
The relative synthesis of the different fermentation products varies according to the composition of 
the microbiota and environmental conditions, including pH, hydrogen partial pressure and available 
substrates (Louis et al., 2014). 
Acetate, which is the most abundant SCFA, is produced by most enteric bacteria as a fermentation 
product, but it is also formed by acetogenic bacteria, such as Blautia hydrogenotrophica, from H2 and 
CO2 or from formate via the Wood–Ljungdahl pathway (Figure 1.9). Acetogenic bacteria can produce 
three molecules of acetate from one molecule of glucose, but non-acetogenic anaerobes which 
comprise most of the microbiota, these produce other SCFAs in addition to or instead of acetate, 
including succinate, propionate, butyrate, formate, d-lactate, l-lactate (Figure 1.9) (Louis et al., 2014). 
Propionate is mostly formed via the succinate pathway by Bacteroidetes and by some Firmicutes that 
belong to the Negativicutes class (such as Phascolarctobacterium succinatutens, Dialister spp. and 
Veillonella spp.). Succinate is a metabolic end-product for some bacteria under some environmental 
conditions. Two other pathways also contribute to the formation of propionate: the acrylate pathway 
and the propanediol pathway (Figure 1.9). The acrylate pathway, in which lactate is a substrate, shows 
a limited distribution, whereas the propanediol pathway, in which deoxyhexose sugars (such as fucose 
and rhamnose) are substrates, is present in some Firmicutes (including Roseburia inulinivorans and 
Ruminococcus obeum) and in Proteobacteria. The proportion of propionate that is present in total 
faecal SCFA correlates with the relative abundance of Bacteroidetes, which confirms that the 
succinate pathway is the dominant source of propionate (Louis et al., 2014). 
Analysis of the genetic potential of gut microbiota indicates that Bacteroides species possess genes 
for a large number of enzymes involved in carbohydrate utilization including glycoside hydrolases, 
glycosyl transferases, polysaccharide lyases, and carbohydrate esterases. Bacteroides are able to 
degrade non-digestible dietary carbohydrates  as well as host carbohydrates including mucus proteins, 
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and may switch to the latter when dietary non-digestible dietary carbohydrates are less abundant 
(Ramakrishna et al., 2013) producing high levels of acetate and propionate (Martins dos Santos et al., 
2010).  
Butyrate is produced by some Firmicutes using either the butyryl-CoA:acetate CoA-transferase 
enzyme or, less commonly, phosphotransbutyrylase and butyrate kinase to catalyse the final steps of 
the pathway (Figure 1.9). Species that use the butyryl-CoA:acetate CoA-transferase route include 
several of the most abundant species in the healthy gut microbiota (including Faecalibacterium 
prausnitzii, Roseburia spp., Eubacterium rectale, Eubacterium hallii and Anaerostipes spp.) which 
are generally net users of acetate such that the concentration of acetate in the gut lumen is determined 
by the balance of production, use and mucosal uptake. A subset of Lachnospiraceae, including 
Eubacterium hallii and Anaerostipes spp., can use lactate and acetate to produce butyrate. Thus, these 
organisms may have an important role in stabilizing the microbial ecosystem by preventing the 
accumulation of lactate (Louis et al., 2014).  
Bacteria belonging to Clostridium clusters IV (Clostridium leptum, Ruminococcus bromii, and 
Faecalibacterium prausnitzii) and XIV (Clostridium coccoides, Eubacterium rectale, Roseburia 
species, and Butyrivibrio fibrisolvens) are considered to be very important carbohydrate-fermenting 
bacteria that are particularly effective in fermenting starch with the production of butyrate (Martins 
dos Santos et al., 2010; Ramakrishna et al., 2013). Moreover, members of Clostridium cluster XIVa 
convert lactate produced by several microbial species from carbohydrate to butyrate while members 
of Clostridium cluster IX convert lactate to propionate (Ramakrishna et al., 2013).  
Bifidobacterium strains have been reported to be very good at hydrolyzing high amylose starch 
(resistant starch), because they have a metabolic pathway that utilize human milk oligosaccharides 
and host glycoproteins. Bifidobacterium longum and Bifidobacterium adolescentis produce acetate 
from glucose while the former has an ATP-binding cassette-type carbohydrate transporter that also 
allows it to use fructose to produce acetate (Ramakrishna et al., 2013) (Figure 1.9).  
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Only a few anaerobes are known to produce both propionate and butyrate, and they do so from 
different substrates: Roseburia inulinivorans produces butyrate from glucose and produces 
propionate from fucose, whereas Coprococcus catus produces butyrate from fructose and produces 
propionate from lactate (via the acrylate pathway) (Louis et al., 2014). 
 
 
 
Figure 1.9. Pathways that are responsible for the biosynthesis of the major microbial metabolites that result from 
carbohydrate fermentation and bacterial cross-feeding. Of the three main short-chain fatty acids (SCFAs; shown in 
red), acetate can be produced by many enteric bacteria from pyruvate via acetyl-CoA and also via the Wood–Ljungdahl 
pathway by acetogens, such as Blautia hydrogenotrophica. Butyrate is formed from two molecules of acetyl-CoA by 
several Firmicutes, and the butyryl-CoA:acetate CoA-transferase is usually used to catalyze the last enzymatic step41. 
The main propionate production pathway is the succinate pathway, which is used by Bacteroidetes to generate propionate 
from carbohydrates and by some Firmicutes to produce propionate from lactate or succinate. Two other propionate 
formation pathways are found in some gut bacteria: the acrylate pathway, which uses lactate, and the propanediol 
pathway, which uses deoxyhexose sugars (such as fucose and rhamnose). Pathways that are involved in hydrogen 
metabolism and ethanol production are also shown. The bacterial species that are shown are based on studies of cultured 
isolates of dominant species and metagenomic analyses and are thus not exhaustive.  Archaea are shown in orange, 
Bacteroidetes are shown in grey, Lachnospiraceae (Firmicutes) are shown in blue, Ruminococcaceae (Firmicutes) are 
shown in purple, Negativicutes (Firmicutes) are shown in green and Proteobacteria are shown in brown. DHAP, 
dihydroxyacetonephospate; PEP, phosphoenolpyruvate (Louis et al., 2014).  
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1.5 Techniques to study the gut microbiota  
 
 
Traditionally, gastro-intestinal bacteria have been studied via cultivation-based techniques, recently, 
findings from culture-based methods have been supplemented with molecular ecology techniques 
that are based on the 16S rRNA gene. These techniques enable characterization and quantification of 
the microbiota, while also providing a classification scheme to predict phylogenetic relationships 
(Zoetendal et al., 2004). In recent years, several next-generation sequencing technologies have been 
developed, which further facilitate the analysis of a large number of microorganisms in different 
environments and human body sites, including the human gut. 16S rRNA sequence analysis and 
metagenomics are two effective sequencing approaches, and both have been used to study 
uncultivated gut microbial communities. The research based on 16S rRNA sequence attempts to 
reveal “who’s there?” in a given microbial community, while shotgun metagenomic sequencing can 
be used to answer the complementary question of “what can they do?” (Wang et al., 2015).  
The choice of a particular molecular-based approach depends on the questions being addressed.  
Microbial community structure can be analyzed via fingerprinting techniques, fluorescence in situ 
hybridization to measure abundance of particular taxa. Others approaches, such as those based on 
functional genes and their expression and the combined use of stable isotopes and biomarkers, are 
being developed and optimized to study metabolic activities of groups or individual organisms in situ 
(Zoetendal et al., 2004) (Figure 1.10).  
 
 
 
1.5.1 Fingerprinting techniques  
Several so-called fingerprinting techniques have been used to study bacterial communities and appear 
to be ideal for monitoring community shifts and comparing communities between gastro-intestinal 
sites and among animals. Denaturing gradient gel electrophoresis (DGGE) was first applied in 
microbial ecology to study bacterial diversity in a marine ecosystem. Since this pioneering study, a 
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variety of microbial ecosystems have been analysed using DGGE or similar techniques, including 
temperature gradient gel electrophoresis (TGGE), and only occasionally temporal temperature 
gradient gel electrophoresis (TTGE). Two additional microbial community fingerprinting techniques 
are single strand conformation polymorphism (SSCP) and terminal-restriction fragment length 
polymorphism (TRFLP) analyses. Although the principles and technical procedures vary, all 
microbial community fingerprinting techniques are PCR-based and generate profiles representing the 
sequence diversity within the selected ecosystem. DGGE, TGGE, and TTGE are based on sequence-
specific melting behaviour of amplicons, SSCP on the secondary structure of single stranded DNA, 
and T-RFLP on specific target sites for restriction enzymes. Interestingly, with the exception of T-
RFLP, all other techniques have been used successfully in mutation detection in clinical research 
before being applied to microbial ecology, which demonstrates their discriminative power (Zoetendal 
et al., 2004). 
 
1.5.2 Fluorescence in situ hybridization 
A frequently applied culture-independent approach to quantify bacterial cells in environmental 
samples is FISH using SSU rRNA-targeted oligonucleotide probes. This method combines the power 
of SSU rRNA probe hybridization with epiflourescent light microscopy, confocal laser microscopy, 
or flow cytometry for direct quantification of individual bacteria. This approach can be used to 
determine the relative importance of specific groups or genera of bacteria. FISH is being increasingly 
used to study the bacterial composition of the gastro-intestinal tract (Zoetendal et al., 2004) and it has 
been automated and combined with computerized image analysis (Daims, 2009). FISH enables five 
ecological issues to be addressed simultaneously: 1) to identify subpopulations in natural ecosystems 
and to locate their habitat; 2) to obtain information on community structure by using nested sets of 
probes; 3) to circumvent cultivation problems; 4) to determine in situ cellular rRNA content; and 5) 
to accurately enumerate defined cell populations (Zoetendal et al., 2004).  
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1.5.3 Sequencing of SSU rRNA clone libraries 
The construction of small subunit (SSU) rRNA libraries is required to inventory bacteria and archaea 
present in a given environment. In fact, sequencing of SSU rRNA genes has became a standard 
procedure in the identification of isolates, and it is now impossible to adequately describe microbial 
communities without SSU rRNA sequence data (Zoetendal et al., 2004).  
As the 16S rRNA gene is universally present across bacteria, is highly conserved, and can be easily 
amplified using universal primers, environmental microbial analyses are often performed using 16S 
rRNA amplicon sequencing. Although the 16S rRNA gene is highly conserved, there are nine 
hypervariable regions that can be used to distinguish between different organisms. The typical 
pipeline for 16S amplicon analyses starts with using primers designed to amplify the hypervariable 
regions of the 16S rRNA gene (typically the V1–V3 region or the V3–V5 region). Sequences are 
clustered into bins called ‘Operational Taxonomic Units’ (OTUs) based upon similarity. A common 
similarity threshold used is 97%, which was derived from an empirical study that showed most strains 
had 97% 16S rRNA sequence similarity (Nguyen et al., 2016). 
After library construction, the sequences of the cloned amplicons are determined and compared to 
sequences deposited databases (http://www. ncbi. nlm.nih.gov/BLAST/ and 
http://rdp.cme.msu.edu/html), and followed by phylogenetic analysis. Sequencing of SSU rRNA 
clone libraries from human feces, colonic and ileal samples and the oral cavity have confirmed that a 
significant fraction of resident bacteria have not been described previously (Zoetendal et al., 2004).  
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Figure 1.10. Molecular methods used singularly or in combination to analyse complex microbial ecosystems 
(Zoetendal et al., 2004).  
 
1.5.4 Metagenomics, metatrascriptomics, metaproteomics and metabolomics 
Metagenomics is an extremely powerful tool that can be used to describe the genetic potential of the 
microorganisms present in a given environment. Metagenomics can be used to study intestinal 
microbiome diversity and dysbiosis, as well as its relationship to health and disease. Moreover, 
functional metagenomics can identify novel functional genes, microbial pathways, antibiotic 
resistance genes, functional dysbiosis of the intestinal microbiome, and determine interactions and 
co-evolution between microbiota and host. However, it has a very limited function in revealing their 
activity or gene expression. With the rapid development of metatranscriptomics, metaproteomics and 
metabolomics, the functional activity of a microbial community can be identified. Metatranscriptomic 
sequencing can be used to determine the activity of genes in a defined environment and metabolomics 
can disentangle the complex array of proteins produced by the intestinal microbiota. Some human 
intestinal disorders, such as colorectal cancer, inflammatory bowel disease and irritable bowel 
syndrome (IBS), have been studied using metabolomics. On the one hand, the metabolomics 
databases, as well as metatrascriptomic and metaproteomic databases, are incomplete and 
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insufficient, and there are many metabolites that are not included in the databases. Although there are 
some limitations with these approaches, they have significant potential clinical applications and the 
combination of the meta-omics may be sufficiently powerful to elucidate the ecologic roles of the 
human gut microbiome (Wang et al., 2015) (Figure 1.11). 
 
 
Figure 1.11. Comparison of different gut microbiome study approaches. The characteristics, limitations, and 
applications of different gut microbiome approaches from cultivation to metabolomics are presented.  
DGGE: Denaturing gradient gel electrophoresis (Wang et al., 2015).  
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Introduction 
2.1 Gut microbiota and childhood obesity  
The adult human gut microbiota has been extensively studied in relation to its role in gut homeostasis 
and various diseases (Schwiertz et al., 2009). Notably, alterations in the gut microbiota and 
metabolome have been associated with the development of metabolic disorders such as obesity 
(Choquet et al., 2010; Vinolo et al., 2011). Obesity is a serious public health issue affecting both 
children and adults and it is defined as a condition in which excess body fat negatively affects the 
human’s health and wellbeing (Aguilera et al., 2013; Choquet et al., 2010). Prevention of obesity is 
proposed to begin in childhood because the comorbidities related to obesity can impact the adulthood 
exerting a long-term effect (Sanchez et al.,2015).  
Current data estimates that approximately 600 million people around the world are obese, with an 
additional 1.9 billion people being overweight (John and Mullin, 2016). In recent years, the 
prevalence of childhood obesity has increased substantially worldwide. Since 1980, the prevalence 
of overweight and obesity has increased remarkably in developed countries; 23.8% of boys and 22.6% 
of girls were overweight or obese in 2013, compared with 16.9% of boys and 16.2% of girls in 1980. 
The prevalence of overweight and obesity is also rising in children and adolescents in developing 
countries, increasing from 8.1% in 1980, to 12.9% in 2013 for boys and 8.4% to 13.4% in girls. In 
both developed and developing countries, sex differences in the levels and trends of overweight and 
obesity are small (Ng et al., 2014) (Figure 2.1A and B).  In Italy, 20.9% of children are overweight, 
9.8% obese, and 2.2 severe obese, with highter prevalence in centre and Southern Italy, according to 
Istituto Superiore di Sanità report (http://www.epicentro.iss.it/okkioallasalute/default.asp) (Fig 2.2).  
Obesity has been associated with several comorbidities, such as cardiovascular events, hypertension 
(Aguilera et al., 2013), insulin resistance (Aguilera et al., 2013; Choquet et al., 2010), dyslipidaemia, 
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metabolic syndrome, liver steatosis, orthopaedic problems, and sleep apnoea, which can occur in 
either the short or long term. Of all the complications of obesity, a cluster of anthropometric, clinical, 
and metabolic alterations, as low levels of high-density lipoprotein-cholesterol (HDL-c), high 
triacylglycerols, high blood pressure and impaired glucose metabolism, predisposes the affected 
individuals to the development of obesity, type 2 diabetes mellitus and cardiovascular diseases. The 
mechanisms linking obesity to its metabolic complications are extremely complex and remain hotly 
debated (Aguilera et al., 2013). Multiple factors drive the obesity epidemic including genetic and 
environmental contributions such as increased food availability, high fat diet, physical inactivity (Tsai 
et al., 2009; Dibaise et al., 2008; Martin et al., 2010) and early feeding environment during pre and 
post-natal period (Bervoets et al., 2013). Epidemiological evidence (Bervoets et al., 2013; Karlsson 
et al., 2012; Ismail et al., 2011; Kalliomaki et al., 2008) suggests that the constant increase in obesity 
can’t be fully accounted for by genetic, food availability and behavioral change alone. There is 
increasing evidence that our gut microbiota plays a critical role in energy balance and metabolism, 
suggesting that it can be considered a major factor in the development of obesity (Tsai et al., 2009; 
Dibaise et al., 2008). 
One of the most cited microbiota related factors differentiating obese and healthy individuals has 
been the shift in the proportion of gut bacterial communities belonging to the Firmicutes and 
Bacteroidetes phyla, which together comprise about 90 % of the microbiota of the adult gut. However, 
subsequent studies have shown discrepancies in the proportion of Bacteroidetes/Firmicutes and its 
relation to obesity and it is likely that the influence of the gut microbiota on obesity is much more 
complex than simply an imbalance in the proportion and or interaction of these phyla (John and 
Mullin, 2016; Riva et al., 2016).  
Analysis of >5000 16S rRNA sequences revealed that genetically obese mice (ob/ob, characterized 
by a mutation in the leptin gene) had a 50% reduction in the abundance of Bacteroidetes, and a 
correspondent increase in the proportion of Firmicutes, compared with lean (ob/+ and Ob+/Ob+) 
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mice. Moreover, the obesity-associated microbiome harbored a substantial increase in genes encoding 
enzymes involved in the breakdown of dietary polysaccharides and SCFAs metabolism. Accordingly, 
these mice had a significantly higher cecal concentrations of SCFAs and a lower fecal energy losses 
than conventional animals, highlighting the increased capacity of the obese microbiome for energy 
extraction from the diet (Ramakrishna et al., 2013; Zoetendal et al., 2004). Furthemore, Bäckhed et 
al found that the germ free mice (GF) had about 40% less total body fat than mice with a normal gut 
microbiota, even though the latter ate 30% less diet than did the GF mice. To get more insight into 
these findings, the authors conventionalized GF mice with a normal gut microbiota harvested from 
the cecum of a “normal” mouse, and found that this conventionalization produced a 60% increase in 
body fat content and insulin resistance within 2 weeks, despite a significant lower food intake. The  
mechanisms of the apparent weight gain implied an increase in the intestinal glucose absorption 
energy extraction from non-digestible food component, and concomitant higher glycemia and 
insulinemia, two key metabolic factors regulating lipogenesis (Bäckhed et al., 2004). 
Human association studies in different parts of the world confirm that there are alterations in the gut 
microbiota in obese compared with lean individuals. Faecalibacterium prausnitzii was increased in 
the fecal microbiota of obese children in southern India that used real-time polymerase chain reaction 
to quantitate specific bacterial groups (Balamurugan et al., 2010). Increases in Lactobacillus spp. 
associated with reduction in Bacteroidetes spp. were reported in obese adults in France (Armougom 
et al., 2009). On the other hand, obese preschool children in Sweden had increased 
Enterobacteriaceae, and reduced Desulfovibrio spp. and Akkermansia spp. compared with their 
healthy counterparts (Karlsson et al., 2012). Interestingly, it is also reported that gut of obese people 
is greatly inhabited with H2-oxidizing methanogenic Archaea. It is supposed that these 
microorganisms oxidize H2 produced by H2-producing bacteria from Prevotellaceae family. Rapid 
H2-utilization accelerates fermentation of polysaccharides by Prevotellaceae and consequently 
results in the more considerable energy uptake by obese individuals (Zhang et al., 2008).  
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Figure 2.1. Age-standardised prevalence of overweight and obesity based on the International Obesity Task Force (IOTF) 
cutoffs. Data are shown based on age (2−19 years), sex, years (1980−2013) and countries (developing and developed 
countries) (Ng et al., 2014).  
 
 
Figure 2.2. Overweight and obese (%) children from 8 to 9 years old divided by Italian regions. Report 2014 Istituto 
Superiore di Sanità http://www.epicentro.iss.it/okkioallasalute/default.asp.  
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2.2 Mechanism linking altered gut microbiota to 
obesity 
2.2.1 Fasting-induced adipose factor (FIAF) and AMP-activated protein kinase (AMPK) 
One of the key mechanisms by which GF animals are protected from diet-induced obesity is elevated 
levels of fasting-induced adipose factor (FIAF). FIAF is a circulating lipoprotein lipase (Lpl) inhibitor 
produced by the intestine, liver and adipose tissue. Conventionalization of GF mice suppresses 
expression of Fiaf in the gut epithelial cells. This leads to a higher adipocyte Lpl activity and results 
in increased cellular uptake of fatty acids, adipocyte triglyceride accumulation and greater fat storage 
(Kobyliak et al., 2015). GF Fiaf–/– mice fed a high-fat high-carbohydrate diet were not protected 
from diet induced obesity, suggesting that FIAF is a mediator of microbial regulation of energy 
storage (Bäckhed et al., 2007). Backhed and colleagues have also demonstrated that GF mice exhibit 
increased levels of phosphorylated AMPK in muscle and liver. AMPK is a key enzyme that controls 
cellular energy status, which in turn activates key enzymes of mitochondrial fatty acid oxidation, 
including acetyl-CoA carboxylase and carnitine-palmitoyltransferase I. This enzyme activation is 
indicative of increased energy expenditure. The exact pathway through which the microbiota signals 
to liver and skeletal muscle AMPK is unclear, but appears to be independent from FIAF (Bäckhed et 
al., 2007) (Figure 2.3).  
 
2.2.2 Activity of short chain fatty acids and monosaccharides  
The gut microbiota that digests complex dietary carbohydrates produces many monosaccharides and 
short chain fatty acids (SCFAs), important energy source and nutrition of the intestinal epithelium 
(Kobyliak et al., 2015). Conventionalization of GF mice doubles the density of small intestinal villi 
capillaries (Stappenbeck et al., 2002), and enhances an uptake of SCFAs from the gut into the portal 
blood and eventually participates in hepatic de novo lipogenesis promoting fat accumulation in the 
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liver and adipose tissue. This reaction is controlled by carbohydrate responsive element binding 
protein (ChREBP) and sterol responsive element binding protein (SREBP-1). Furthermore, 
monosaccharides that are produced by microbial fermentation and absorbed and transferred to the 
liver via portal vein, activate ChREBP, which increases the transcription of several proteins involved 
in hepatic de novo lipogenesis (Kobyliak et al., 2015).  
SCFAs act in the gut as signaling molecules and are specific ligands for at least two G protein-coupled 
receptors, GPR41 and GPR43, mainly expressed in intestinal epithelial cells (Kobyliak et al., 2015). 
Samuel et al. have demonstrated that conventionally raised Gpr41–/– mice and GF Gpr41–/– mice 
colonized with only Bacteroides thetaiotaomicron and Methanobrevibacter smithii are significantly 
leaner than wild-type littermates. Gpr41-deficiency is associated with reduced expression of peptide 
YY (PYY), an enteroen-docrine cell-derived hormone that normally inhibits gut motility, increased 
intestinal transit rate, and reduced harvest of energy (short-chain fatty acids) from the diet. These 
results reveal that Gpr41 is a regulator of host energy balance through effects that are dependent upon 
the gut microbiota (Samuel et al., 2008) (Figure 2.3).  
 
 
Figure 2.3. Mechanism linking altered gut microbiota to obesity (Kobyliak et al., 2015).  
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2.2.3 Increased permeability of the gut barrier 
Another mechanism may include the permeability of the intestinal wall. A high-fat diet can alter the 
composition of the intestinal microbiota and this modification may lead to an increased permeability 
of the gut barrier by an altered distribution of some tight junction proteins (ZO-1 and occludin). This 
modification of the wall permeability may also lead to an increase in certain molecules in plasma 
such as lipopolysaccharide (LPS), resulting in metabolic endotoxemia. The LPS can bind to 
TLR4/CD14 (toll-like receptor-4/cluster of differentiation-14) receptors that are responsible for 
signaling cascades. These signaling cascades lead to the production of proinflammatory cytokines, 
particularly tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6), which are involved in the 
development of atherosclerosis, obesity and insulin resistance (Sanchez et al., 2015).  
 
2.2.4 Control of food intake and appetite 
It has been suggested that gut microbiota may also affect food intake and satiety via gut peptide 
signalling. Gastro-intestinal hormones such as glucagon-like peptide-1 (GLP-1), PYY, 
cholecystokinin (CCK) and ghrelin play a critical role in relaying signals of nutritional and energy 
status from the gut to the central nervous system in order to control food intake and glycemic 
regulation (Sanchez et al., 2015).  
Experimental studies have shown that GLP-1 is upregulated by prebiotics in obese mice suggesting 
that alterations in intestinal microbiota may stimulate or suppress the secretion of gastro-intestinal 
hormones (Cani et al., 2004; Cani et al., 2009).  
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2.3 Interventional strategies in childhood obesity  
At the moment, the most important strategies to manage childhood obesity are therapeutic lifestyle 
changes, such as changing dietary habits and the physical activity level (Bervoets et al., 2013). 
Dietary factors are based on limited consumption of sugar-sweetened beverages and meals with 
servings of vegetable and fruits, avoiding fast foods, and encouraging limited portions of food. 
Physical activity is based on levels of activity from moderate to vigorous for one or more hours/day. 
Sedentary activity should be limited to less than 2 h/day after age two (Magrone and Jirillo, 2015).  
When lifestyle modifications continue to fail, pharmacological interventions and possibly bariatric 
surgery could be considered (Bervoets et al., 2013). Future treatments for obesity may be possible 
through the modulation of gut microbiota using antibiotics, probiotics, prebiotics, and possibly even 
microbiota transplants (Tsai et al., 2009). 
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2.4 Aim of the project 
“The gut microbiota in obese and normal-weight 
children” 
 
Childhood obesity is one of the mayor public health problem. Prevention and management of obesity 
is proposed to begin in childhood when environmental factors exert a long-term effect on the risk for 
obesity in adulthood (Sanchez et al., 2015). It is generally believed that the gut microbiota is 
established during the first 3 years of life but data are scarce regarding its development during 
childhood. Although it has been suggested that the microbiota reaches a relatively stable adult-like 
state in the first three years of life, other evidence indicates that it continues to develop through 
adolescence (Hollister et al., 2015). As such, childhood may provide unique opportunities for 
microbiota interventions to promote health or prevent disease. It is therefore vital to establish a 
baseline understanding of pediatric gut microbiota structure and function, as during this period the 
gastro-intestinal tract undergoes a transition from an immature to a mature state (Hollister et al., 
2015).  
The goal of the present study was to characterize the composition of the gut microbiota in obese and 
normal-weight children. We firstly performed a preliminary analysis on 61 patients from the same 
geographic area to reduce variation unrelated to obesity using DGGE (denaturing gradient gel 
electrophoresis) and Real-time PCR in order to quantify specific target bacteria. We evaluated the 
gut microbiota biodiversity, both bacterial and fungal, in obese and normal-weight school-aged 
children. We choose a wide pediatric age from 6 to 16 years old as most of the studies on gut 
microbiota in children were performed in the first 3 years of life. After a first evaluation that a 
microbial differences existed between obese and normal-weight, we enlarged the cohort and we 
studied the gut microbiota composition by using 16S rRNA gene-targeted sequencing. We further 
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compared the gut microbiota profiles with BMI z-scores and short chain fatty acids (SCFAs) the main 
fermentative metabolites produced by bacteria, to gain insights into the structure and activity of the 
microbiota in pediatric obesity.  
We present a detailed analysis of the alterations of the gut microbiota and changes in correlation 
network structure linked to childhood obesity. 
 
 
2.4.1 EXPERIMETAL DESIGN: 
 
 
 
 
 
 
 
Figure 2.4. Experimental and project design. First experimental approach by using DGGE and qPCR tecniques. In the 
second part of the project the numbers of participants were increased and 16S gene target-sequencing and SCFAs 
quantification were performed to analyze the gut microbiota composition and the microbial fermentation activity.  
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Relative Abundance in Bacterial
and Fungal Gut Microbes in Obese Children:
A Case Control Study
Francesca Borgo, PhD,1 Elvira Verduci, MD,2 Alessandra Riva, MSc,1 Carlotta Lassandro, MSc,1
Enrica Riva, MD,2 Giulia Morace, PhD,1 and Elisa Borghi, PhD1
Abstract
Background: Differences in relative proportions of gut microbial communities in adults have been correlated with intestinal
diseases and obesity. In this study we evaluated the gut microbiota biodiversity, both bacterial and fungal, in obese and normal-
weight school-aged children.
Methods: We studied 28 obese (mean age 10.03 – 0.68) and 33 age- and sex-matched normal-weight children. BMI z-scores were
calculated, and the obesity condition was defined according to the WHO criteria. Fecal samples were analyzed by 16S rRNA
amplification followed by denaturing gradient gel electrophoresis (DGGE) analysis and sequencing. Real-time polymerase chain
reaction (PCR) was performed to quantify the most representative microbial species and genera.
Results: DGGE profiles showed high bacterial biodiversity without significant correlations with BMI z-score groups. Compared to
bacterial profiles, we observed lower richness in yeast species. Sequence of the most representative bands gave back Eubacterium
rectale, Saccharomyces cerevisiae, Candida albicans, and C. glabrata as present in all samples. Debaryomyces hansenii was present
only in two obese children. Obese children revealed a significantly lower abundance in Akkermansia muciniphyla, Faecalibacterium
prausnitzii, Bacteroides/Prevotella group, Candida spp., and Saccharomyces spp. (P = 0.031, P = 0.044, P = 0.003, P = 0.047, and
P = 0.034, respectively).
Conclusion: Taking into account the complexity of obesity, our data suggest that differences in relative abundance of some core
microbial species, preexisting or diet driven, could actively be part of its etiology. This study improved our knowledge about the
fungal population in the pediatric school-age population and highlighted the need to consider the influence of cross-kingdom
relationships.
Introduction
O
ver the last decade, the microbial composition of
the gut has been widely investigated, and recog-
nized as having an impact in various physiological
and pathological conditions.1 The Human Microbiome
Project2 and Metagenomics of the Human Intestinal Tract
(MetaHIT) (www.metahit.eu/) project clearly demon-
strated that gut microorganisms are not just passive resi-
dents, carrying out a range of biological functions that are
important in nutrition and well-being of the individual.
Molecular analyses revealed the presence of more than
1000 microbial species and highlighted the deep diversity
within human gastrointestinal (GI) tracts.3 However, these
species belong to only 8 of the 55 known bacterial phyla,
with the Firmicutes (low-GCC gram-positives), Bacter-
oidetes, and Actinobacteria (high-GCC gram-positives)
being the most widely represented.4
Moreover, the human microbiota is more complex than a
bacterial community. It also involves Archeabacteria and
fungi.5 Very few studies encompass the fungal gut popu-
lation, and even fewer in the pediatric population. Thus,
the exact role of colonizing fungi has not been fully ex-
plored. Coexistence of cross-kingdom communities within
the human gut could affect the final relationship with the
host. The most representative genera are Candida and
Saccharomyces.6
The composition and activity of the gut microbiota co-
develop with the host from birth and is subjected to a
complex interplay that depends on the host genome,
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nutrition, and lifestyle. The gut microbiota in relation to
pediatric metabolic disorders has been poorly studied, al-
though in recent years has emerged as a significant factor
involved in obesity, even if no causal relationship has been
established.7
Turnbaugh et al.8 reported that adult obesity is associated
with microbial compositional changes at the phylum level.
They found that individuals with high BMIs had a lower
proportion of Bacteroidetes and a higher proportion of
Actinobacteria when compared to leaner individuals.
However, a number of studies have failed to confirm this
association or reported the opposite association.9,10 Karls-
son et al.11 investigated the gut microbial biodiversity in
preschool children with normal and excessive body weight;
they found in the overweight group a significant reduction
of Akkermansia muciniphyla and Desulfovibrio spp., to-
gether with an increase of Enterobacteriaceae.
In our study we aimed at evaluating, both qualitatively
and quantitatively, gut microbiota biodiversity in obese
and normal-weight children aged 8–12 years. Prevention
and treatment of childhood obesity involve mainly school-
aged children, and additional research needs to be done on
such a cohort in order to understand the critical window of
a child’s life in which environmental factors such as diet
and microbiota can be shaped to promote health.
Methods
Subjects and Sample Collection
This observational case control study included 28 obese
children (15 females and 13males), mean age 10.03 (standard
deviation [SD] 0.68), among patients consecutively admitted
to the pediatric department of the San Paolo Hospital, Milan,
Italy, betweenDecember2013andSeptember 2014 inorder to
evaluate obesity-related metabolic profile, and 33 sex- and
age-matched normal-weight children. Inclusion criteria were
children living in north Italy born fromCaucasian parentswith
birthweight ‡2500 grams, gestational age 37–42 weeks, sin-
gleton birth, no neonatal disease or congenital malformation.
Exclusion criteria were having chronic or acute intestinal
diseases and treatmentswith antibiotic and probiotic/prebiotic
in the previousmonth, obesity-related comorbidity conditions
(e.g., insulin resistance, nonalcoholic fatty liver disease).
Data were collected for all subjects concerning mode of
delivery and exclusively breastfeeding or formula feeding.
Weight (kg), height (cm), and BMI (kg/m2) were trans-
formed to age- (in days) and sex-specific z scores ac-
cording to WHO growth standards.12,13 Obesity was
defined by using WHO criteria.14 Fasting blood samples
were analyzed for insulin and glucose. Insulin resistance
was estimated by homeostatic model assessment (HOMA)
and defined as HOMA >3.16 according to the most recent
cut-off for the pediatric population.15 Abdominal ultraso-
nography (US) was performed according to a randomized
sequence to evaluate liver echogenicity.
A fresh fecal sample was self-collected at home by each
enrolled subject and stored immediately at -20°C. The
collection took place in the same week as the dietary
record. Subsequently, the fecal samples were transported
to the laboratory and stored at -20°C until further anal-
ysis. The dietary habits of the children were assessed at
recruitment by means of an age-adjusted food frequency
questionnaire made up of 116 items.16
DNA Extraction and 16S Ribosomal
(rRNA Bacteria) and ITS Ribosomal
(Fungi) DNA Amplification
Total microbial DNA extraction was performed with the
Spin Stool DNA Plus Kit (Stratec Molecular, Berlin, Ger-
many) according to manufacturer instruction, using 200mg
aliquot of wet feces. The V2-V3 region of the gene that
encodes for 16S rRNA was amplified using the following
primers: HDA1-GC (50-CGC CCG GGG CGC GCC CCG
GGC GGGGCGGGGGCACGGGGG G-ACT CCT ACG
GGA GGC AGCAGT-03) and HDA2 (50-GTA TTA CCG
CGGCTGCTGGCAC-03). Primers were used in a reaction
mix (Thermo Scientific Dream Taq Master Mix) at a final
concentration of 0.5lM. The amplification cycles were as
follow: initial denaturation at 94°C for 5 minutes, followed
by 35 cycles at 94°C for 1 minute, 56°C for 1 minute, 68°C
for 1 minute, and a final extension at 68°C for 7 minutes.17
Polymerase chain reaction (PCR) products (220 bp) were
visualized on a 1.5% agarose gel and subsequently subjected
to denaturing gradient gel electrophoresis (DGGE) analysis.
For fungi, the 5.8S ITS rDNA region was amplified by
means of a nested-PCR approach using the primers ITS1 (50-
TCC GTAGGTGAACCTGCGG-30), ITS4 (50-TCC TCC
GCT TAT TGA TAT GC-30), NL1 with a GC clamp (50-
CGC CCG CCG CGC GCG GCG GGC GGG GCG GGG
GCA TAT CAA TAA GCG GAG GAA AAG-30), and LS2
(50-ATT CCC AAA CAA CTC GAC TC-30). Amplification
cycles were as follows: initial denaturation at 94°C for
3 minutes and 35 cycles of 94°C for 30 seconds, 52°C for
30 seconds, and 74°C for 2 minutes followed by 74°C for 10
minutes.18 PCR products were separated by gel electro-
phoresis on a 1.0% (wt/vol) agarose gel, detected by ethi-
dium bromide staining, and subsequently subjected to
DGGE analysis.
Denaturing Gradient Gel Electrophoresis Analysis
DGGE was performed using a PhorU system (Ingeny
International, Goes, The Netherlands) in 1X tris-acetate-
EDTA (TAE) buffer at 60°C. PCR products were loaded
onto 8% polyacrylamide gels in 1X TAE. The electropho-
retic conditions were the following: 18 hours at 90V in a
40%–60% denaturating agent gradient. The gels were
stained in 1X TAE buffer with SYBR Green I nucleic acid
stain (Roche Products Ltd., Welwyn Garden City, UK) for
30 minutes and visualized by UV radiation. Banding pat-
terns of DGGE profiles were analyzed with Fingerprinting II
software (Bio-Rad Laboratories, Hercules, CA), using the
Pearson product moment correlation coefficient and the
unweighted-pair group method with averages (UPGMA) for
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the generation of dendrograms. Pearson coefficient is a
measure of the degree of similarity. Two identical profiles
create a similarity value of 100%, whereas completely dif-
ferent profiles result in a similarity value of 0%.8
Excision and Sequence Analysis of Products
Individual bands were cut out from the gel, placed in 50ll
sterile distilled water, and incubated overnight at 4°C. Two
microliters of the eluate were amplified with the original
primer pairs and amplification products checked by agarose
gel electrophoresis. PCR products were purified using the
NucleoSpin Extract II kit (Macherey-Nagel GmbH, Du¨ren,
Germany) and subjected to Sanger sequencing (Eurofins
Biolab S.r.l., Milan, Italy). The sequences were compared
with those available in the National Center for Biotechnol-
ogy Information (NCBI) GenBank (www.ncbi.nlm.nih.gov/
) and those in the Ribosomal Database Project (RDP) using
the Sequence Map tool (rdp.cme.msu.edu/).
Quantification by Real-Time Polymerase
Chain Reaction
Absolute quantification by real-time PCR was per-
formed using the following control strains: Escherichia
coli American Type Culture Collection (ATCC) 25922T,
Akkermansia muciniphyla DSM 22959T, Candida albi-
cans ATCC 90028T, Deutsche Sammlung von Mikroor-
ganismen und Zellkulturen; Bacteroides uniformis,
Lactobacillus reuteri, Bifidobacterium animalis, Faeca-
libacterium prausnitzii, and Saccharomyces cerevisiae
(from the Clinical Microbiology Laboratory collection,
Health Sciences Department, Universita` degli Studi di
Milano). Firstly, the microbial DNA was extracted for
each control strain using Prepman Ultra (Applied Bio-
systems, Foster City, CA). Real-time PCR was carried out
using the StepOne instrument (Applied Biosystems) and
SYBRÒ Green chemistry (Thermo Scientific, Waltham,
MA). The analysis was performed in a total volume of
15 ll and each sample analyzed in triplicate. Standard
curve was carried out for each qPCR run using five serial
dilutions of control DNA. The specific 16S rRNA primers
and qPCR conditions used for Bacteroides/Prevotella
group, Bifidobacterium spp., Enterobacteriaceae group,
and F. prausnitzii are reported by Bartosch et al.;16 for
Lactobacillus spp. and A. muciniphyla we used the con-
ditions designed by Delroisse et al.17 and Collado et al.20
The specific yeast quantification was carried out for
Candida spp. and Saccharomyces spp. as described by
Hierro et al.21 and Zott et al.,22 respectively.
Data Analysis
Statistical analysis has been performed using Graph Pad
Prism (Graph Pad Software, La Jolla, CA) statistical soft-
ware. Variables have been expressed as mean and standard
deviation. Mean values were compared among subjects us-
ing the Whitney U test, and ANOVA was used to compare
variables between all groups. A probability value (P value)
less than 0.05 was considered statistically significant.
Results
Cohort Composition
Twenty-eight children were included in the obese (O)
group and 33 in the control normal-weight (N) group. BMI
z-scores were 2.9 (SD 0.66) and 0.29 (SD 0.79), respectively
(P< 0.001). Eighty percent of normal-weight and 54% of
obese children were born by vaginal delivery; furthermore,
50% of N and 53% of O were exclusively breastfed. Com-
pared to normal-weight children, obese children showed
higher dietary intakes of energy—1906 (SD 474) Kcal vs.
2593 (SD 989) Kcal, P=0.0007; proteins, 64 (SD 13) grams
vs. 97 (SD 31) grams, P < 0.0001; carbohydrates 271 (SD 55)
grams vs. 368 (SD 137) grams, P=0.0004; total fats 58
(SD15) grams vs. 92 (SD37) grams,P<0.0001; saturated fats
19 (SD 6) grams vs. 31.5 (SD 11) grams, P < 0.0001; mono-
unsaturated fats 20 (SD 6) grams vs. 31 (SD 11) grams, P <
0.0001; and polyunsaturated fats 7 (SD 3.5) grams vs. 13
(SD 7) grams, P < 0.0001.
Gut Microbial Ecosystem
The DGGE analysis of the gut bacterial population in-
dicated a high degree of individual variation in the intes-
tinal microbial community profiles obtained by using
universal 16S rRNA primers (Figure 1a), while the DGGE
patterns obtained for the yeast population contained a
relatively low number of bands and had low interindividual
variability (Figure 1b).
Figure 1a shows an example of the unweighted pair group
method with arithmetic mean (UPGMA) dendrogram ob-
tained for the children’s microbiota. Two main clusters
(50% similarity) are reported; one is represented by a sole
severely obese child and the other group included four
subclusters without significant differences among BMI z-
score groups. The most representative bands—13 individual
bands, identified from A to P (Figure 1a)—were excised
from DGGE gel and subjected to sequencing. The respec-
tive bacterial species are indicated in Table 1. A similarity
rate ‡90% was considered significant. In particular, se-
quencing of excised bands revealed that band F/G (Eu-
bacterium rectale) was present in all children, while band H
(F. prausnitzii) were absent in two severely obese children.
The UPGMA dendrogram obtained for the fungal gut pop-
ulation revealed two main clusters (37% similarity), one
represented by the sole severely obese child and the second
composed by two subclusters without significant differences
among BMI z-score groups (Figure 1b). The sequencing of
fungal gut population DGGE excised bands, reported in
Table 1, revealed that the bands relative to Saccharomyces
cerevisiae, Candida albicans, and Candida glabrata were
present in all samples, whereas bands 7 and 11 (Debar-
yomyces hansenii) were present only in two obese children.
Microbial Genome Quantification by Real-Time
Polymerase Chain Reaction
Quantification of the bacterial and yeast groups using real-
time PCR was performed on N and O distinct populations
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(Figure 2). We did not observe differences in the Bifido-
bacterium spp. (P= 0.606), Lactobacillus spp. (P= 0.420),
and Enterobacteriaceae (P= 0.168), whereas A. mucini-
phyla,F. prausnitzii, andBacteroides/Prevotella groupwere
significantly less abundant in obese children (P= 0.031,
P= 0.044, and P= 0.003, respectively). The average copy
number of the yeasts was higher in the normal-weight pop-
ulation compared to the obese population, with a significant
P value forCandida spp. (P= 0.047) and for Saccharomyces
spp. (P= 0.034). No significant differences in microbiota
Figure 1. Representative cluster analysis of DGGE profiles in obese and normal-weight children (panels A and B). Panel A: bacterial
population; panel B: fungal population. O = obese; N =normal weight.
Table 1. Sequenced DGGE bands and relative species identification
B
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s
Band letters Nearest species Similarity Accession number
A Parabacteroides distasonis 92% NR 074376
B Alistipes putredinis. 98% NR 113152
C Clostridium parabutiricum 98% NR 11903
D Paraprevotella clara 96% NR 113073
E Flavonifractor plautii 94% NR 452852
F/G Eubacterium rectale 100% NR 074634
H Faecalibacterium prausnitzii 97% NR 043680
L Clostridium aldenense 100% NR 043680
M Clostridium spp. 97% NR 029355
N/O Gemmiger formicilis 93% NR 104846
P Flavobacterium spp. 96% NR 108535
F
u
n
g
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ec
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s
1/2/4/5/6/13 Saccharomyces cerevisiae 100% KM103045
10 Candida albicans 99% AM998790
3 Candida parapsilosis 99% EF568035
7/11 Debaryomyces hansenii 98% KF214434.1
8/9/11 Candida glabrata 99% AF336837
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composition were observed comparing different types of
delivery: Bifidobacterium spp. (P= 0.868), Lactobacillus
spp. (P= 0.908), Enterobacteriaceae (P= 0.959), A. muci-
niphyla (P= 0.800), F. prausnitzii, (P= 0.389), Bacteroides/
Prevotella group (P= 0.070), Candida spp. (P= 1), and
Saccharomyces spp. (P= 0.959).
The lack of significant differences was also observed
comparing breast and formula feeding: Bifidobacterium
spp. (P = 0.228), Lactobacillus spp. (P= 0.354) and En-
terobacteriaceae (P = 0.102), A. muciniphyla (P = 0.384),
F. prausnitzii (P = 0.612), Bacteroides/Prevotella group
(P = 0.236), Candida spp. (P= 0.658), and Saccharomyces
spp. (P = 0.684).
Discussion
Key activities of the gut microbiota are the efficient
extraction of calories from ingested food and the regulation
of fat storage by modulation of lipoprotein lipase activity
and subsequent triglyceride storage. The diet could induce
strong modifications of the gut microbiota composition,
and indeed, obese people have been reported to have lower
bacterial diversity in the gastrointestinal tract compared to
lean subjects.23 Modifications in the proportions of mi-
croorganisms in the gut and, consequently, in the con-
centrations of metabolites produced and released by them
in the lumen, have been suggested to play a role in the
development of several pathological conditions24 such as
metabolic disorders.
In this study we evaluated, both qualitatively and
quantitatively, the gut microbiota biodiversity in obese and
normal-weight children. The combined use of two meth-
ods—DGGE (qualitative) and real-time (quantitative)—
allows for a good evaluation of microbial ecology profile in
the two studied populations. The DGGE profiles of total
bacterial population demonstrated high interindividual
heterogeneity in the microbial species. We failed to find
common pattern strongly associated to high BMI z-score,
even though a lower microbial biodiversity was high-
lighted in subjects with severe obesity.
The presence of interindividual differences is well reported
in the literature, although the presence has been demonstrated
of a core of microbiota, relatively stable and resilient,25 that
depends on the age, health, diet, and even geographical lo-
cation of the individuals. To rule out differences related to the
above conditions, our cohort was selected to minimize dif-
ferences related to age and geographical location. Both
groups of children had a ‘‘Western-style’’ diet, high in fat and
refined sugars. The quantification of the common genera that
are part of the core microbiota showed no significant differ-
ences in the number of genomes of Lactobacillus spp., Bifi-
dobacterium spp., and Enterobacteriaceae.
It is well known from the literature that the significant
less abundance of A. muciniphyla is related with an ex-
cessive weight in adult and preschool children.11,26 In this
study we corroborate this finding in school-aged children.
A. muciniphyla is a mucin-degrading bacterium (phylum
Verrucomicrobia) and the dominant colonizer of the in-
testinal mucus layer.27 In the mouse, a high-fat diet in-
duced increased body mass, endotoxemia, adiposity,
fasting hyperglycemia, and insulin resistance, while all of
the above were reversed with the administration of A.
muciniphyla.26 In addition, A. muciniphyla increases the
expression of acylglycerols, important compounds in gut
barrier integrity, and reverses the thinning of the mucus
layer caused by a high-fat diet.
In addition, we found in obese children a reduction of F.
prausnitzii. Different authors suggested that a lower pres-
ence of F. prausnitzii could result from a long-standing
inflammation.28 F. prausnitzii appears to have significant
anti-inflammatory activity with decreased production of
proinflammatory cytokines (IL-8, IL-12, and IFN-c) and
increased production of anti-inflammatory IL-10 in cell
cultures.29 Studies in germ-free mice suggest that F.
prausnitzii in conjunction with another common commen-
sal, Bacteroides thetaiotaomicron, plays a role in goblet
Figure 2. Box and whisker plots to compare relative abundance of microbial species in obese and normal-weight children. The box plot
representation shows the median (designated by a line) and the 25th and 75th percentiles. Significant values (P-values) between the two
groups are displayed on the plots. *P < 0.05; **P< 0.01. O = obese; N = normal weight.
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cells differentiation and in the production of the mucus
layer.30An intact mucus layer is an important component of
the intestinal barrier that limits exposure of the epithelial
monolayer to proinflammatory bacteria in the gut lumen.
Concerning the Bacteroides/Prevotella group, we found a
lower abundance of this microbial group in obese subjects.
This data is in agreement with other authors reporting in the
obese adult population a variation of the Firmicutes/Bac-
teroides ratio, with an increase in Firmicutes.7–8,31
In order to obtain a complete picture of the studied cohort,
the fungal microbiota has been investigated. DGGE profiles
of fungal population showed a lower biodiversity, expressed
by a lower bands number, compared with bacteria profiles,
without significant differences between normal-weight and
obese children. However, we have to consider that the
overall fungal population is underrepresented compared to
the bacterial one, and the DGGE technique may in turn
underestimate some species that are quantitatively poorly
present. At this time, our knowledge on commensal fungi
inhabiting the gut of children is incomplete. Nonetheless,
the few literature data on adult population are in agreement
with our results on Ascomycota as the most detected phy-
lum. Indeed,C. albicans,C. glabrata, and S. cerevisiaewere
the most representative species in both groups. Debar-
yomyces hansenii, sequenced from two excised bands, was
found only in two obese children; this species in closely
related to food, in particular to cheeses and dry-cured meat
products. Future studies are needed to better understand if
the presence of D. hansenii is due to the ingestion of yeast-
containing foods or if this species might contribute to obe-
sity pathology.
However, we found significant differences in the two
groups in terms of abundance. Normal-weight group was
characterized by a higher number of genomes of Candida
spp. and of Saccharomyces spp. Hoffmann and cowork-
ers32 analyzed the influence of diet on fungal and bacterial
levels in the gastrointestinal tract. Candida spp. was pos-
itively correlated with carbohydrate consumption and
negatively correlated with total saturated fatty acids, but no
correlation was observed for Saccharomyces spp. with
both diets. Moreover, Candida species are well-known
human commensals, whereas for the Saccharomyces spe-
cies we cannot rule out if they are transiently present be-
cause of diet (bread, pizza) or true commensals.
The influence of trans-kingdom relationships and diet on
the coexistence of the microbial communities within the
human gut has not yet been defined. One possible scenario
could be the role of Candida spp. in breaking down starch
in carbohydrate foods, leading to the release of simple
sugars, which are in turn fermented by bacteria (for ex-
ample, Prevotella and Ruminococcus).
One limitation of the present study is that Archaebacteria
are not included in the analysis of the gut microbial ecology,
although their contribution to obesity is still debated. Animal
studies suggested a potential role for methanogens Archaea,
mainly Methanobrevibacter smithii, in promoting obesi-
ty.33,34 Literature data on humans, however, are inconsistent,
with some authors reporting a negative association with
BMI35,36 and others reporting a positive association.37,38
Further studies, especially on obese children, would be
useful in elucidating their role.
In conclusion, taking into account the complexity of
obesity, our data suggest that changes of some core mi-
crobial species, preexisting or diet induced, could actively
be part of the syndrome’s etiology. Obese children are
highly prone to become obese adults, and in order to fight
obesity-related complications, prevention and prompt
treatment are crucial. The most important strategies to
manage childhood obesity are therapeutic lifestyle chan-
ges, but the failure rate of such interventions is still high.
The microbiota analysis of obese children could provide
new elements of the puzzle to pave the way for designing
customized diets and improve the current strategies.
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Summary
An altered gut microbiota has been linked to obesi-
ty in adulthood, although little is known about
childhood obesity. The aim of this study was to
characterize the composition of the gut microbiota
in obese (n5 42) and normal-weight (n536) chil-
dren aged 6 to 16. Using 16S rRNA gene-targeted
sequencing, we evaluated taxa with differential
abundance according to age- and sex-normalized
body mass index (BMI z-score). Obesity was asso-
ciated with an altered gut microbiota characterized
by elevated levels of Firmicutes and depleted levels
of Bacteroidetes. Correlation network analysis
revealed that the gut microbiota of obese children
also had increased correlation density and cluster-
ing of operational taxonomic units (OTUs).
Members of the Bacteroidetes were generally better
predictors of BMI z-score and obesity than Firmi-
cutes, which was likely due to discordant
responses of Firmicutes OTUs. In accordance with
these observations, the main metabolites produced
by gut bacteria, short chain fatty acids (SCFAs),
were higher in obese children, suggesting elevated
substrate utilisation. Multiple taxa were correlated
with SCFA levels, reinforcing the tight link between
the microbiota, SCFAs and obesity. Our results
suggest that gut microbiota dysbiosis and elevated
fermentation activity may be involved in the etiolo-
gy of childhood obesity.
Introduction
The gut microbiota is involved in the regulation of multiple
host pathways and participates in metabolic and immune-
inflammatory axes connecting the gut with the liver, muscle
and brain. The gut microbiota co-develops with its host
from birth and is subjected to a complex interplay that is
influenced by host genome, nutrition and lifestyle
(Nicholson et al., 2012). Diet can have a particularly
marked impact on the gut environment, affecting factors
such as gut transit time and pH. In particular, alterations in
the intake of carbohydrates, proteins and fats can signifi-
cantly affect the composition of the microbiota (Scott et al.,
2013). One of the main activities of the gut microbiota is to
break down substrates such as resistant starch and dietary
fiber, which are incompletely hydrolysed by host enzymes
in the small intestine. The main fermentation products
resulting from fiber breakdown are the short chain fatty
acids (SCFAs) acetate, propionate and butyrate, which
play different roles in energy salvage (Schwiertz et al.,
2009). Microbially-derived SCFAs provide an additional
source of energy for the body: propionate is taken up by
the liver and used as a precursor for liponeogenesis, gluco-
neogenesis and protein synthesis; acetate is used as a
substrate for cholesterol synthesis; and butyrate is the
main energy supply for colonic epithelial cells (Kallus et al.,
2012).
The adult human gastrointestinal tract microbiota has
been extensively studied in relation to its role in gut
homeostasis and various diseases (Schwiertz et al.,
2009). Notably, alterations in the gut microbiome and
metabolome have been associated with the development
of obesity (Choquet et al., 2010; Vinolo et al., 2011). Obe-
sity is a multifactorial disease that predisposes to several
comorbidities (Ang et al., 2013) and is considered to be a
global epidemic by the World Health Organisation
(Schwiertz et al., 2009). In recent years, the prevalence of
childhood obesity has increased substantially worldwide,
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and currently 23% of children and adolescents in devel-
oped countries can be classified as overweight or obese
(Ng et al., 2014).
Information regarding the structure and function of the
gut microbiota during childhood is limited. Although it has
been suggested that the microbiota reaches a relatively
stable adult-like state in the first three years of life, other
evidence indicates that it continues to develop through
adolescence (Hollister et al., 2015). As such, childhood
may provide unique opportunities for microbiota interven-
tions to promote health or prevent disease. It is, therefore,
vital to establish a baseline understanding of pediatric gut
microbiota structure and function, as during this period the
gastrointestinal tract undergoes a transition from an imma-
ture to a mature state (Hollister et al., 2015).
The goal of the present study was to characterize the
composition of the gut microbiota in obese and normal-
weight children using 16S rRNA gene-targeted sequenc-
ing. We recruited a large cohort of children from the same
geographic area to reduce variation unrelated to obesity.
We compared gut microbiota profiles with SCFAs and BMI
z-scores to gain insights into the structure and activity of
the microbiota in pediatric obesity.
Results
Pediatric cohort characteristics
A total of 78 children were enrolled at the Pediatric Depart-
ment of San Paolo Hospital, Milan, Italy. Fecal samples
were collected from 36 normal-weight (N) and 42 obese
(O) children (N, BMI z-score: 22.12 to 1.56; O, BMI z-
score: 2.14–5; p<0.0001). Cohort characteristics, includ-
ing age, sex, BMI z-score, mode of delivery in childbirth
and history of breastfeeding or formula feeding as an infant
were considered (Supporting Information Table S1). There
was no significant relationship between history of breast-
feeding or formula feeding as an infant with obese and
normal-weight classification (Chi-square test; p50.610).
Children born by Caesarean section tended to be obese,
although this trend did not reach statistical significance at
the p50.05 level (Chi-square test; p5 0.068). Dietary
habits were also collected and obese children showed
higher dietary intakes of energy and macronutrients (pro-
teins, carbohydrates, sugars and fats) compared to
normal-weight subjects (Supporting Information Table S3).
SCFAs are increased in the stool of obese children
We observed significantly higher concentrations of acetate,
propionate and butyrate, as well as total SCFAs, in the
stool of obese compared to normal-weight subjects
(p< 0.05 for all comparisons; Supporting Information Table
S2). Moreover, we found that the concentration of total
SCFAs was significantly associated with obesity
(p5 0.0317) and was positively correlated with BMI
z-score (p5 0.001).
The intestinal microbiota is altered in obese children
At the phylum level, the predominant bacterial taxa in feces
of both obese and normal-weight subjects were Bacteroi-
detes and Firmicutes, followed by Actinobacteria,
Verrucomicrobia and Proteobacteria (Fig. 1A, Supporting
Information Table S4). The most abundant families were
Ruminococcaceae, Lachnospiraceae, Bacteroidaceae,
Veillonellaceae, Bifidobacteriaceae, Prevotellaceae, Verru-
comicrobiaceae, Rikenellaceae and Christensenellaceae
(Fig. 1B, Supporting Information Table S4). The most
abundant genera were Bacteroides, Subdoligranulum,
Faecalibacterium, Dialister, Bifidobacterium, Pseudobutyri-
vibrio and Blautia (Supporting Information Fig. S1,
Supporting Information Table S4).
The overall composition of the intestinal microbiota, con-
sidered at OTU level as well as taxonomic levels ranging
from genus to phylum, was significantly affected by obesity,
as determined by non-parametric multivariate analysis of
variance testing (perMANOVA; p< 0.05 for all levels). Ordi-
nation showed that samples from normal-weight and
obese children were distinctly grouped (Fig. 1C). This
grouping was confirmed for every taxonomic level by the
analysis of similarity (ANOSIM) test, which evaluates sig-
nificance of sample grouping (p< 0.01 for all levels). The
intestinal microbiota of obese children was enriched in Fir-
micutes (N: 60.96 14.1, O: 72.1612.1; mean6 sd) and
depleted in Bacteroidetes (N: 30612.6, O: 16.66 11.8)
(Supporting Information Table S5). Accordingly, the Firmi-
cutes/Bacteroidetes ratio was significantly elevated in
obese children (p< 0.0001; N: 2.661.83, O: 7.76 7.1)
(Fig. 1D). In agreement with previous observations, the Fir-
micutes/Bacteroidetes ratio for obese children displayed a
much larger range than for normal-weight children, which
may be partially attributable to the wide range of BMI z-
score in the obese group. Consistent with the shifts
observed at phylum level, at the family level Ruminococca-
ceae (N: 33.3611.5, O: 42.56 12.7) was enriched and
Bacteroidaceae (N: 21.46 12.2, O: 106 7.1) was deplet-
ed. At the genus and OTU levels, we observed significant
depletion of Bacteroides (N: 21.46 12.2, O: 10.56 7.1) as
well as Bacteroides OTU 7 (best BLAST hit: Bacteroides
vulgatus with 100% sequence similarity of 422 bp). There
were, however, no significant shifts in members of the
Ruminococcaceae (Supporting Information Table S5).
Gut microbiota richness estimates were not significantly
different between samples from obese and normal-weight
children (Observed species: p50.59; Chao1 estimated
richness: p50.98). Likewise, alpha diversity metrics,
which take into account both community richness and
evenness, were not significantly different between groups
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(Shannon: p5 0.065; inverse Simpson p50.34) (Support-
ing Information Fig. S2). We also found that mode of
delivery and infant feeding were not significantly associat-
ed with microbiota composition at any taxonomic level
(perMANOVA, p>0.05 for all levels). In order to determine
whether the higher proportion of Caesarean deliveries
among the obese group could impact the difference in
microbiota profiles, we grouped the samples according to
delivery mode (vaginal or Caesarean section) and calculat-
ed if there was a difference in the abundance of taxonomic
groups. No significant differences were found at any taxo-
nomic level. Therefore, we conclude that delivery mode did
not significantly influence the composition of the
microbiota.
BMI z-score and SCFAs are associated with intestinal
microbiota composition
Childhood obesity is typically defined using age and sex
normalized BMI (BMI z-score), to classify subjects into
normal-weight and obese. In order to gain a more fine-
grained understanding of the relationship between the
intestinal microbiota and obesity, we evaluated how BMI
z-score was associated with microbiota composition. BMI
z-score and the SCFAs acetate and propionate were sig-
nificantly associated with microbiota composition at every
taxonomic level (OTU to phylum; p< 0.05 at all levels).
Additionally, alpha diversity metrics were largely negatively
correlated with BMI z-score and SCFA levels (Supporting
Fig. 1. Abundant bacterial taxa in stool samples of normal-weight (n536) and obese (n5 42) children.
Phylum-level (A) and family-level (B) taxon profiles are shown. Abundant taxa, defined as having a mean relative abundance of >1%, are
shown.
C. Redundancy analysis ordination of the gut microbiota according to normal-weight (blue) and obese (red) groups.
D. Firmicutes/Bacteroidetes ratio for normal-weight (N) and obese (O) children. The ratio is significantly higher in obese compared to normal-
weight children (p< 0.0001).
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Information Table S6). We performed redundancy analysis
to visualize the relationship between microbiota composi-
tion, BMI z-score and SCFAs (Fig. 2). This analysis
revealed a strong relationship between BMI z-score and
acetate, and to a lesser extent, butyrate levels.
BMI z-score was positively correlated with the abun-
dance of Firmicutes (as well as Ruminococcaceae) and
negatively correlated with Bacteroidetes (as well as Bacter-
oidaceae and Bacteroides) (Table 1). At the OTU level,
Faecalibacterium OTU 3 (Best BLAST hit: Faecalibacte-
rium prausnitzii with 100% seq. similarity over 402 bp) was
positively correlated with BMI z-score, and Bacteroides
OTUs 7 and 49 (Best BLAST hit: Bacteroides stercoris
spp. with 99% seq. similarity over 422 bp) were negatively
correlated with BMI z-score.
The abundances of multiple taxa were also correlated
with levels of major SCFAs. Several genera within the Bac-
teroidetes were negatively correlated with acetate levels,
and multiple genera within the Firmicutes were either posi-
tively or negatively correlated with acetate (Supporting
Information Table S7). At the OTU level, Faecalibacterium
OTU 3 was positively correlated with acetate. Compared to
acetate, the number of correlations was much more limited
for propionate and butyrate. The family Prevotellaceae, the
genus Prevotella as well as Prevotella OTU 26 (Best
BLAST hit: Prevotella copri with 99% seq. similarity over
422 bp) were positively correlated with propionate levels.
The genus Faecalibacterium as well as Faecalibacterium
OTU 3 were positively correlated with butyrate levels.
Comparing models to predict BMI z-score based on
microbiota composition
We next determined the best microbial predictors of BMI z-
score by comparing generalized linear regression models
at different taxonomic levels. This revealed that the total
explanatory power of the models increased at more refined
taxonomic levels (Supporting Information Fig. S3). Bacter-
oides was the main contributor to the genus-level model
(relative importance: 0.172), followed by two genera of the
Ruminococcaceae, Faecalibacterium and Subdoligranu-
lum (rel. imp.: 0.08 and 0.03 respectively). At the OTU-
level, the main contributors to the model were Bacteroides
OTU 7 (rel. imp.: 0.12), Faecalibacterium OTU 3 (rel. imp.:
0.08) and Bacteroides OTU 49 (rel. imp.: 0.07) (Supporting
Information Fig. S3).
The obese gut microbiota has an altered correlation
network structure
We performed a correlation network analysis to evaluate if
obesity was associated with changes in the correlation
structure and putative interaction structure of the gut
microbiota. We found that networks constructed from sam-
ples of normal-weight children had fewer edges, a lower
mean degree and lower transitivity, indicating that there
were fewer significant correlations and less clustering of
OTUs compared to samples from obese children (Fig. 3A
and B; Supporting Information Table S8). The between-
ness centrality was higher in normal-weight sample
networks, which indicates that only a few OTUs are highly
connected in the network.
We next evaluated whether there were differences in
intra-taxon correlations within the families Bacteroidaceae
and Ruminococcaceae. Interestingly, in both networks
Bacteroidaceae OTUs with intra-family correlations were
positively correlated with one another, whereas Rumino-
coccaceae OTUs had both positive and negative intra-
family correlations (Supporting Information Table S8). To
further explore the difference in intra-taxon correlations
between these groups we extracted clusters of correlating
Bacteroidaceae and Ruminococcaceae OTUs (Supporting
Information Table S9). We found that Bacteroidaceae
OTUs form two communities based on co-abundance pat-
terns, with the most abundant (Bacteroidaceae CB1:
8 OTUs, including OTUs 7 and 49) negatively correlated
with BMI z-score and the less abundant not significantly
correlated (Bacteroidaceae CB2: 2 OTUs). Ruminococca-
ceae was composed of three communities based on
co-abundance patterns, and while the most abundant
(Ruminococcaceae CR1: 11 OTUs, including OTU 3) was
Fig. 2. Redundancy analysis of gut microbiota composition with
respect to BMI z-score, acetate, propionate and butyrate. The
direction of the arrows shows the correlation between variables.
Normal-weight samples are represented by blue dots and obese
with red dots.
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positively correlated with BMI z-score, the second was
negatively correlated (Ruminococcaceae CR2: 8 OTUs),
and the third (CR3: 20 OTUs) was not significantly correlat-
ed (Supporting Information Figs. S4 A, B).
Discussion
The gut microbiota is affected by many factors, such as
diet, genetics, health status, environment and lifestyle
(Rodrıguez et al., 2015). Childhood and adult obesity are
accompanied by changes in the composition of the gut
microbiota (Karlsson et al., 2012; Bervoets et al., 2013;
Borgo et al., 2016). In the present study we found altera-
tions in gut microbiota composition and SCFA levels in a
cohort of 42 obese and 36 normal-weight Italian children.
We observed that children born by Caesarean section
tended to be obese, although this result did not reach sta-
tistical significance. Past studies have found that
Caesarean section delivery increases the risk of obesity
(Goldani et al., 2011; Mueller et al., 2015; Portela et al.,
2015) and impacts the infant gut microbiota (Gr€onlund
et al., 1999). In our study, delivery mode and infant feeding
history (breast-fed vs. formula-fed) were not significantly
associated with obesity or the gut microbiota composition
of children (mean age511). The impact of delivery mode
and infant feeding history on the gut microbiota may, there-
fore, be lost after the first years of life, although it is still
unclear exactly when (Penders et al., 2006; Biasucci et al.,
2010). Gut microbiota composition has been reported to
begin to converge toward an adult-like microbiota by the
end of the first year of life and fully resemble the adult
microbiota by 2.5 years of age (Clemente et al., 2012),
although other studies have shown that the microbiota of
children up to 4 years of age differs from that of adults
(Kulka et al., 2013; Hollister et al., 2015), suggesting that
conversion to an ‘adult-like’ microbiota may be a long and
gradual process.
Recent scientific advances implicate the gut microbiota
as a contributor to over-nutrition. The gut microbiota ena-
bles hydrolysis of indigestible polysaccharides to easily-
absorbable monosaccharides and activation of lipoprotein
lipase by direct action of the villous epithelium. Conse-
quently, glucose is rapidly adsorbed and fatty acids are
stored in excess (Kalliom€aki et al., 2008), providing an
additional source of energy for the body (Turnbaugh et al.,
2006). The significantly higher concentration of SCFAs in
obese participants in our study may indicate that in obese
children colonic fermentation is elevated, or alternatively
that there is decreased SCFA absorption due to low-grade
inflammation or more rapid gut transit. This has previously
been observed in cohorts of both children (Payne et al.,
2011) and adults (Schwiertz et al., 2009; Fernandes et al.,
2014). Elevated fecal concentrations of total or individual
SCFAs might result from increased microbial production,
shifts in microbial cross-feeding patterns or low mucosal
absorption (Schwiertz et al., 2009).
We observed a clear alteration in the gut microbiota in
obese children at every taxonomic level. This was charac-
terized at the phylum level by an increased abundance of
Firmicutes and a decreased abundance of Bacteroidetes
in obese children. It has been hypothesized that an
increased ratio of Firmicutes to Bacteroidetes may contrib-
ute to the pathophysiology of obesity and is associated
with increased production of SCFAs and energy harvest
from colonic fermentation (Turnbaugh et al., 2006; Fer-
nandes et al., 2014). Although an elevated Firmicutes/
Bacteroidetes ratio in obese subjects has been reported in
multiple studies (Turnbaugh et al., 2009; Xu et al., 2012;
Bervoets et al., 2013), a reduced Firmicutes/Bacteroidetes
ratio in obese adults has also been found (Schwiertz et al.,
2009). A recent meta-analysis concluded that there were
no statistically significant differences across multiple stud-
ies in the Firmicutes/Bacteroidetes ratio between obese
and normal-weight adults (Walters et al., 2014). In agree-
ment with this meta-analysis, some pediatric studies have
Table 1. Bacterial taxa correlated with BMI z-score.
Taxonomic level Taxon R p-value
Phylum Firmicutes 0.4145 0.0001
Bacteroidetes 20.4538 <0.0001
Class Clostridia 0.3688 0.0008
Bacteroidia 20.4538 <0.0001
Order Clostridiales 0.3687 0.0008
Bacteroidales 20.4538 <0.0001
Family Ruminococcaceae 0.3778 0.0006
Bacteroidaceae 20.4930 <0.0001
Genus Bacteroides 20.4930 <0.0001
OTU OTU 7: Bacteroides vulgatus 20.4321 <0.0001
OTU 3: Faecalibacterium prausnitzii 0.3058 0.0064
OTU 49: Bacteroides stercoris 20.3252 0.003
Pearson correlation coefficient (r) and p-value are shown for significantly correlating taxa and operational taxonomic units (OTUs).
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found an increase in Firmicutes and a decrease in Bacter-
oidetes (Bervoets et al., 2013; Ferrer et al., 2013) while
others have not (Abdallah Ismail et al., 2011; Payne et al.,
2011). Although in our study the Firmicutes/Bacteroidetes
ratio was significantly elevated in obese individuals, we
observed large variation in the ratio, particularly within the
obese group. This large variation, as well as the contradict-
ing results from previous studies, suggests that the
Firmicutes/Bacteroidetes ratio may not be a robust marker
for obesity.
We reasoned that the classification of individuals into
normal-weight and obese groups might be too coarse of a
description for the physiological differences present at dif-
ferent BMI z-scores. We found that the alpha diversity of
the gut microbiota was negatively correlated with BMI
z-score and we recovered the same broad trends as we
observed with obesity classification such as a positive cor-
relation with the Firmicutes/Bacteroidetes ratio, but with
additional insights such as positive correlation of Faecali-
bacterium OTU 3 (F. prausnitzii) with BMI z-score and a
Fig. 3. Correlation networks of samples from normal-weight and obese children.
A, B. Networks show significant positive (green) and negative (pink) pairwise correlations between operational taxonomic units (OTUs). OTUs
are coloured by phylum affiliation and sized by mean relative abundance.
C, D. Correlating communities of Bacteroidaceae (CB) and Ruminococcaceae (CR) and their abundances with respect to BMI z-score.
Relative abundances (C) and z-score transformed abundances (D) are shown. Data points were processed using Lowess smoothing and 95%
confidence intervals are shown.
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negative correlation of Bacteroides OTU 7 and 49 (B. vul-
gatus and B. stercoris respectively) with BMI z-score.
Faecalibacterium, a group of major butyrate producers in
the colon (Louis et al., 2009), was also positively correlated
with acetate and butyrate, reinforcing the tight link between
SCFAs and obesity. Literature data are conflicting about
the level of F. prausnitzii in obesity, with studies showing
positive (Balamarugan et al., 2010), negative (Borgo et al.,
2016) or no association (Feng et al., 2014). These contra-
dictory results may be due to experimental factors such as
small cohort sizes or the use of different primer sets, or
may be explained by the existence of multiple F. prausnitzii
phylotypes (Louis et al., 2009; Hippe et al., 2016). Indeed,
Hippe and colleagues (2016) suggested that the two identi-
fied phylotypes display different physiological properties
and seem to produce different amounts of butyrate in the
gut. Propionate levels were positively correlated with mem-
bers of the Prevotellaceae, which are known propionate
producers (Schwiertz et al., 2009), although this was not
related to BMI z-score. Interestingly, increase of colonic
propionate has been shown to prevent weight gain in over-
weight adults by stimulating the release of PYYand GLP-1
from human colonic cells and thereby reducing energy
intake (Chambers et al., 2014).
In order to determine if the structure of the gut micro-
biota is also altered in obesity, we performed a correlation
network analysis and found that there were fewer correla-
tions and less clustering of OTUs in normal-weight
compared to obese children. The betweenness centrality
was higher in the normal-weight network, which indicates
that in the obese microbiota there are more OTUs that are
highly connected to other OTUs. It is tempting to speculate
that the altered network structure in obese children may be
involved in the increased fermentation capacity of the gut
microbiota.
Interestingly, intra-taxon correlations within the families
Bacteroidaceae and Ruminococcaceae demonstrated that
in both networks Bacteroidaceae OTUs were positively
correlated with one another, whereas Ruminococcaceae
OTUs had both positive and negative intra-family correla-
tions. This indicates a lack of intra-family ecological
cohesion for Ruminococcaceae across these samples and
may explain why Bacteroidetes taxa were generally better
predictors of BMI and obesity than Firmicutes taxa. To fur-
ther investigate the difference between Bacteroidaceae
and Ruminococcaceae responses, we extracted from the
complete network the communities of co-abundant OTUs
from these two groups. We identified five distinct correlat-
ing communities (2 Bacteroidaceae [CB1 and CB2] and 3
Ruminococcaceae [CR1-CR3]). Interestingly, while Rumi-
nococcaceae CR1 was positively correlated with BMI z-
score, Ruminococcaceae CR2 was negatively correlated.
The divergent response of members of the Ruminococca-
ceae with respect to BMI z-score may indicate different
niche preferences within this group and may also help to
explain why the increased Firmicutes/Bacteroidetes ratio is
not found in all studies, as it groups together Firmicutes
populations with discordant shifts in obesity. Divergent
responses of members of the clostridia have previously
been observed in other conditions such as inflammation
(Berry et al., 2012). It is likely that the extensive physiologi-
cal and metabolic diversity in members of the clostridia is
responsible for these contrasting responses, and additional
studies are needed to better characterize and functionally
categorize the members of this abundant group.
Although it is recognized that the gut microbiota has the
potential to change along with the development of its host,
information regarding the structure and function of the
microbiome in children remains limited (Hollister et al.,
2015). We hypothesized that an aberrant gut microbiota
composition and activity might contribute to the develop-
ment of childhood obesity. We found that members of the
Bacteroidetes and certain populations of Firmicutes were
associated with childhood obesity, although members of
the Firmicutes exhibited contrasting shifts. Additional stud-
ies are needed to better characterize the members of
Firmicutes and their roles in obesity. Obesity is often asso-
ciated with altered dietary habits, and in the present study
obese children had higher caloric intake. It is therefore not
possible to determine if an altered microbiota is a causa-
tive factor in pediatric obesity or a consequence of diet,
and this must be tested with future research that takes into
account diet and physiology and which includes detailed
functional analyses of the metabolic activity of the gut
microbiota. Together, this will advance our understanding
of the role of the gut microbiota in obesity and provide
opportunities to improve health and prevent disease.
Experimental procedures
Subjects and sample collection
Seventy-eight children (36 males/42 females, 9–16 years)
were enrolled in the study at the Pediatric Department of San
Paolo Hospital in Milan from December 2013 to February
2015. The enrollment conditions were performed as previously
described (Borgo et al., 2016). Briefly, children’s BMI was cal-
culated by reported weight/height2 (kg m22), and classification
of obese (O) and normal weight (N) was made according to
Cole (Cole et al., 2000). Weight (kg), height (cm) and BMI
(kg m22) were transformed to age and sex-specific z-scores
(Cole et al., 1995). Inclusion criteria were: children living in
Northern Italy born from Caucasian parents with birth
weight 2500 g, gestational age 37–42 weeks and singleton
birth. Children with neonatal disease, congenital malformation,
antibiotic or probiotic/prebiotic usage in the previous six
months, chronic or acute intestinal and obesity-related co-
morbidity conditions were excluded. Data concerning mode of
delivery and type of feeding were collected for all subjects and
the dietary habits were assessed at recruitment by means of
an age-adjusted food frequency questionnaire made up of 116
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items (Verduci et al., 2007). Fecal samples were collected
24 h before medical examination and stored at 2208C until
processing.
The study was conducted in accordance with the local med-
ical ethical committee (protocol number 2015/ST/135). Written
informed consent was given by a parent for all enrolled
subjects.
DNA extraction and preparation of 16S rRNA gene
amplicon libraries
The total bacterial DNA extraction was performed using the
Spin stool DNA kit (Stratec Molecular, Berlin, Germany),
according to the manufacturer’s instructions and amplified by
PCR. Amplification was performed with a two-step barcoding
approach according to Herbold and colleagues, 2015. In
the first-step PCR, 16S rRNA genes of all Bacteria
were amplified with forward primer S-D-bact-0341-b-S-17 (5-
CCTACGGGNGGCWGCAG-30) and reverse primer S-D-bact-
0785-a-A-21 (5-GACTACHVGGGTATCTAATCC-30), which
also contained head adaptors (50-GCTATGCGCGAGCTGC-
30). In the second-step PCR, PCR products from the first step
were amplified with primers consisting of the 16 bp head
sequence and a sample-specific 8 bp barcode from a previ-
ously published list at the 50 end (Hamady et al., 2008). Each
PCR reaction (20 lL in first step, 50 lL in second step) con-
sisted of 103 Taq buffer (Fermentas, USA), 2 mM dNTPmix
(Fermentas), 25 mM MgCl2 (Fermentas), 5 U ll
21 Taq DNA
polymerase (Fermentas), 20 mg ml21 bovine serum albumin
(Fermentas), 50 lM of each of the forward and reverse pri-
mers and 5 ll of sample. Thermal cycle conditions were: 958C
for 3 min; 958C for 30 s, a primer-specific annealing tempera-
ture of 558C for 30 s, 728C for 1 min for 25 cycles and an
elongation time of 728C for 7 min (step1); 528C for 30 s, 728C
for 1 min for 5 cycles (step 2) and an elongation step of 728C
for 7 min. The first PCR reaction was performed in triplicate,
pooled for use as a template in the second step and evaluated
qualitatively by gel electrophoresis. The barcoded amplicons
were purified between the first step and the second step and
after the second step with ZR-96 DNA Clean-up Kit (Zymo
Research, USA) and quantified using the Quant-iT PicoGreen
dsDNA Assay (Invitrogen, USA). An equimolar library was
constructed by pooling samples, and the resulting library was
sent sequenced on the Illumina MiSeq platform at Microsynth
AG (Balgach, Switzerland). Sequence data have been depos-
ited in the NCBI Short Read Archive under SRP073251.
Short chain fatty acids (SCFAs) measurement
Stool samples were analysed for acetic acid, propionic acid
and butyric acid using capillary electrophoresis. For determi-
nation of SCFAs concentration one aliquot of frozen fecal
sample (50 mg) was used and 200 ll of Milli-Q filtered water
was added. The solution was mixed by vortexing for 10 min
and then centrifuged 30 min at 21,000 3 g. A standard mix
composed of acetic acid, propionic acid, butyric acid, lactic
acid, formic acid and succinic acid with consecutive concen-
tration of 50 lM, 100 lM, 250 lm and 350 lM, were run as
external standards and calibrated. Caproic acid (100 mM final
concentration) was used as internal control. A buffer with
0.01M NaOH, 500 lM CaCl2 and 100 lM caproic acid was
prepared to run samples. Because we detected interference
between phosphates and propionic acid peaks, a final concen-
tration of 500 lM of CaCl2 was added in order to precipitate
phosphates usually present in human fecal matter. Ceofix
Anions 5 kit (Beckman Coulter, USA) was utilized to prepare
anion buffers for the machine. SCFAs concentration was
determined in 100ml supernatant using P/ACE MDQ Molecular
Characterisation System Beckam Coulter (USA) with a fused
silica capillary of 75 lm internal diameter 3 363 lm outer
diameter (Polymicro Tecnologies, USA). Thirty-two karat soft-
ware (Beckman Coulter, USA) was used for data processing.
SCFAs concentration in fecal samples was expressed in
micromoles per gram (mmol g21) of feces.
Sequence pre-processing and data analysis
Sequence data were sorted into libraries using the 8 nt
sample-specific barcode and primer using a custom-made in-
house script, quality-filtered according to the Earth Micro-
biome Project guidelines and paired end reads were
concatenated (Bokulich et al., 2013). Reads were then clus-
tered into species-level operational taxonomic units (OTUs) of
97% sequence identity, checked for chimeras using
USEARCH, and taxonomically classified using the Ribosomal
Database Project n€aive Bayesian classifier (Wang et al.,
2007). Statistical analysis was performed using the statistical
software R (https://www.r-project.org/). To avoid biases related
to uneven library depth, sequencing libraries were sub-
sampled to a number of reads smaller than the smallest
library (2000 reads). The statistical significance of factors
affecting microbiota composition was evaluated using non-
parametric permutational multivariate analysis of variance
(perMANOVA), significant clustering of groups was evaluated
with analysis of similarities (ANOSIM), ordination was per-
formed using redundancy analysis (RDA) in the vegan
package (Oksanen et al., 2010). Alpha and beta diversity met-
rics were also calculated with the vegan package. Indicator
species analysis was performed using the indicspecies pack-
age (De Caceres et al., 2009). Network analysis was
performed for all OTUs present in at least 30% of samples as
recommended in (Berry and Widder, 2014) using graphical
lasso technique cclasso to mitigate biases associated with
compositional data (Danaher et al., 2014). Network topological
and node-level properties were determined using the igraph
package (Csardi, 2015) and networks were visualized using
Cytoscape (Shannon et al., 2003). Statistical analysis of
cohort-related data was performed using Student’s t-test, chi-
square test, correlation analysis (Pearson correlation coeffi-
cient) and linear regression modeling. Variables were
expressed as mean6 standard deviation (sd), and for multiple
comparisons p-values were adjusted with the False Discovery
Rate method. A p-value less than or equal to 0.05 was consid-
ered statistically significant.
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Fig. S1. Abundant bacterial taxa in stool samples of normal-
weight (n536) and obese (n542) children. Genus level
taxon profiles are shown. Abundant taxa, defined as hav-
ing a mean relative abundance of >1%, are shown.
Fig. S2. Intestinal microbiota richness and diversity in nor-
mal-weight and obese children. Observed species, Chao1
estimated richness, Shannon diversity, and inverse Simpson
diversity estimators show no significant difference between
the two groups (Observed species: p50.59; Chao1:
p50.98; Shannon: p50.065; Inverse Simpson p50.34).
Fig. S3. Generalized linear regression models at different
taxonomic levels. (A) The coefficient of determination (R2),
which indicates the proportion of the variance in the depen-
dent variable that is predictable from the independent vari-
able, increases at genus and OTU levels. (B) The Akaike
information criterion (AIC), a measure of the relative quality
of statistical models for a given set of data, is lowest at
genus and OTU levels.
Fig. S4. Correlating communities of Bacteroidaceae (CB)
and Ruminococcaceae (CR) and their abundances with
respect to BMI z-score. Relative abundances (A) and z-
score transformed abundances (B) are shown. Data points
were processed using Lowess smoothing and 95% confi-
dence intervals are shown.
Table S1. Characteristics of the study cohort. The cohort
was composed of normal-weight (N) and obese (O) chil-
dren. Body mass index (BMI) was calculated as weight/
height2 (kg/m2), and was transformed to age- and sex-
adjusted z-scores. Values are expressed as mean 6 sd.
aInformation not available for two subjects. bInformation not
available for three subjects.
Table S2. Short chain fatty acid (SCFA) levels in the stool
of normal-weight (N) and obese (O) subjects. Concentra-
tions are calculated as lmol/g wet weight and are
expressed as mean 6 sd. Total SCFA is calculated as the
sum of acetate, propionate, and butyrate concentrations.
Table S3. Daily caloric and dietary intake in obese and nor-
mal-weight children. Values are expressed as mean 6 sd.
Table S4. The relative abundance of abundant bacteria
taxa in the study. Abundant taxa are defined as having a
mean abundance greater than 1%. *Taxa significantly
increased or decreased in obese children (complete details
are presented in Table S4).
Table S5. Taxa that were increased (1) or decreased (2)
in abundance in obese children (O).
Table S6. Correlation of alpha diversity metrics with BMI z-
score and SCFAs. Observed OTUs, Chao1 estimated rich-
ness, Shannon and inverse Simpson diversity indexes were
correlated and the Pearson correlation coefficients (r) and
respective p-values are shown. *indicates p<50.05 and
**indicates p <50.01.
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Table S7. Taxa correlated with acetate concentration. The
Pearson correlation coefficients (r) and respective p-values
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Table S8. Properties of correlation networks generated
from samples from normal-weight (N) or obese children
(O). Nodes are OTUs and edges are significant correlations
between OTUs. Other parameters are metrics related to the
topology of the network.
Table S9. Clusters of correlating Bacteroidaceae and Rumi-
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Figure S1. Abundant bacterial taxa in stool samples of normal-weight (n=36) and obese 
(n=42) children. Genus level taxon profiles are shown. Abundant taxa, defined as having a mean 
relative abundance of >1%, are shown. 
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Figure S2. Intestinal microbiota richness and diversity in normal-weight and obese children. 
Observed species, Chao1 estimated richness, Shannon diversity, and inverse Simpson diversity 
estimators show no significant difference between the two groups (Observed species: p=0.59; 
Chao1: p=0.98; Shannon: p=0.065; Inverse Simpson p=0.34).   
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Figure S3. Generalized linear regression models at different taxonomic levels. (A) The 
coefficient of determination (R2), which indicates the proportion of the variance in the dependent 
variable that is predictable from the independent variable, increases at genus and OTU levels. (B) 
The Akaike information criterion (AIC), a measure of the relative quality of statistical models for 
a given set of data, is lowest at genus and OTU levels. 
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Figure S4: Correlating communities of Bacteroidaceae (CB) and Ruminococcaceae (CR) and 
their abundances with respect to BMI z-score. Relative abundances (A) and z-score transformed 
abundances (B) are shown. Data points were processed using Lowess smoothing and 95% 
confidence intervals are shown. 
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Table S1. Characteristics of the study cohort. The cohort was composed of normal-weight (N) 
and obese (O) children. Body mass index (BMI) was calculated as weight/height2 (kg/m2), and 
was transformed to age- and sex-adjusted z-scores. Values are expressed as mean ± sd. 
aInformation not available for two subjects. bInformation not available for three subjects.  
 
 N (n=36) O (n=42) 
Age (years) 11±0.33 11±1.99 
Sex (male:female) 17:19 21:21 
3.0±0.7 BMI z-score 0.3±0.82 
Delivery type (vaginal: caesarean) 
Infant diet  (breast-fed: formula-fed) 
28:8 
14:22 
22:18a 
18:21b 
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Table S2. Short chain fatty acid (SCFA) levels in the stool of normal-weight (N) and obese 
(O) subjects. Concentrations are calculated as µmol/g wet weight and are expressed as mean ± 
sd. Total SCFA is calculated as the sum of acetate, propionate, and butyrate concentrations. 
 
 N (n=36) O (n=42) p-value 
Acetate 30.3±13.0 40.4±18.9 0.0081 
Propionate 8.8±5.8    12.5±7.7 0.0206 
Butyrate 8.4±5.3 12.4±9.8 0.0272 
Total SCFA 47.5±20.4 65.3±32.4 0.0049 
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Table S3. Daily caloric and dietary intake in obese and normal-weight children. Values 
are expressed as mean ± sd.  
Variable Obese children 
 
Normal weight 
children  P-value P-value† 
kcal/day 2264.13 (746.31) 1722.01 (383.78) 0.001 * 0.001* 
Protein 
g/day 94.00 (32.76) 68.56 (19.47) <0.001 * 0.001* 
Carbohydrates 
g/day 301.06 (120.66) 201.94 (47.66) <0.001 * 0.001* 
Sugars 
g/day 110.16 (65.70) 75.12 (31.92)  0.005 * 0.012* 
Fats 
g/day 82.38 (30.80) 70.02 (18.36) 0.128 0.033* 
† Adjusted for age and sex. *Statistically significant 
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Table S4. The relative abundance of abundant bacteria taxa in the study. Abundant taxa are 
defined as having a mean abundance greater than 1%. * Taxa significantly increased or decreased 
in obese children (complete details are presented in Table S4).  
 
 Normal-weight Obese 
Taxonomic 
level 
Taxon Mean sd Mean sd 
Phylum 
Bacteroidetes* 30 12.6 16.6 11.8 
Firmicutes* 60.9 14.1 72.1 12.1 
Actinobacteria 5.6 6.1 6.3 4.9 
Verrucomicrobia 2.5 7.6 2.3 5.5 
Proteobacteria 1.2 1.1 2.0 2.9 
Family 
Ruminococcaceae* 33.3 11.5 42.5 12.7 
Lachnospiraceae 16.4 6.5 17.9 9.7 
Bacteroidaceae* 21.4 12.2 10 7.1 
Veillonellaceae 6.1 5.7 6.5 7.5 
Bifidobacteriaceae 5.1 6.0 5.3 4.5 
Prevotellaceae 3.6 8.5 2.8 5.2 
Verrucomicrobiaceae 2.5 7.6 2.3 5.5 
Rikenellaceae 2.8 2.0 2.0 2.6 
Christensenellaceae 2.0 2.3 2.3 3.7 
Genus 
Bacteroides* 21.4 12.2 10.5 7.1 
Subdoligranulum 10.7 8.4 16.7 12.3 
Faecalibacterium 10.0 6.3 12.7 8.7 
Dialister 5.9 5.8 5.6 7.1 
Bifidobacterium 5.1 6.0 5.3 4.5 
Pseudobutyrivibrio 5.1 4.1 4.4 3.9 
Blautia 3.6 1.8 4.4 2.4 
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Table S5. Taxa that were increased (+) or decreased (-) in abundance in obese children (O). 
 
 
Taxonomic 
level 
Taxon O p-value 
Phylum Firmicutes + 0.001 
Bacteroidetes - <0.0001 
Class Clostridia + 0.004 
Bacteroidia - <0.0001 
Order Clostridiales + 0.003 
Bacteroidales - <0.0001 
Family 
Ruminococcaceae + 0.01 
Bacteroidaceae - <0.0001 
Genus Bacteroides - <0.0001 
OTU 
OTU  7: 
Bacteroides 
vulgatus 
- <0.0001 
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Table S6. Correlation of alpha diversity metrics with BMI z-score and SCFAs. Observed 
OTUs, Chao1 estimated richness, Shannon and inverse Simpson diversity indexes were correlated 
and the Pearson correlation coefficients (r) and respective p-values are shown. * indicates p<=0.05 
and ** indicates p <=0.01.  
 
 Observed OTUs Chao1 richness Shannon Inverse Simpson 
r p-value r p-value r p-value r p-value 
BMI  
z-score 
-0.1562 
 
0.1720 
 
-0.0240 
 
0.8345 
 
-0.2657 0.0186* 
 
-0.1946 
 
0.0877 
 
Acetate 
-0.2956 
 
0.0085** 
 
-0.2826 
 
0.0121* 
 
-0.3513 
 
0.0016** 
 
-0.3581 
 
0.0012 ** 
 
Propionate 
-0.1876 
 
0.1000 
 
-0.2166 
 
0.0567 
 
-0.2584 
 
0.0223* 
 
-0.2575 
 
0.0227* 
 
Butyrate 
-0.2387 
 
0.0353* 
 
-0.2701 
 
0.0167* 
 
-0.2639 
 
0.0195* 
 
-0.2354 
 
0.0379* 
 
Total SCFA 
-0.2917 
 
0.0095** 
 
-0.3003 
 
0.0075** 
 
-0.3498 
 
0.0016** 
 
-0.3454 
 
0.0019** 
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Table S7. Taxa correlated with acetate concentration. The Pearson correlation coefficients (r) 
and respective p-values are shown. 
Taxonomic 
level 
Taxon 
 
r p-value 
Phylum Firmicutes 0.3107 0.005 
Bacteroidetes -0.3145 0.005 
Class Clostridia 0.2765 0.01 
Bacteroidia -0.3145 0.005 
Order Clostridiales 0.2767 0.01 
Bacteroidales -0.3145 0.005 
Family 
Ruminococcaceae 0.3120 0.005 
Bacteroidaceae -0.2876 0.01 
Porphyromonadaceae -0.2845 0.01 
Rikenellaceae -0.3107 0.005 
Genus 
Ruminococcaceae  Incertae sedis 
(Firmicutes) 
-0.2683 0.01 
Bacteroides (Bacteroidetes) -0.2876 0.01 
Parabacteroides (Bacteroidetes) -0.2737 0.01 
Alistipes (Bacteroidetes) -0.3117 0.005 
Oscillabacter (Firmicutes) -0.3205 0.004 
Subdoligranulum (Firmicutes) 0.2737 0.01 
Faecalibacterium (Firmicutes) 0.4487 <0.0001 
OTU OTU 3: Faecalibacterium 
prausnitzii 
0.4487 <0.0001 
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Table S8. Properties of correlation networks generated from samples from normal-weight 
(N) or obese children (O). Nodes are OTUs and edges are significant correlations between 
OTUs. Other parameters are metrics related to the topology of the network. 
 
 N O 
Nodes 138 143 
Edges 370 941 
Mean Degree 5.36 13.16 
Transitivity 0.047 0.131 
Average Path Length 3.10 2.22 
Assortativity -0.0535 0.169 
Fragmentation 0 0 
Betweeness Centrality 0.0701 0.0226 
Closeness Centrality 0.00123 0.00137 
Percent Positive corr. in network 69.5 65.5 
Bacteroidaceae (intra-family corr.; 
pos./neg.) 
[2/0] [13/0] 
Ruminococcaceae (intra-family corr.; 
pos./neg.) 
[31/5] [50/18] 
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Table S9: Clusters of correlating Bacteroidaceae and Ruminococcaceae OTUs extracted from the 
complete correlation network. The closest related species and similary (%) are shown.  
Bacteroidaceae 
Correlating 
community 
OTU_ID Closest related species Similarity 
(%) 
CB1 OTU_7 Bacteroides vulgatus 100 
 OTU_60 Bacteroides fragilis 100 
 OTU_13 Bacteroides caccae 100 
 OTU_51 Bacteroides thetaiotaomicron 100 
 OTU_49 Bacteroides stercoris 99 
 OTU_119 Bacteroides cellulosilyticus 100 
 OTU_9 Bacteroides uniformis 100 
 OTU_207 Bacteroides xylanisolvens 99 
CB2 OTU_312 Bacteroides eggerthii 99 
 OTU_65 Bacteroides finegoldii 95 
Ruminococcaceae 
Correlating 
community 
OTU_ID Closest related species Similarity 
(%) 
CR1 OTU_118 Clostridium leptum 92 
 OTU_1 Faecalibacterium prausnitzii 100 
 OTU_479 Faecalibacterium prausnitzii 97 
 OTU_122 Ruminococcus callidus 99 
 OTU_4 Gemmiger formicilis 100 
 OTU_48 Ruminococcus bicirculans 100 
 OTU_68 Clostridium leptum 95 
 OTU_87 Clostridium methylpentosum 90 
 OTU_127 Ruminococcus flavefaciens 95 
 OTU_22 Ruminococcus bromii 98 
 OTU_3 Faecalibacterium prausnitzii 100 
CR2 OTU_58 Clostridium papyrosolvens 87 
 OTU_38 Gemmiger formicilis 94 
 OTU_96 Ruminococcus bromii 90 
 OTU_63 Clostridium thermocellum 89 
 OTU_78 Ruminococcus bromii 86 
 OTU_53 Ruminococcus champanellensis 90 
 OTU_164 Clostridium methylpentosum 94 
 OTU_67 Clostridium leptum 100 
CR3 OTU_37 Ruminococcus lactaris 95 
 OTU_33 Clostridium thermocellum 90 
 OTU_93 Clostridium papyrosolvens 88 
79 
 
 OTU_15 Clostridium viride 90 
 OTU_23 Ruminococcus bicirculans 87 
 OTU_17 Ruminococcus bromii 88 
 OTU_44 Clostridium viride 90 
 OTU_461 Clostridium viride 92 
 OTU_168 Ruminococcus flavefaciens 91 
 OTU_81 Clostridium thermocellum 88 
 OTU_103 Ruminococcus albus 90 
 OTU_29 Clostridium viride 92 
 OTU_155 Ruminococcus albus 91 
 OTU_110 Clostridium thermocellum 90 
 OTU_83 Ruminococcus albus 90 
 OTU_8 Ruminococcus bicirculans 91 
 OTU_108 Faecalibacterium prausnitzii 93 
 OTU_86 Ruminococcus champanellensis 85 
 OTU_10 Clostridium viride 91 
 OTU_181 Clostridium viride 89 
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2.7 Conclusion 
 
In summary, according to the results of the papers presented above, a clear alteration in the gut 
microbiota composition and in SCFAs production is present in obese school-aged children. In 
our first results DGGE profiles showed high bacterial biodiversity without significant 
correlations with BMI z-score, but the use of specific primers in Real-Time PCR revealed a 
significantly lower abundance in some bacterial and fungal species in obese children.  
The next use of a high-throughput technique as 16S gene targeting sequencing, allowed 
identifying significant differences in bacterial population, with a depletion in Bacteroidetes and 
an increasing in Firmicutes in obese children. Members of the Bacteroidetes resulted better 
predictors of BMI z-score and obesity than Firmicutes, which was likely due to discordant 
responses of Firmicutes OTUs, in particular within the members of Ruminococcaceae.  
The correlation network analysis summarizes all the gut microbiota alterations found in both 
studies. The harmony and equilibrium between OTUs presented in normal-weight subjects 
seemed to be lost in obese children. The main hypothesis can be linked to an increased 
fermentation activity in the obese group creating preferential niches in the gut with subsequent 
formation of more correlation communities. In accordance with these observations, the main 
metabolites produced by gut bacteria, short chain fatty acids (SCFAs), were higher in obese 
children, suggesting elevated substrate utilization or more rapid transit time. The more elevated 
SCFAs production may be linked to the increased introduction of kcal and macronutrients by 
day in the obese children leading to an increased fermentation activity and SCFAs production, 
which are used as further source of energy for the body.  
Another important evidence of gut microbiota implication with obesity, are the several 
correlations found between gut bacterial communities and SCFA levels and BMI z-score, 
reinforcing the tight link between the microbiota, SCFAs, and obesity.  
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In summary, our results suggest that gut microbiota dysbiosis and elevated fermentation activity 
may be involved in the etiology of childhood obesity. In particular, obesity was associated with 
an altered gut microbiota characterized by elevated levels of Firmicutes and a depletion of 
Bacteroidetes, with discordant responses in Firmicutes members. Therefore, future research 
should include a better characterization of Firmicutes members and a complete metabolites 
analysis in order to understand the complex interaction between gut microbiota, metabolites 
and diet.  
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CHAPTER 3: 
THE INFLUENCE OF DIET 
ON GUT MICROBIOTA BY 
USING MURINE MODELS 
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Introduction 
3.1 Diet and its impact on gut microbiota composition  
Current evidence suggests that gut microbiota plays a role in metabolic regulation and food 
digestion and availability. Its potential to modulate energy regulation as well as systemic 
inflammation are pointed up in paragraph 2.2 (Sanchez et al., 2015). 
In recent years, efforts to modify the intestinal microbiota composition by dietary interventions 
have substantially increased  and the impact of different diets on the microbiota has been well 
demonstrated (Milani et al., 2016).  
The effect of diet is clearly demonstrated by the changes seen over a period of 2.5 years in one 
infant gut microbiota with introduction of solid foods. In this study, using 16S rRNA gene 
sequencing the authors demonstrated increasing bacterial diversity over time, with ingestion of 
solid foods causing a sustained increase in Bacteroidetes spp., fecal short-chain fatty acid levels, 
enrichment of genes associated with carbohydrate utilization, vitamin biosynthesis, and 
xenobiotic degradation (Koenig et al., 2011).  
The most significant data are available on the influence of specific diet components such as 
dietary fibers, fat and proteins on the human gut composition. In this context, it is very relevant 
to highlight the role of dietary fibers, defined as glycans consisting of tri or higher polymeric 
saccharides that are not adsorbed in the small intestine, nor digested by human enzymes. 
Humans consuming resistant starch undergo a gut microbiota change with a significant increase 
in Ruminococcus bromii and other starch-degrading bacteria such as Oscillobacter spp. and 
Eubacterium rectale. Dietary fibers are known to enhance growth and activity of butyrate-
producing microorganisms such as Roseburia spp., Eubacterium rectale and Faecalibacterium 
prausnitzii. Moreover, Bifidobacterium spp. and lactobacilli populations are stimulated by the 
presence of dietary fibers directly or indirectly by cross-feeding (Milani et al., 2016). 
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Polysaccharides serve as primary modulators of the composition and function of the microbiota. 
Polysaccharides, which are widely consumed components of human food, are therefore 
functionally analogous to small-molecule drugs. Because of their relative safety (that is, their 
lack of acute toxicity), availability and low cost, it might be feasible systematically and 
empirically to determine which dietary polysaccharides, alone or in combinations, can improve 
human health in different situations (Sonnenburg and Bäckhed, 2016). 
In a Western-based diet, which is characterised by a low presence of fibers and a high 
occurrence of fat, a paucity of fiber-degrading bacteria such as Prevotella spp., Succinivibrio 
spp., Treponema spp. and bifidobacteria has been observed (Milani et al., 2016). Furthemore, 
also the geographic area has an impact on gut microbiota composition as elegantly 
demonstrated by De Filippo and co-authors in which they compared the gut microbiota of 
children consuming a high fiber diet in Burkina Faso to a modern Western high-fat/high-sugar 
diet in Europe. They demonstrated that the gut microbiota in children from West Africa had a 
higher prevalence of Bacteroidetes and depletion in Firmicutes with some bacterial species 
being unique for fiber degradation such as Prevotella spp. and Xylanibacter spp. which were 
absent in the children from Europe (De Filippo et al., 2010).  
A high-fat, high-sugar Western diet, instead of a low-fat, plant polysaccharide-rich diet, was 
shown to promote a shift in the gut microbiota composition toward high numbers of Clostridia 
and a significant decrease in Bacteroidetes. By contrast, a diet containing high levels of fibers 
promotes an increase of Bacteroidetes and a decrease of Firmicutes (Milani et al., 2016).  
Very little is known about the influence of fat and protein intake on the gut microbiota 
composition. Recently, the comparison of the gut microbiota composition of two human 
cohorts, receiving either a plant or meat-based diet, highlighted distinct profiles. Notably, the 
meat-based diet was shown to increase the abundance of bile-tolerant bacteria such as genera 
of Alistipes, Bilophila and Bacteroides, with a concomitant decrease of Firmicutes, in a plant-
based diet the most abundant members were associated with the metabolism of plant 
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polysaccharides such as Roseburia spp. Eubacterium rectale and Ruminococcus bromii (David 
et al., 2014).  
Regarding meat consumption, recent investigations show that choline and carnitine, originating 
from fat and meat, are metabolized by specific components of the gut microbiota to 
trimethylamine, which in turn can be coverted to Trimethylamine- N-oxide (TMAO) in the 
liver. TMAO alters cholesterol metabolism in the intestines and in the liver. In the presence of 
TMAO, there is increased deposition of cholesterol in (and a decreased removal of cholesterol 
from) peripheral cells, such as those in the artery wall. In phosphatidylcholine-fed GF mice or 
mice treated with antibiotics, plasma levels of TMAO were increased, suggesting that the 
microbiota is involved in metabolic processing of dietary choline or carnitine. Specific 
microbiota profiles are associated with TMAO synthesis. In this context, individuals possessing 
an enterotype of Prevotella genus, displayed higher plasma TMAO concentrations compared 
to subjects with a different enterotype (Milani et al., 2016; Koeth et al., 2013).  
Moreover, a protein-rich but carbohydrate-poor diet affects the gut microbiota and fatty acid 
profiles in obese individuals. Residual proteins and peptides are metabolized by the microbiota 
by proteolysis or through gut fermentation, leading to the production of gasses (e.g. H2, CH4, 
CO2, H2S and SCFAs) (Russell et al., 2011).  
 
3.1.1 Plasticity of the gut microbiota 
The human gut microbiota responds rapidly to large changes in diet. Evidences suggest the 
existence of these fast, diet-induced dynamics like the switch between plant and meat-based 
diets, as the addition of more than 30 grams per day of specific dietary fibers or a diet with 
high-fiber/low-fat or viceversa for 10 days. In all cases, the composition and function of the 
microbiota shifted over 1–2 days (Walker et al., 2011; Wu et al., 2011). Such marked shifts in 
response to nutrient availability are perhaps unsurprising given that populations of microbes 
can double within one hour and the gut extensively purges the community every 24–48 hours. 
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This responsiveness might represent an advantageous feature of enlisting microbes as part of 
the digestive structure, especially when considering the possible day-to-day variation in food 
that is available to foragers. It might also be an inescapable consequence of dealing with a 
complex and competitive microbial community that undergoes rapid turnover (Sonnenburg and 
Bäckhed, 2016). 
Despite these rapid dynamics, long-term dietary habits are a dominant force in determining the 
composition of an individual’s gut microbiota. Despite detectable responses of the microbiota 
within 24 hours of dietary intervention, a 10-day feeding study in 10 people failed to alter the 
major compositional features and the overall classification of each participant’s microbiota (Wu 
et al., 2011). Some, but not all, cross-sectional studies reported that long-term dietary trends 
are linked to features of microbiota composition (Muegge et al., 2011; Wu et al., 2011; Koeth 
et al., 2013). A particular change in diet can have a highly variable effect on different people 
owing to the individualized nature of their gut microbiota. For example, Ruminococcus bromii-
related taxa bloomed in response to resistant-starch intervention in most of the 14 obese men in 
one study; the lack of response in the other individuals might reflect an absence of such taxa in 
those people (Walker et al., 2011).  
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3.2 Murine models to study the gut microbiota 
Murine models have been widely used in biomedical research. Extensive similarities in 
anatomy, physiology and genetics have allowed numerous information about biology.  
Experimental manipulations of murine models in gut microbiota research allow functional 
research on host-microbe interactions, thus helping to assess causality in disease-associated 
alterations in gut microbiota composition. Although results from such experiments have yielded 
important breakthroughs in understanding the dynamic and complex relationship between the 
gut microbiota and its host, the translation of such results from murine models to humans 
remains nontrivial due to the existence of some key differences between the two systems that 
need to be taken into account (Nguyen et al., 2015).  
 
3.2.1 The anatomy of the mouse and human intestinal tract 
Mice and humans are quite similar in physiology and anatomical structures, for this reason 
mouse models have been widely used in biomedical studies. However, the anatomy of the 
mouse and human intestinal tract have prominent differences (Table 3.1), which might be 
shaped by their diverging diets, feeding patterns, body sizes and metabolic requirements 
(Nguyen et al., 2015). For example, the gastro-intestinal tract is approximately 8.5 m long in 
humans and 30 cm long in mice (Bowcutt et al., 2014). The average small intestine/colon length 
ratio is 2.5 in mice versus 7 in humans and the surface ratio of small intestine/colon is only 18 
in mice compared to 400 in humans (Nguyen et al., 2015).  The mouse cecum is also large 
relative to its total gastro-intestinal tract and is an important site for the fermentation of plant 
materials as well as for the production of vitamin K and B, which mice reabsorb through 
coprophagy (Figure 3.1). By contrast, the human cecum is relatively small, with an anatomical 
structure similar to that of the colon and does not hold a clear function. These morphological 
differences reflect murine adaptation toward an expanded colon and cecum capacity, allowing 
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them to extract nutrients from the relatively larger proportion of indigestible food components 
in their diet, as compared with humans (Donaldson et al., 2013; Nguyen et al., 2015). Humans 
also have an appendix, which is absent in mice and mouse intestinal villi are taller than in 
humans. This morphological difference increases the surface area of the mouse small intestine 
like a compensation mechanism for the lack of mucosal folds in the mouse intestine. The mouse 
colon is rather smooth with no division, whereas the human large intestine is sub-
compartmentalized into pouches (called haustra), which are absent in the mouse colon. These 
major anatomical differences in the gut compartmentalization between mice and humans, 
especially with regards to the greater fermentation capacity of mice (in the cecum), probably 
impact the diversity and composition of the gut microbial communities in the colon. These 
communities are not only responsible for the fermentation of indigestible food components, but 
also for the production of essential complements to the host such as vitamin K and B and short 
chain fatty acids (SCFAs) (Nguyen et al., 2015). 
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Table 3.1. Similarities and differences in the anatomy of the mouse and human gastro-intestinal tract (Nguyen et 
al., 2015). 
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Figure 3.1. Gross anatomy of the human and the mouse gastro-intestinal tract. (A) The human colon is 
divided into different sections (i.e. ascending, transverse and descending colon) with the presence of taenia coli 
and compartmentalization in haustra, which are absent in the mouse colon (B). (C) Cross-section of a human colon, 
which has a thicker muscular wall and mucosa compared with the mouse colon (D). M, mucosa; ME, muscularis 
externa; TC, taenia coli.Taenia coli: three longitudinal smooth muscle ribbons along the outside of the colon. 
Haptens: small molecules that can elicit immune responses when attached to larger non-immunogenic carriers.  
Haustra: small pouches segmenting the large intestine, caused by tension of shorter exterior muscle ribbons (cf. 
taenia coli) (Nguyen et al., 2015).  
 
3.2.2 Dietary impact 
Usually, laboratory mice are fed a standardized chow diet, a closed formula diet in which the 
producer does not disclose the exact amount of each ingredient. In most experiments, mice are 
fed the same diet, obtained from the same supplier, throughout the experiment. The nutritional 
content of chow varies from batch to batch, depending on agronomical market fluctuations. 
Even with these variations, chow diet is composed mainly of plant materials and thus differs 
considerably to the composition of a daily human diet.  
Some xenobiotics, such as antibiotics, can also strongly affect the gut microbiota composition 
and function. Humans, through diet or treatments, are often exposed to such compounds and 
their potential synergistic effects.The mouse models have the advantage of allowing researchers 
to control for the impact of such compounds on the gut microbiota, by either minimizing 
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exposure or recording levels of exposure. Furthermore, dietary variations between humans 
represent a large potential source of gut microbiota inter-individual variation, which would not 
be detected in lab mice under uniform chow diet. In summary, it is essential to keep in mind 
that the murine models’ controlled diet might skew analyses by focusing only on a subset of 
the mouse gut microbiota inter-individual variance. On the other hand, controlling mouse diets 
provides a clearer experimental setup to disentangle the associations between the gut microbiota 
composition and function, and the perturbations studied, such as disease and host physiology 
(Nguyen et al., 2015). 
 
3.2.3 Methods to manipulate the gut microbiota: gnotobiotic defined microbiota 
The use of germ-free technology for investigating the interactions between the host and its 
associated microbiota has evolved substantially since the first conference on germ-free life in 
1939. By controlling the microbial composition of the environment in which the animals are 
reared, scientists have been able to obtain information about how microorganisms affect the 
normal physiological functions of the host (Bibiloni, 2012).  
Gnotobiotics or gnotobiology is the study of animals that are free of all microorganisms or 
colonized only by known species. The term arises from the Greek gnotos, meaning “known,” 
and bios, meaning “life”. Terms pertinent to any discussion of gnotobiology include: 
• Axenic or germ free (GF): an animal free of all microorganisms including bacteria, 
viruses (with the exception of endogenous retroviruses), fungi, protozoa, and other 
parasites (Ericsson and Franklin, 2015).  
• Monoxenic or mono-associated animals: animals colonized by only one microbial 
species. These animals are generated by reconstituting GF mice with a single agent.  
To create mono-associated mice, GF mice are inoculated with a pure bacterial culture, 
usually by gastric gavage. Monoassociated mice allow for the study of responses to a 
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single agent (most commonly bacterial) or identification of bacterial species responsible 
for specific bacterial products (Ericsson and Franklin, 2015).  
• Defined microbiota animals: animals with a defined set of microorganisms. These are 
generated by reconstituting GF mice with “cocktails” or consortia of bacteria. GF mice 
may also be reconstituted with more complex microbiota that are not completely 
defined. Sources for reconstitution may include other mice or xenobiotic sources 
including humans and other animal species (Ericsson and Franklin, 2015).  
• Humanized gnotobiotic mice: humanized gnotobiotic mice, which result from the  
inoculation of human gut microbiota samples in germ-free mice, provide a powerful 
tool for gut microbiota studies because these models can recapitulate a large part of the 
human gut microbiota phylogenetic composition (100% of phyla, 11/12 classes and ~ 
88% of genus level taxa) (Nguyen et al., 2015). Humanizing the microbiota of mice 
usually involves gavage of either a fresh or a frozen fecal sample, resulting in the 
transfer of the entire complex microbiota. When transferring complex microbiota, much 
of the bacterial diversity is reproduced, and this humanized microbiota can be stably 
transferred to subsequent generations (Ericsson and Franklin, 2015).  
 
In summary, mouse models are a powerful tool in gut microbiota research, and offer the 
possibility to perform experiments that would be too invasive for human subjects and with 
better control over confounding factors. These models provide unique possibilities to 
manipulate the human microbiota and assess causality in the role of the gut microbiota in health 
and disease and finally get closer the development of preventive and therapeutic treatments 
(Nguyen et al., 2015). 
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3.3 Aim of the project: 
 
“Fine-scale spatial architecture of intestinal 
microbial communities in a mouse model of diet” 
 
 
Extensive research has shown that diet modulates the composition and function of the gut 
microbiota in humans and other mammals.   
We previously demonstrated the impact of diet linked to obesity and the possible role of gut 
microbiota in the pathophysiology of obesity. In order to obtain a more detailed idea of the role 
of the gut microbiota respect to diet, we performed a diet-shift experiment for one week in wild-
type mice with different diets (polysaccharides free, fiber free and control diet) in order to 
evaluate the gut microbiota composition and its spatial organization in condition of fiber and 
polysaccharides privation. For this purpose, we collected faecal samples and samples from all 
colon’ compartments (proximal, middle and distal) and from lumen and ephitelium.We used 
genomic technologies to study the composition and diversity of host-associated microbial 
populations, we studied their spatial organization, and functional interactions by using 
fluorescence in situ hybridization (FISH) and laser capture microdissection (LCM) of fixed gut 
sections. First, highly penetrant organic fixatives were used to maintain the structure of the 
luminal contents throughout the entire sample preparation. Second, laser capture 
microdissection was used to specifically sample microbes that were either located from 
proximal to distal colon and near or distant to the mucosal surface. Third, we sequenced LCM 
samples and stool samples by using 16S gene target approach. To better determine the 
difference between lumen and epithelium contents, we focused on the distal colon using FISH 
analysis, to study target bacteria and investigate their spatial organization. Studying the 
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epithelium and lumen environments, we also addressed how mucus thickness and goblet cells 
were affected by increased microbial metabolization. 
This high-resolution system to capture and examine spatial organization of intestinal microbes 
should facilitate microbial analysis, furthering our understanding of host–microbial 
interactions. 
 
3.4 PRELIMINARY DATA 
 
3.4.1 EXPERIMENTAL DESIGN:  
 
 
Figure 3.2. Experimental setup of mice experiments, sampling and analysis. Three groups of mice were fed 
with control diet, fiber free and polysaccharide free diet (Table 3.2). The entire colon was cryopreserved in OCT 
and then subsampled in 6 different blocks (1 cm each) corresponding to distal colon, middle colon and proximal 
colon. 4 areas from each secion-block were cut with the laser microdissection microscope, while faecal samples 
were collected at three different time points in one week. Bacterial DNA was extracted from laser microdissected 
samples and from fecal samples and the 16S rRNA region were amplified for sequencing analysis.  
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3.4.2 MATERIALS AND METHODS  
 
 
Animal experiments and samples collection 
9 Wild-type C57BL/6, 2 weeks old were fed with a standard diet (R/M-H Ssniff®, Germany). 
The mice were divided in 3 groups (n=3 per group): the first was submitted to a fiber free diet 
(FF) and the second to a polysaccharide free diet (PF) for 1 week. A control group (CON) was 
fed with the previous standard diet (Table 3.2). The mice were housed in a controlled 
environment (12h daylight cycle) with free access to food and water. Mice were weighed at day 
1 and day 7 during the weekly dietary treatment and faecal pellet were collected three times 
during the week of diet shift (day 1, 4 and 7). At day 7, they were sacrificed by cervical 
dislocation, and the large intestine was collected, cryopreserved in OCT (Thermoscientific, 
USA) and stored at -80°C for further analysis. 
 
Tissue fixation, fluorescence in situ hybridization (FISH)  
The distal colon was fixed in 4% paraformaldehyde overnight and subsequently treated with 
20% sucrose overnight. The tissues were immediately frozen with isopentane (VWR, USA) and 
then cut at the cryotome (Leica CM3050, Germany) (10 µm thickness) using superfrost ultra 
plus slides (Thermoscientific, USA). Cryosections were stored at -20°C or immediately use for 
FISH analysis. Briefly, cryosections were quickly washed in 1X PBS then submitted to a 
dehydration step in ethanol series (50-80-96%) for 3 minutes each. 20 µl of hybridization buffer 
were applied with subsequent adding of 5 µM of specific probes. After 2 hours of hybridization 
in a humidified chamber at 46°C, the slides were washed in specific wash buffers (Daims, 
2009). The humidified chamber was made by folding a paper towel soaked up with 
hybridization buffer put into a 50 ml conical centrifuge tube. After hybridization, the slides 
were transferred into the preheated wash buffer and put into the water bath (48°C) for 10 
minutes. Subsequenly, the slides was dipped into ice-cold MILLI-Q water (Millipore GmbH, 
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Vienna, Austria) for approximately three seconds and dried under an air-jet. Finally 1:1000 
DNA stain, 4’, 6 diamidino-2-phenylindole (DAPI) solution, (in PBS) were applied for 5 min 
and then washed in cold MILLI-Q water (Daims, 2009). All slides were stored in a box 
impermeable to light at -20 °C for analysis on the confocal laser scanning microscope (CLSM) 
and before visualization they were embedded with CitiFluor (Agar Scientific Ltd., Stansted, 
UK). The specific bacterial probes (Thermoscientific, USA) used for FISH analysis are listed 
in Table 3.3. Total bacteria were staining using the general bacterial probe mix (EUB338 I-III), 
and the NONEUB probe was used as a negative control. Hybridized samples were displayed 
on a confocal scanning laser microscope (Leica TCS SP8X, Germany; software LAS-AF, 
Austria). A set of 25-30 fields view for lumen and 15-20 for epithelium (X 63) were collected 
for each mouse for each set of probe. The microscope was equipped with an Ar-laser (495nm) 
for excitation of the Fluos-dyes and two He-Ne-lasers (550 nm and 635 nm) for excitation of 
Cy3 and Cy5. The pinhole size was set to 1µm and resolution used for all images ranged from 
1024x1024 to 2396x2396 pixels and zoom factor of 1 were used for all pictures.  
Alcian blue staining  
Cryosection were submitted to alcian blue staining (alcian blue solution 1% w/v in 3% acetic 
acid, pH 2.5) in order to visualize goblet cells and mucins. Briefly, the samples were washed 
quickly in PBS 1X, then alcian blue were applied for 30 minutes at room temperature. The 
slides were washed with tap water and subsequently with MILLI-Q water. Lastly, slides were 
embedded with CitiFluor (Agar Scientific Ltd., Stansted, UK). Samples were visualized on 
optical microscope (Carl Zeiss GmbH, Germany, software Axio vision 4.8, Germany) and a set 
of 40 view (X100) of the ephitelial cells were collected. Moreover, 35-40 field (X100) of mucus 
or epithelium area were collected in order to measure the mucus layer thickness.  
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Laser capture microdissection (LCM)  
The whole large intestine was cryopreserved in OCT (Thermoscientific, USA), 7 cm long, and 
subsampled in six parts corresponding to distal colon, middle colon and proximal colon. 
Proximal (lumen content) and distal (epithelium or mucus) areas were collected from each 
compartment (1 cm tissue block) (Figure 3.2 and 3.3). Unfixed cryosections were mounted onto 
UV-treated polyethylene terephthalate (PET) 1.4 µm thick LCM slides (Leica) and submitted 
to laser microdissection with a Laser Microdissection Systems Leica LCM700. The laser setting 
was the following: power 50, aperture 12, speed 100, specimen balance 25, head current 100%, 
pulse frequency 3500.  Eight areas (10,000 µm2) per section per mouse; four for epithelium or 
mucus and four for lumen content were dissected. 48 samples per mouse were collected for a 
total of 432 samplings. The mucus content was collected with a distance not more than 100 µm 
away from mucosa. One area outside the sample (10,000 µm2) was collected as a negative 
control for each cryosection.  
 
MUC2 and FISH staining combination 
Part of distal colon was fixed in methacarn solution (60% absolute methanol, 30% chloroform, 
10% glacial acetic acid) overnight. In order to enable immunofluorescence imaging of MUC2, 
we used methacarn fixation, which preserves the mucus layer structure compared to traditional 
formaldehyde-based fixatives in which the mucus collapses (Earle et al, 2015). The sections 
were washed in 70% ethanol 3 times for 10 min. Afterwards they were embedded in paraffin 
and then cut at the microtome (Leica, Germany) with a thickness of 10 µm. Sections were 
incubated at 46ºC for 1 hour, slides not used immediately were stored at 4ºC. Sections were 
deparaffinized in two changes xylene for 10 min each and then rehydrated in ethanol washes 
(95% and 90%) for 10 min each. A mixture of hybridization buffer and EUB 338 I-III probe 
was applied on the samples and incubated for 2 hours in humidified chambers at 46 ºC. After 2 
hours, the slides were washed in the corresponding wash buffer as described by Daims, 2009. 
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Rabbit polyclonal MUC2 primary antibody (H-300 Santa Cruz technologies) was diluted 1:100 
in 0.9M NaCl, 20mM Tris-H Cl (pH: 7.2) and 50 µl were added for each section, covered with 
plastic coverslip and incubated overnight at 4⁰C in the dark. The day after the slides were 
washed 10 min in 0.9M NaCl, 20mM Tris-HCl (pH: 7.2) buffer at 4⁰C and then incubated for 
1 hour with 1:1000 Alexa 488 goat anti-rabbit secondary antibody Cy3 labelled at 4⁰C in dark 
conditions. After the incubation 50 µl of 1:1000 DAPI solution (in PBS) were applied for 5 
minutes at room temperature in the dark, and washed in cold MilliQ water. Slides were stored 
in the dark at -20 °C until visualization on the CLSM.  
 
DNA extraction, preparation of 16S gene target amplicons libraries from fecal samples 
and laser microdissected samples  
Extraction of nucleic acids from faecal samples was performed using a phenol-chloroform 
bead-beating procedure (Griffiths et al., 2000). Amplification was performed with a two-step 
barcoding approach according to Herbold et al, 2015. Briefly, DNA was subjected to a two-step 
PCR amplification targeting the 16S rRNA gene using a forward primes S-D-bact-0341-b-S-17 
(5’-CCTACGGGNGGCWGCAG-3’) and a reverse primer S-D-bact-0785-a-A-21 (5’-
GACTACHVGGGTATCTAATCC-3’). The first PCR reaction was performed in triplicate with 
25 cycles. In the second-step PCR, PCR products from the first step were amplified in 5 cycles 
with primers consisting of the 16 bp head sequence and a sample-specific 8 bp barcode from a 
previously published list at the 5′ end. Each PCR reaction (20 μL in first step, 50 μL in second 
step) consisted of 10× Taq buffer (Fermentas, USA), 2 mM dNTPmix (Fermentas), 25 mM 
MgCl2 (Fermentas), 5 U/μl Taq DNA polymerase (Fermentas), 20 mg/ml bovine serum albumin 
(Fermentas), 50 μM of each of the forward and reverse primers and 5μl of sample. Thermal 
cycle conditions were: 95°C for 3 min, 95°C for 30 s, a primer-specific annealing temperature 
of 55°C for 30 s, 72°C for 1 min for 25 cycles and an elongation time of 72°C for 7 min (step1); 
52°C for 30 s, 72°C for 1 min for 5 cycles (step 2) and an elongation step of 72°C for 7 min.  
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For laser microdissected samples, cryosections were captured in U/V treated tissue lysis buffer 
(ATL) (from the QiAmp mini DNA extraction kit, Qiagen) and DNA was extracted using the 
QiAmp mini DNA extraction kit according to the manufacturer’s instructions. The same set of 
16S primers and master mix components were used as described above. Laser microdissected 
samples underwent a 10 repeat PCR cycle as follows; 95⁰C incubation for 3 mins, 95⁰C for 30 
secs, 55⁰C for 30 secs, 72⁰C for 1 min, with a final 72⁰C phase for 7 mins. The second step was 
performed with 30 repeat cycle PCR programme as above, using 52⁰C instead of 55⁰C 30 sec 
step.  
For both kind of samples the first PCR reaction was performed in triplicate, pooled for use as a 
template in the second step and evaluated qualitatively by gel electrophoresis. The barcoded 
amplicons from stool samples were purified after the second step with ZR-96 DNA Clean-up 
Kit (Zymo Research, USA) and the LCM samples were purified with Agencourt AMPure beads 
(Beckman Coulter Genomics, Danvers, MA). All samples were quantified using the Quant-iT 
PicoGreen dsDNA Assay (Invitrogen, USA). An equimolar library was constructed by pooling 
samples, and the resulting library was sent to be sequenced on the Illumina MiSeq platform at 
Microsynth AG (Balgach, Switzerland).  
 
Sequence analysis  
Sequence data were sorted into libraries using the 8 nt sample-specific barcode and primer using 
a custom-made in-house script, quality-filtered according to the Earth Microbiome Project 
guidelines, and paired end reads were concatenated (Bokulich et al., 2013). Reads were then 
clustered into species-level operational taxonomic units (OTUs) of 97% sequence identity, 
checked for chimeras using USEARCH, and taxonomically classified using the Ribosomal 
Database Project näive Bayesian classifier (Wang et al., 2007). Sequence data has been 
deposited in the NCBI Short Read Archive under BioProject: PRJNA338397. 
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To avoid biases related to uneven library depth, sequencing libraries were subsampled to a 
number of reads smaller than the smallest library (7500 reads for stool samples and 1000 reads 
for LCM samples) and the negative controls were excluded.  
 
Images analysis 
Images analysis were performed with the software digital image analysis in microbial ecology 
(Daime) and biovolume fraction and spatial arrangement of cells were calculated (Daims et al., 
2006). 
The biovolume fraction is the measure of the specifically labelled target population relative to 
the biovolume of the total biomass. The total biomass was stained by the general probe EUB 
338 I-III. Automatic or semi-automatic 2D-segmentation were performed for each set of probes 
to detect the microbial cells and the goblet cells according to Daims et al, 2006.   
In order to detect the real distribution of the cells (clusters formation, randomly distribution or 
mutual avoidance patterns), we performed the spatial arrangement analysis using the Linear 
Dipole algorithm for one population. The distance range was set from 0 to 120 µm every one 
cell and the analysis was performed with random dipoles adjusted to 200,000 per distance. The 
reference space for the analysis was specified by using the EUB338 images as reference space 
masks. The obtained pair correlation function (g(r)) indicates whether populations coaggregate, 
avoid each other, or are randomly distributed at distance r (in µm). Random distribution is 
indicated by g(r) =1, whereas g(r)>1 suggests co-aggregation and g(r) <1 mutual avoidance of 
the population (Daims et al., 2006). The spatial arrangement analysis was performed for each 
mouse for each location (lumen and epithelium areas) and single measurements were pooled 
by calculating the arithmetic mean curves with respective 95% confidence intervals.  
In order to avoid overestimation of clusters and mutual avoidance patterns, the area of the cells 
were measured for the probes Dsp653 (Desulfovibrio piger) and Lab158 (Lactobacillus spp. 
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and Enterococcus spp.), in which the biomass detected was quite low (less then 2%). Once 
images have been segmented the area of the selected objects were measured. 
The measurement of the thickness of the mucus layer was performed after Alcian blue staining.  
About 35-40 randomly selected fields were taken for each distal colon’s mouse with a 100X 
magnification. A minimum of 10 different measurements were made perpendicular to the inner 
mucus layer per field. A total of about 3150-3600 measurements were performed and measured 
by using Fiji software (Schindelin et al, 2012).  
 
Statistical analysis 
Statistical analysis were performed using the statistical software R (https://www.r-project.org/) 
and Graph Pad Prism (Graph Pad Software, Inc., la Jolla, CA, USA).  
The statistical significance of factors were evaluated using permutational multivariate analysis 
of variance (perMANOVA). Alpha diversity metrics and beta diversity were calculated using 
the vegan package (Oksanen et al.,2010) and indicator species analysis was carried out with the 
indicspecies package (De Caceres et al., 2009). The differences in the relative abundance 
between diets and compartments were performed using ANOVA for normal distribution or 
Kruskal-Wallis test for non-nomal distribution. Post-hoc tests were used for multiple 
comparisons between dietary groups (Tukey’s and Dunn’s tests after ANOVA and Kruskal-
Wallis, respectively) and paired t test was used to compare the changes in relative abundance 
between day 1 and day 7 of weekly dietary treatment.  
Variables were expressed as mean ± standard deviation (SD) and a p-value less or equal then 
0.05 was considered statistically significant. 
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Table 3.2. Composition of mice’s diet. 
 
  Proximate  
contents 
Diet without 
polysaccharides  
Diet with 
polysaccharides 
without cellulose  
  Control diet 
Crude protein, % 18.5 18.5   19 
Crude fat, % 7.1                                                7.1                                    3.3 
Crude fiber,% - -                               4.9 
Crude ash, % 5.3 5.3  6.4                     
Starch, % - 35.1  36.6 
Sucrose, % 65.1 13                                 4.7 
ME(atwater) MJ/kg 16.9 16.7  12.8 
Protein, kcal % 18.3 18.6  33 
Fat, kcal% 15.8 16.1  9 
Carbohydrate, 
kcal % 
65.8 65.3            58 
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Table 3.3. List of probes used for FISH analysis. 
 
Probe name specificity probe sequence (5'->3') 
 
fluoroph
ore 
 
FA 
(%) 
 
References 
Baci731A_87 
 
 
Bacteroides_acidifaciens 
OTU_731 
 
GCG CCG GTC GCC 
ATC AAA AGT TTG 
 
Cy5 
dope 
35 Alm et al., 1996 
Baci731B_87 
 
Bacteroides_acidifaciens 
OTU_731 
 
G CCG GTC GCC ATC 
GGA AGT TTG 
 
Cy5 
dope 
35 Alm et al., 1996 
Dsp653 
 
Desulfovibrio piger 
 
CCA CCC TCT CCC 
GGA TTC 
 
Cy3 30 Reichert, 2012 
 
Erec482 
 
most of the Clostridium 
coccoides-Eubacterium 
rectale group 
(Clostridium cluster 
XIVa and XIVb) 
 
GCT TCT TAG TCA RGT 
ACC G 
 
Cy3 
dope 
0 Franks et al., 1998 
Lab158 
 
Lactobacillus 
and Enterococcus spp. 
 
GGT ATT AGC AYC TGT 
TTC CA 
 
Cy3 10 Harmsen et al, 1999 
Bac303 
 
most Bacteroidaceae 
and Prevotellaceae, 
some 
Porphyromonadaceae 
 
CCA ATG TGG GGG 
ACC TT 
 
Cy3 
dope 
10 Manz et al., 1996 
ACA652 
 
Acinetobacter 
 
ATCCTCTCCCATACTCT
A 
 
Cy3 35 Wagner et al, 1994 
Gam42a Gammaproteobacteria  GCC TTC CCA CAT CGT 
TT  
Cy5 35 Alm et al., 1996 
Bet42a 
competitor 
Betaproteobacteria GCC TTC CCA CTT CGT 
TT  
Cy3  35 Alm et al., 1996 
EUB338-I 
 
most Bacteria 
 
GCTGCCTCCCGTAGGA
GT 
 
Flous 0-50 Amann et al. 1990 
EUB338-II 
 
Planctomycetales 
 
GCAGCCACCCGTAGG
TGT 
 
Fluos 0-50 Daims et al. 1999 
EUB338-III 
 
Verrucomicrobiales 
 
GCTGCCACCCGTAGGT
GT 
 
Fluos 0-50 Daims et al. 1999 
Non-EUB 
 
Complementary to 
EUB338 
(Negative control) 
ACTCCTACGGGAGGC
AGC 
 0-50 Wallner et al. 1993 
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Figure 3.3. Pictures performed at the laser microdissection microscope (A) example of mucus and lumen 
samplings (B): mucus or epithelium, (C): lumen content.  
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3.4.3 RESULTS  
 
Sample collections  
To address how microbial population changes after a weekly dietary treatment and how mucus 
thickness is affected by diet shift, we fed three wild-type mice with a control diet (CON), three 
with diet deficient in fiber (FF) and three with diet deficient in polysaccharide (PF). Mice 
weights were assessed at day 1 and day 7 during the weekly dietary treatment. No statistical 
significant difference was present between day 1 and day 7 for each group [(FF (p=0.3845), PF 
(p=0.7546), CON (p=0.3388)] (Figure 3.4). Faecal pellet were collected at day 1, 4 and 7 and 
after the weekly dietary treatment, the mice were sacrificed and colon segments were harvested 
and fixed. 48 samples for each mouse were collected with laser microdissection microscope for 
a total of 432 samples.  
 
Figure 3.4. Weight of mice assessed at day 1 and day 7 during the weekly dietary treatment.  
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The intestinal microbiota is altered by diet composition 
At the phylum level, the predominant bacterial taxa in the stool samples were Bacteroidetes             
and Firmicutes, followed by Proteobacteria and Verrucomicrobia (Figure 3.5A).  
The most abundant families were S24-7, Lachnospiraceae, Prevotellaceae, Desulfovibrionace
ae, Ruminococcaceae, Rikenellaceae, Bacteroidaceae, Verrucomicrobiaceae, Lactobacillacea
e, Porphyromonadaceae, Alcaligenaceae and Erysipelotrichaceae (Figure 3.5B).  
The most abundant genera were S24-7 members, Blautia, Desulfovibrio, Prevotella, Alistipes, 
Bacteroides, Alloprevotella, Incertae_Sedis (Lachnospiraceae), Akkermansia, Incertae_Sedis         
(Ruminococcaceae), Lactobacillus, Parasutterella, Parabacteroides, Intestinimonas and Incer
tae_Sedis (Erysipelotrichaceae) (Figure 3.5C).   
A dramatic drop in all alpha diversity metrics in FF and PF diets at days 4 and 7 respect to         
CON was present (ANOVA: Observed species: p<0.0001; Chao1 estimated richness:                                
p<0.001; Shannon:p=0.0001; Inverse Simpson: p=0.0014) (Figure 3.6A). Accordingly, a clear     
shift of communities at day 4 and 7 in FF and PF was present and it was further represented in 
the ordination analysis and in Beta diversity (p<0.0001) (Figure 3.6B and C).  
In agreement with the previous observations, perMANOVA results considering diet and days 
and interaction diet and days, was significant at every taxonomic level (phylum to OTUs, 
p<0.05). Therefore, we compared the relative changes in abundance of the microbiota between 
days 1 and 7 for each group (Figure 3.7). An increased relative abundance of Proteobacteria 
from day 1 to 7 was significant for PF (Two tailed Paired t-test: p=0.0012). A similar trend was 
observed for FF but this trend was not statistical significant (p= 0.1317). A decrease of 
Bacteroidetes was present for both FF and PF but not significant (p=0.1140, p=0.1223). At 
family and genus level, an increase of Ruminococcaceae was significant only for FF while an 
increase of Desulfovibrio spp. at family and genus level was present only in PF, further 
confirmed by indicator species analysis. No statistical significant increase or decrease in 
relative abundance was found for CON at any taxonomic level (Table 3.4).  
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Indicator species analysis, which evaluated the impacts of environmental change on taxa, was 
used to identify the indicators OTUs changed from day 1 to 7. We identified 9 indicator OTUs 
for both FF and PF groups. The most of the bacterial species identified were implicated in fiber 
and polysaccharide degradation, meaning that the identifications of these species were diet 
dependent (Table 3.5).  
 
 
 
 
Figure 3.5. Abundant bacterial taxa in stool samples of fiber free (FF), polysaccharide free (PF) and control 
(CON) diet mice divided by diet intervention days. Phylum-level (A) and family-level (B) and genus-level (C) 
taxon profiles are shown. Abundant taxa, defined as having a mean relative abundance of >1%, are shown. 
 
A B 
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Figure 3.6.  (A) Intestinal microbiota richness and diversity of fiber free (FF), polysaccharide free (PF) and    
control (CON) diet mice divided by dietary intervention days. (Tukey’s test after ANOVA day 1 vs day 7:                 
FF: Observed species: 0.0001; Chao1 estimated richness: 0.0008; Shannon: 0.0083; Inverse Simpson: p= 0.0471; 
PF: Observed species: 0.0003; Chao1 estimated richness: 0.0002; Shannon: 0.0154, Inverse Simpson: p= 0.05; C
ON: Observed species: 0.9999; Chao1 estimated richness: 0.9920; Shannon: 0.9971; Inverse Simpson: p= 0.661)
(B) Principal component analysis shows a grouping of samples at day 4 and 7 in PF and FF diet (C) Beta                      
diversity shows a significant difference in the three groups (ANOVA:p<0.0001).  
 
 
 
 
 
 
Figure 3.7. Shift of relative abundance at phylum and family level. The changes in relative abundance of taxa 
(day 1 relative abundance minus day 7 relative abundance) for each mouse is shown for the phylum-level (A) and 
family-level (B). Only taxa that displayed a mean change of at least 0.1% relative abundance are shown.  
A B 
C 
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Table 3.4. Paired t test between day 1 and 7 from phylum to genus level. No significant taxa were different for 
CON. Significant shift respect to CON are shown. p-values <0.05 are represented.  
 
 
Taxonomic level Taxon Significant shift PF FF 
Phylum Proteobacteria + 0.0012 - 
Family S 24-7 - 0.0133 0.0024 
Ruminococcaceae + - 0.0162 
Desulfovibrionaceae + 0.0103 - 
Lactobacillaceae - - 0.0422 
Genus S 24 7 unclassified - 0.0133 0.0011 
Prevotella 
(Prevotellaceae) 
- 0.05 0.0335 
Desulfovibrio 
(Desulfovibrionaceae) 
+ 0.0103 - 
 Ruminococcaceae 
unclassified   
+ - 0.0020 
 
Lactobacillus 
(Lactobacillaceae)  
- - 0.0422 
 
Parabacteroides 
(Porphyromonadaceae)  
+ - 0.0356 
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Table 3.5. Indicator OTUs from day 1 to 7 for FF and PF groups. A p value <0.05 is shown. 
OTU_ID associated  with FF Closest related species Similarity (%) p value 
OTU_4006 Bacteroides intestinalis 91 0.010 
OTU_20 Clostridium thermocellum 88 0.045 
OTU_21 Clostridium xylanolyticum 91 0.005 
OTU_314 Clostridium thermocellum 90 0.010 
OTU_1942 Clostridium saccharolyticum 93 0.020 
OTU_140 Bacteroides xylanolyticus 95 0.010 
OTU_322 Clostridium xylanolyticum 95 0.015 
OTU_2119 Clostridium xylanovorans 89 0.025 
OTU associated with PF Closest related species Similarity (%) p value 
   OTU_516 Parabacteroides distasonis           84 0.010 
OTU_3061 Clostridium saccharolyticum 89 0.010 
                OTU_164 Eubacterium cylindroides 88 0.025 
OTU_2569 Bacteroides cellulosilyticus 80 0.015 
OTU_1617 Ruminococcus obeum 92 0.015 
OTU_1895 Bacteroides eggerthii 99 0.010 
OTU_3122 Desulfovibrio desulfuricans 88 0.050 
OTU_1725 Ruminococcus champanellensis 87 0.030 
OTU_2942 Desulfovibrio intestinalis 88 0.040 
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Microbial communities’ composition in mice colon  
At the phylum level, the predominant bacterial taxa in mice colon were Firmicutes and Bacter
oidetes followed by Actinobacteria and Proteobacteria (Figure 3.8A). The most abundant fa
milies were Lachnospiraceae, Ruminococcaceae, S24-7 (Bacteroidetes), Erysipelotrichaceae, 
Lactobacillaceae, Propionibacteriaceae, Streptococcaceae, vadinBB60 (Clostridiales), Veill
onellaceae, Coriobacteriaceae, Rikenellaceae, Porphyromonadaceae and Clostridiaceae (Fig
ure 3.8B). The most abundant genera were Lachnospiraceae unclassified, S24-7 unclassified         
(Bacteroidetes), Anaerotruncus (Ruminococcaceae), Lactobacillus (Lactobacillaceae), Rumin
ococcaceae unclassified, Blautia (Lachnospiraceae), Ruminococcus (Ruminococcaceae), Pro
pionibacterium, Hespellia, Coprobacillus(Erysipelotrichaceae), vadinBB60 unclassified (Clo
stridiales), Streptococcus (Streptococcaceae),Coprococcus (Lachnospiraceae), Dialister (Vei
llonellaceae),  Erysipelotrichaceae unclassified,  Odoribacter (Porphyromonadaceae), Alistip
es (Rikenellaceae), Roseburia (Lachnospiraceae), Enterorhabdusm (Coriobacteriaceae), Par
asporobacterium(Lachnospiraceae), Allobaculum (Erysipelotrichaceae), Pseudoflavonifract
or (Ruminococcaceae) and  Intestinimonas (Ruminococcaceae) (Figure 3.8C). 
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Figure 3.8. Abundant bacterial taxa in colon of fiber free diet (FF), polysaccharide free (PF) and control 
(CON) diet mice divided by compartment (distal colon, middle colon, proximal colon) and location [distal 
(lumen) and proximal (epithelium or mucus)]. Phylum-level (A) family-level (B) and genus-level (C) taxon 
profiles are shown. The mean of the relative abundance >1% for each group is shown.  
 
Faecal and LCM samples have a different microbial profile 
16S rRNA gene profiles showed that microbial populations associated with the intestinal 
mucosa were distinct from those found in fecal samples in CON group. At phylum level the 
most abundant in ascending order were Bacteroidetes, Firmicutes, Proteobacteria and 
Verrucomicrobia, while in LCM samples Firmicutes, Bacteroidetes, Actinobacteria and 
Proteobacteria predominated (T Student test: p<0.0001). At family level only S24-7, 
Lachnospiraceae, Ruminoccoccae, Erysipelotricaceae and Porphyrimonodaceae were shared 
with a significant difference between faecal and LCM samples for all families (T Student test: 
p<0.0001) (Figure 3.9).  
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Figure 3.9. Comparison between stool and LCM samples in gut microbial communities. Pie chart performed 
at phylum (A, B) and family level (C,D) for CON group. A mean of relative abundance <1 % is shown.  
 
The privation of fibers and polysaccharides affected the diversity and richness of colonic 
intestinal compartments 
A similar reduction in alpha diversity is present in compartmentalized samples (p<0.0001 for 
all alpha diversity metrics) (Figure 3.10A). In agreement, a strong difference in CON diet vs. 
FF and PF was present as shown in the PCoA and in the Beta diversity (p<0.0001) (Figure 
3.10B). perMANOVA analysis showed that diet, compartments (distal colon, middle colon, 
proximal colon) and location (distal, proximal) included their interactions, were significant at 
every taxonomic level (p<0.05). A clear separation within proximal, middle and distal colon is 
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present in CON, but the privation of fiber and above all the absence of polysaccharides 
compromised the beta diversity from proximal to distal colon (Figure 3.11A, B and C).  
Beta diversity for epithelium and lumen area confirmed perMANOVA data (p<0.0001) (Figure  
3.12A and B). Moreover, Bray Curtis mean distances for epithelium and lumen were significant 
for the three groups (proximal-distal: p=0.0155, proximal-proximal: 0.0196 and distal-distal: 
0.0001) (Figure 3.13), showing a different bacterial distribution between lumen and epithelium.  
 
 
Figure 3.10. (A) Intestinal microbiota richness and diversity of fiber free (FF), polysaccharide free (PF) and 
control (CON) diet mice divided by compartment (distal colon, middle colon, proximal colon) and location 
(distal and proximal). Observed species, Chao1 estimated richness, Shannon diversity, and inverse Simpson 
diversity estimators show significant difference between the three groups [(ANOVA=p<0.0001, Tukey’s test: FF 
vs CON: Observed species:p<0.0001; Chao1 estimated richness: p<0.0001; Shannon : p<0.0001; Inverse 
Simpson: p<0.0001; PF vs CON: Observed species:p<0.0001; Chao1 estimated richness: p<0.0001; Shannon : 
p<0.0001; Inverse Simpson: p<0.0001; PF vs FF Observed species:p=0.5104; Chao1 estimated richness:0.9818; 
Shannon :0.0785; Inverse Simpson:0.3152)]. (B) Principal component analysis shows a grouping of samples 
between CON vs PF and FF.  
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Figure 3.11. Beta diversity divided by diet. A clear separation is present for CON between proximal, middle 
and distal colon but the diet shift destroys the diversity of microbial communities from proximal to distal colon.  
 
 
 
(A) CON (B) FF 
(C) PF 
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Figure 3.12. Beta diversity for epithelium (A) and lumen (B) show a significant difference (p<0.0001 for all 
comparison).  
 
Figure 3.13. Mean of Bray Curtis distances for all groups (epithelium-lumen p=0.0155, epithelium-epithelium 
p=0.0196 , lumen-lumen p=0.0001).  
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Diet influences the gut microbiota composition from proximal to distal colon  
Preferential colonization niches are normally present from proximal to distal colon. In the distal 
colon of CON, we observed an increase in: Lachnospiraceae (38% vs. 31%, p=0.0006); 
Erysipelotrichaceae (7.2% vs 5.2%,p=0.0076); Coriobacteriaceae (4% vs 2%, p=0.0001); 
Propionibacteriaceae (3.8% vs 2.3%, p=0.0033); and a decrease in: S24-7 (4.4% vs 6.8%, 
p=0.0007); Ruminococcaceae (19.6% vs 24.4%, p=0.0022); Streptococcacaeae (1.1% vs 3.7%, 
p<0.0001); vadinBB60 (1.8% vs 3.3%, p=0.0003); Veillonellaceae (1.9% vs 3.1%, p=0.0027) 
respect to proximal colon (Figure 3.14, Table 3.7).  
Comparing the relative abundance in proximal, middle and distal colon, a more variability 
between compartments was present in CON; whereas in FF and PF groups this variability 
seemed to be partially lost at phylum and family level (Table 3.6, 3.7 and S3.1, S3.2) and they 
seemed to be diet dependent.  
Several changes were present in PF and FF group respect to CON. In PF, an increase of 
Bacteroidetes is reported only in the proximal colon but a decrease of them is reported in the 
distal and middle colon. Firmicutes tended to increase in all compartments, Actinobacteria in 
middle and proximal colon and Proteobacteria  increased only in the distal colon (Table 3.7).  
 In FF diet, Firmicutes decreased in the middle colon but increased in the proximal part. 
Bacteroidetes increased in the middle and proximal colon and Actinobacteria increased in the 
middle part (Table 3.7).  
At family level, Lachnospiraceae decreased in FF but increased in PF in distal colon, 
Ruminococcaceae and S24-7 increased in FF in distal and proximal colon but decreased in PF 
in middle and proximal part. Lactobacillaceae and Propionibacteriaceae increased in FF and 
PF in all compartments. Several families decreased in PF and FF: Streptococcaceae 
Erysipelotrichaceae, VadinBB60, Veillonellaceae, Coriobacteriaceae, Rikenellaceae, 
Porphyromonadaceae and Clostridiaceae (Table S3.2). Details regarding shifts in the single 
compartments are presented in tables 3.7 and S3.2. 
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Figure 3.14. Microbial composition for distal, middle e proximal colon in CON diet at family level. 
Significant differences between compartments are represented also in Tables 3.6 ans S3.1. 
 
 
Table 3.6. Comparison between compartments: distal, middle and proximal colon considering each group 
of diet. Multiple comparisons were performed with Dunn’s test after Kruskal-Wallis test for each group of diet 
at phylum level.  
 
Phylum level profiles CON FF PF 
Sign. Sign. Sign. 
Firmicutes m vs. Firmicutes d **** ns ns 
Firmicutes m vs. Firmicutes p *** ns ns 
Firmicutes d vs. Firmicutes p **** ns ns 
Bacteroidetes d vs. Bacteroidetes m **** ns ns 
Bacteroidetes m vs. Bacteroidetes p **** ns * 
Bacteroidetes d vs. Bacteroidetes p **** ns ns 
Actinobacteria d vs. Actinobacteria m **** ns ns 
Actinobacteria d vs. Actinobacteria p **** ns ns 
Actinobacteria m vs. Actinobacteria p ns ns ns 
Proteobacteria d vs. Proteobacteria m ** ns * 
Proteobacteria d vs. Proteobacteria p ns ns * 
Proteobacteria m vs. Proteobacteria p ns ns ns 
 
Legend= d:distal colon, m:middle colon, p:proximal colon, ns:not significant, CON: 
control diet, FF: fiber free diet, PF: ploysaccharyde free diet.  
**** p≤0.0001; ***p≤0.001; **p≤0.01; *p≤0.05. 
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Table 3.7. Comparison between diets considering each compartment separately.  Multiple comparison 
Dunn’s test for each group of diet performed at phylum level.  
 
Phylum level profile Distal  colon Middle 
colon 
Proximal 
colon 
Sign. Shift Sign. Shift Sign. Shift 
Firmicutes con vs. Firmicutes ff ns   - **** ff- **** ff+ 
Firmicutes con vs. Firmicutes pf ***   pf + ns - **** pf+ 
Firmicutes ff vs. Firmicutes pf * pf + ** pf+ ns - 
Bacteroidetes con vs. Bacteroidete ff ns - ** ff+ **** ff+ 
Bacteroidetes con vs. Bacteroidetes pf ** pf- ** pf- *** pf+ 
Bacteroidetes ff vs. Bacteroidetes pf * pf- *** pf- * pf+ 
Actinobacteria con vs. Actinobacteria ff ns - ** ff+ ns - 
Actinobacteria con vs. Actinobacteria pf ns - **** pf+ * pf+ 
Actinobacteria ff vs. Actinobacteria pf ns - ** pf+ ns - 
Proteobacteria con vs. Proteobacteria ff ns - ns - ns - 
Proteobacteria con vs. Proteobacteria pf ** Pf+ ns - ns - 
Proteobacteria ff vs. Proteobacteria pf ns - ns - ns - 
Legend= con: control diet, ff: fiber free diet, pf: ploysaccharyde free diet, ns: not significant, += increase,  
- = decrease in relative abundance (%) of pf and ff respect to con are shown.  
**** p≤0.0001; ***p≤0.001; **p≤0.01; *p≤0.05. 
 
 
Longitudinal gradients along colon compartments  
The differences between compartments are in agreement with distance decay analysis along all 
sections. Distance decay is a geographical term, which describes the effect of distance on spatial 
interactions. Distance decay analysis revealed a longitudinal gradient from proximal to distal 
colon [CON (p<0.0001), FF (p<0.0001), PF (p=0.0002)] (Figure 3.15) and a negative 
correlation between section’s similarity and distance across sections. When the distance across 
sections increased the similarity between them decreased.  
A distance-decay relationship with a negative correlation is also present for epithelium [CON 
(p<0.0001), FF (p=0.0002), PF (p<0.0001)] and lumen [CON (p<0.0001), FF (p<0.0001), PF 
(p=0.0002)].  
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Figure 3.15. Distance-decay analysis for each group of diet shows the presence of a longitudinal gradient along 
all colon sections.  
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Supplementary results 
Table S3.1. Comparison between compartments: distal, middle and proximal colon considering each group 
of diet separately. Multiple comparison were performed with Dunn’s test after Kruskal-Wallis test for each group 
of diet at family level.  
 
Family level profiles CON FF PF 
Sign. Sign. Sign. 
Lachnospiraceae d vs. Lachnospiraceae m ns ns ns 
Lachnospiraceae d vs. Lachnospiraceae p *** ns ns 
Lachnospiraceae m vs. Lachnospiraceae p * ns ns 
Ruminococcaceae d vs. Ruminococcaceae m ns ns ns 
Ruminococcaceae d vs. Ruminococcaceae p * ** ns 
Ruminococcaceae m vs. Ruminococcaceae p ns * ns 
S24-7 d vs. S24-7 m *** ns ns 
S24-7 d vs. S24-7 p ** ns ns 
S24-7 m vs. S24-7 p ns ns ns 
Erysipelotrichaceae d vs. Erysipelotrichaceae m ns ns ns 
Erysipelotrichaceae d vs. Erysipelotrichaceae p * ns ns 
Erysipelotrichaceae m vs. Erysipelotrichaceae p * ns ns 
Propionibacteriaceae d vs. Propionibacteriaceae m *** ns ns 
Propionibacteriaceae d vs. Propionibacteriaceae p ** ns ns 
Propionibacteriaceae m vs. Propionibacteriaceae p * ns ns 
Lactobacillaceae d vs. Lactobacillaceae m  **** ** ns 
Lactobacillaceae d vs. Lactobacillaceae p ns *** ns 
Lactobacillaceae m vs. Lactobacillaceae p *** ns * 
Streptococcaceae d vs. Streptococcaceae m *** ns ns 
Streptococcaceae d vs. Streptococcaceae p ** ns ns 
Streptococcaceae m vs. Streptococcaceae p * ns ns 
vadinBB60 d vs. vadinBB60 m ** ns ns 
vadinBB60 d vs. vadinBB60 p * ns ns 
vadinBB60 m vs. vadinBB60 p ns ns ns 
Veillonellaceae d vs. Veillonellaceae m *** ns * 
Veillonellaceae d vs. Veillonellaceae p ns * *** 
Veillonellaceae m vs. Veillonellaceae p ns ns ns 
Coriobacteriaceae d vs. Coriobacteriaceae m **** * ns 
Coriobacteriaceae d vs. Coriobacteriaceae p *** ** ns 
Coriobacteriaceae m vs. Coriobacteriaceae p ns ns ns 
Rikenellaceae d vs. Rikenellaceae m **** ns ns 
Rikenellaceae d vs. Rikenellaceae p ns ns ns 
Rikenellaceae m vs. Rikenellaceae p **** ns ns 
Porphyromonadaceae d vs. Porphyromonadaceae m **** ns ns 
Porphyromonadaceae d vs. Porphyromonadaceae p ** ns ns 
Porphyromonadaceae m vs. Porphyromonadaceae p * ns ns 
Clostridiaceae d vs. Clostridiaceae m **** ns ns 
Clostridiaceae d vs. Clostridiaceae p ns ns ns 
Clostridiaceae m vs. Clostridiaceae p *** ns ns 
          Legend= d: distal colon, m: middle colon, p:proximal colon, ns:not significant, CON: control diet,  
         FF: fiber free diet, PF: ploysaccharyde free diet.  
         **** p≤0.0001; ***p≤0.001; **p≤0.01; *p≤0.05. 
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Table S3.2. Comparison between diets considering each compartment separately. Multiple comparison 
Dunn’s test for each group of diet performed at family level.  
 
Family level profile Distal  colon Middle 
colon 
Proximal 
colon 
Sign. shift Sign. shift Sign. shift 
Lachnospiraceae con vs. Lachnospiraceae ff * ff- ns - ns - 
Lachnospiraceae con vs. Lachnospiraceae pf ns - ns - ns - 
Lachnospiraceae ff vs. Lachnospiraceae pf * pf+ ns - ns - 
Ruminococcaceae con vs. Ruminococcaceae ff * ff+ ns - ** ff+ 
Ruminococcaceae con vs. Ruminococcaceae pf ns - ns - ns - 
Ruminococcaceae ff vs. Ruminococcaceae pf ns - * pf- ** pf- 
S24-7 con vs. S24-7 ff **** ff+ ns - ** ff+ 
S24-7 con vs. S24-7 pf ns - ns - ns - 
S24-7 ff vs. S24-7 pf * pf- ** pf- **** pf- 
Erysipelotrichaceae con vs. Erysipelotrichaceae ff ** ff- **** ff- * ff- 
Erysipelotrichaceae con vs. Erysipelotrichaceae pf ns - ** pf- ns - 
Erysipelotrichaceae ff vs. Erysipelotrichaceae pf ns - ns - ns - 
Lactobacillaceae con vs. Lactobacillaceae ff **** ff+ **** ff+ * ff+ 
Lactobacillaceae con vs. Lactobacillaceae pf ** pf+ **** pf+ **** pf+ 
Lactobacillaceae ff vs. Lactobacillaceae pf ns - ** pf+ ** pf+ 
Veillonellaceae con vs. Veillonellaceae ff **** ff- **** ff- **** ff- 
Veillonellaceae con vs. Veillonellaceae pf * pf+ ** pf- ** pf- 
Veillonellaceae ff vs. Veillonellaceae pf **** pf+ *** pf+ *** pf+ 
Coriobacteriaceae con vs. Coriobacteriaceae ff * ff- * ff- ns ff- 
Coriobacteriaceae con vs. Coriobacteriaceae pf ns - ns - ns pf- 
Coriobacteriaceae ff vs. Coriobacteriaceae pf ns - ns - ns - 
Rikenellaceae con vs. Rikenellaceae ff *** ff- ns - ns - 
Rikenellaceae con vs. Rikenellaceae pf ** pf- ** pf- **** pf- 
Rikenellaceae ff vs. Rikenellaceae pf ns - *** pf- * pf- 
Porphyromonadaceae con vs. Porphyromonadaceae ff **** ff- **** ff- **** ff- 
Porphyromonadaceae con vs. Porphyromonadaceae pf *** pf- **** pf- **** pf- 
Porphyromonadaceae ff vs. Porphyromonadaceae pf ns - ns - ns - 
Clostridiaceae_con vs. Clostridiaceae ff **** ff- **** ff- **** ff- 
Clostridiaceae_con vs. Clostridiaceae pf * pf- **** pf- **** pf- 
Clostridiaceae ff vs. Clostridiaceae pf ns - ns - ns  
Propionibacteriaceae con vs. Propionibacteriaceae ff ns - * ff+ ns - 
Propionibacteriaceae con vs. Propionibacteriaceae pf ns - **** pf+ * pf+ 
Propionibacteriaceae ff vs. Propionibacteriaceae pf ns - ** pf+ ns - 
Streptococcaceae con vs. Streptococcaceae ff ns - **** ff- **** ff- 
Streptococcaceae con vs. Streptococcaceae pf ns - **** pf- **** pf- 
Streptococcaceae ff vs. Streptococcaceae pf ns - ns - ns - 
vadinBB60 con vs. vadinBB60 ff ns - **** ff- * ff- 
vadinBB60 con vs. vadinBB60 pf ns - *** pf- * pf- 
vadinBB60 ff vs. vadinBB60 pf ns - ns - ns - 
Legend= con: control diet, ff: fiber free diet, pf: ploysaccharyde free diet, ns: not significant, += increase,  
- = decrease in relative abundance (%) of pf and ff respect to con are shown.  
**** p≤0.0001; ***p≤0.001; **p≤0.01; *p≤0.05. 
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Fluorescence in situ hybridization revealed a differential localization of specific bacteria  
cells in lumen and epithelium  
 
Biovolume fraction and spatial arrangement of Bacteroides acidifaciens 
 
The quantification of B. acidifaciens revealed an elevated abundance in PF (34.8±12.2; mean 
± SD) respect to FF (17.3±10) and CON (14.7±10.7), (Kruskal Wallis test: p<0.0001) (Figure 
3.17A). Comparing lumen vs epithelium we found a significant difference in the localization of 
cells in PF (p=0.0077) characterized by an elevated abundance in epithelium area.  No statistical 
significant difference in the localization of cells were found for FF (p=0.052) and CON 
(p=0.3649) (Figures 3.16A and B, 3.17B). In order to see if an inter and intra-group variation 
in the three groups was present, the ratio epithelium/lumen was calculated and one-sample t test 
was performed. We did not find a significant difference inter and intra-group (p=0.3511 and 
p=0.053 respectively).  
Spatial arrangement of cells revealed a similar trend for the three groups of diet in the lumen 
with co-aggregation patterns around 10 µm of distance and in a lesser extent at 25 µm; in 
particular another co-aggregation peak is described for FF at 45 µm of distance. A randomly 
distribution pattern is described for FF and PF but a trend of mutual avoidance is presented for 
CON from 35 to 80 µm (Figure 3.18A).  
In the epithelium area a different trend is described.  A co-aggregation pattern is presented for 
CON and FF at 10 µm then a randomly distribution pattern is described until 80 µm. Another 
co-aggreagtion pattern is detected for FF at 30 µm while in PF was observed a randomly 
distribution behavior and a mutual avoidance distribution from 60 to 80 µm (Figure 3.18B). 
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Figure 3.16. Representative picture of a distal colon stained with DAPI (blue) EUB I-II-III 338 DOPE in Fluos (green) 
for all Bacteria and  the specific probe Baci731A_87, Baci731B_87 in Cy3 (red). Images were performed with confocal 
laser scanning microscope with: magnification 63X, resolution 2920x2920 for picture A (epithelium) and 1752x1752 
for picture B (lumen), zoom factor 1. 
 
  
 
Figure 3.17. (A) Biovolume fraction (%) for each groups divided by lumen and epithelium. (B) Biovolume fraction 
of combined pictures of lumen and epithelium. Kruskal Wallis test was used to analyze the differences between 
the three groups and Dunn’s test for multiple comparisons. **** p ≤0.001, **p≤0.01.  
 
A B 
A B 
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Figure 3.18. Pair-cross correlation (PCC) function curves of CON, FF and PF groups. To compare the results 
of bacterial cells localization, single measurements of each mouse for each location [lumen (A) and epithelium 
(B)] were pooled by calculating the arithmetic mean curves with respective 95% confidence interval (CI). The 
mean PCC curves for CON (pink line) versus FF (green line) and PF (blue line) was plotted with their respective 
95% CI (same colour of the samples) against distances in a range from 0–85 µm.  
 
 
Biovolume fraction of Clostridium cluster XIVa and XIVb and distance analysis  
The quantification of Clostridium cluster XIVa and XIVb (most of Clostridium coccoides and 
Eubacterium rectale) group revealed a decreased abundance in CON (2.0±2.0; mean ± SD) 
respect to FF (10.7±9.1) and PF (11.5±7.6). There was a statistical significant difference in the 
three groups of diets driven by a low abundance in the CON group (Kruskal Wallis test: 
p<0.0001) and the difference between CON compared to FF and PF was highly significant 
(Dunn’s test: p<0.0001) (Figure 3.20A). Comparing lumen vs epithelium we found a significant 
difference in the localization of cells in PF (p= 0.0002), in FF (p= 0.0003) and in CON (p= 
0.0099) with an elevated abundance in the epithelium area respect to the lumen (Figure 3.20B). 
In order to see if a variation inter and intra-group were present, the ratio epithelium/lumen was 
calculated and one-sample t test was performed. We found a significant differences among the 
three groups (p=0.003) and also an intra-groups variation (p=0.03), indicating the presence of 
individuability between samples.  
Spatial arrangements of bacterial cells are represented in figures 3.21 and 3.22. A different trend 
is presented for CON with clusterization from 0 to 10 µm in the lumen and a mutual avoidance 
A B 
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from 15 to 80 µm of distance. In the epithelium, a different pattern is described: a pronounced 
clusters formation seemed to be present from 0 to 25 µm and a random distribution pattern from 
30 to 80 µm. In FF, clusters are presented from 0 to 30 µm in the lumen while in the epithelium 
a random distribution is described from 0 to 30 µm. From 30 to 80 µm of distance a mutual 
avoindance of cells is reported for both lumen and epithelium.  
As shown in the CLSM images of epithelium and lumen area (Figure 3.19) co-aggregations of 
coccoid cells are presented but only in PF respect to CON and FF. In order to measure the 
behavior of these co-aggregates, a spatial arrangiament for rods and cocci separately was further 
performed. The mutual avoidance detected in figure 3.21 regarding PF group represented the 
pattern of rods and cocci considered together. Figure 3.22 shows the behavior of rods and cocci 
separately, revealing a different behaviour. Rods had a remarkable mutual avoidance 
distribution and cocci showed a random distribution pattern and a clusters presence from 15 to 
30 µm in lumen. In the epithelium, clusters were detected from 0 to 15 µm and mutual 
avoidance from 20 to 80 µm in the epithelium. Cocci distributions is in accordance to Figures 
3.19A and B, in which they seem to be very close to each other but very far away from the 
others cocci aggregates.  
In summary, the spatial arrangements analysis showed different patterns in both lumen and 
epithelium, suggesting a diet-dependent distribution.  
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Figure 3.19. (A,B) Representative picture of the distal colon of a PF mouse stained with DAPI (blue) EUB I-II-III 338 
DOPE in Fluos (green) for all Bacteria and and the specific probe Erec_482 in Cy5 (pink). Images were performed 
with confocal laser scanning microscope with: magnification 63X, resolution 1864x1864, zoom factor 1. (C,D) 
Representative picture of the distal colon of a CON (C) and FF (D) mouse respectively stained in the same conditions.  
 
 
A B 
C D 
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Figure 3.20. (A) Biovolume fraction (%) for each groups divided by lumen and epithelium. (B) Biovolume fraction 
of combined pictures of lumen and epithelium. Kruskal Wallis test was used to analyse the differences between 
the three groups and Dunn’s test for multiple comparisons. **** p ≤0.001, *** p≤0.001, **p≤0.01.  
 
  
Figure 3.21. Pair-cross correlation (PCC) function curves of CON, FF and PF groups. To compare the results 
of bacterial cells localization, single measurements of each mouse for each location (lumen and epithelium) were 
pooled by calculating the arithmetic mean curves with respective 95% confidence interval (CI). The mean of PCC 
curves was plotted for CON (pink line) versus FF (green line) and PF (blue line) with their respective 95% CI 
(same colour of the samples) against distances in a range from 0–80 µm for lumen (A) and epithelium (B). 
 
A B 
A B 
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Figure 3.22. Spatial arrangement analysis of the positive hybridization signals of rods and cocci in PF mice. 
Pair cross correlation function curves (PCC) of PF mice: single measurements of each mouse for each location 
(lumen and epithelium) and for each bacterial shape (rods and cocci) were pooled by calculating the arithmetic 
mean curves with respective 95% CI of PF samples. The mean of PCC curves was plotted with their respective 
95% CI (same colour of the samples) against distances in a range from 0–80 µm.  
 
 
 
Biovolume fraction and cluster analysis of Desulfovibrio spp. 
 
Desulfovibrio spp. was detected by FISH analysis only in one PF mouse (Figure 3.23A and B) 
The biovolume fractions of Desulfovibrio spp. were 3±2.5 (mean±SD) in the lumen and 2±1.8 
(mean±SD) in the epithelium. 
Spatial arrangement of cells was performed by calculating the areas of the cells, and the box-
plots (Figure 3.24) show the presence of different out-groups, probably representing co-
aggregation of cells in both lumen and epithelium.  
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Figure 3.23. Representative picture of a distal colon stained with DAPI (blue) EUB I-II-III 338 DOPE in Fluos (green) 
for all Bacteria and the specific probe Dsp_653 in Cy5 (pink). Images were performed with confocal laser scanning 
microscope with: magnification 63X, resolution 1512x1512, zoom factor 1 for epithelium (A) and lumen (B).  
 
 
 
Figure 3.24. Cluster analysis of Desulfovibrio spp. The cluster analysis revealed the presence of co-aggregates 
of different sizes in both lumen and epithelium.  
 
 
Biovolume fraction of Bacteroidaceae, Prevotellaceae and Porphyromonadaceae 
 
The quantification of Bacteroidaceae, Prevotellaceae and Porphyromonadaceae revealed a 
different abundance in the three groups (FF: 25.7±16.6, PF: 34.1±21.0, CON: 39.9±13.7; mean 
± SD). There is a statistical significant decrease in FF and in PF respect to CON (Kruskal Wallis 
test: p<0.0001) (Figure 3.26A). Comparing lumen vs epithelium we found a significant 
difference in the localization of cells in FF (p= 0.0363) characterized by an elevated abundance 
A B 
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in lumen area.  No statistical significance in the localization of cells were found for PF (p= 
0.2654) and CON (p=0.990) (Figures 3.26B, 3.25A and B). The ratio epithelium/lumen 
revealed no difference inter and intra-group (p=0.1532 and p=0.7073 respectively).  
Spatial arrangement analysis showed a similar trend for the three groups of mice in both lumen 
and ephiltelium, with cell aggregations from 0 to 25 µm in the epithelium and a more randomly 
distribution pattern in the lumen for shorter distances. A mutual avoidance of cells is presented 
from 40 to 80 µm (Figure 3.27A and B).  
 
    
Figure 3.25. Representative picture of a distal colon stained with DAPI (blue) EUB I-II-III 338 DOPE in Fluos (green) 
for all Bacteria and the specific probe Bac_303 in Cy3 (red). Images were performed with confocal laser scanning 
microscope with: magnification 63X, resolution1944x1944, zoom factor 1 for epithelium (A) and lumen (B).  
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Figure 3.26. (A) Biovolume fraction (%) for each groups of mice divided by lumen and epithelium. (B) Biovolume 
fraction of combined pictures of lumen and epithelium. Kruskal Wallis test was used to analysed the differences 
between the 3 groups and Dunn’s test for multiple comparisons. **** p ≤0.001, *p≤0.05.  
 
 
 
Figure 3.27. Pair-cross correlation (PCC) function curves of CON, FF and PF groups. To compare the results 
of localization of bacterial cells, single measurements of each mouse for each location (lumen and epithelium) 
were pooled by calculating the arithmetic mean curves with respective 95% confidence interval (CI). The mean 
PCC curves for CON (pink line) versus FF (green line) and PF (blue line) was plotted with their respective 95% 
CI (same colour of the samples) against distances in a range from 0–80 µm for lumen (A) and epithelium (B). 
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Lactobacillus spp. and Enterococcus spp. detection in mouse’s distal colon 
Lactobacillus spp. were detected in the distal colon in two FF, two PF and in the three CON 
mice (Figure 3.28) with a low abundance [(FF:0.70±0.9 mean±SD; PF: 0.43±0.32; CON: 
0.72±0.70, (Kruskal Wallis test: p=0.00806)] and divided by location [FF lumen: 0.88±1.0 
mean±SD; FF epithelium:0.33±0.26 (p=0.9967); PF lumen:0.45±0.33; PF epithelium: 
0.40±0.30 (p=0.4088); CON lumen:1.0±0.77;CON epithelium:0.34±0.31(p<0.0001)].   
 Cluster analysis revealed co-aggregation of cells above all in the lumen area, in particular CON 
showed a clear clusterization of cells (Figure 3.29).  
 
    
 
Figure 3.28. Representative picture of a distal colon stained with DAPI (blue) EUB I-II-III 338 DOPE in Fluos 
(green) for all Bacteria and the specific probe LAB_158 in Cy3 (red). Images were performed with confocal laser 
scanning microscope with: magnification 63X, resolution1944x1944, zoom factor 1 for epithelium (A) and lumen 
(B). (C) shows co-aggregate presence in CON.  
A B
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Figure 3.29. Cluster analysis of Lactobacillus spp. and Enterococcus spp. The cluster analysis revealed the 
presence of co-aggregates of different sizes above all in CON and more localized in the lumen.  
 
No bacteria presence was found in the inner mucus layer 
It has been reported that the inner mucus layer can be dominated by Acynetobacter spp. 
(Donaldson et al, 2015). Acynetobacter spp. was detected in the sequencing data at low 
abundance. Therefore, Acynetobacter specific probe and Acynetobacter baumanni positive 
control were tested to find a possible presence of these bacteria in the inner mucus layer. FISH 
analysis revealed the absence of these bacteria close to the mucus layer. We can conclude that 
it has been probably a contamination or FISH analysis could not detect Acynetobacter spp. 
(Figure 3.30A and B).  
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Figure 3.30. Acynetobacter baumanni positive control stained with Eubmix 338 I, II, III DOPE in fluos (green), 
the specific probe Aca 652 Cy3 (red), Gam42a Cy5+ Bet42a competitor (pink), dapi (blue), resolution:2376px x 
2376px, size: 150,00 um x 150,00 um, zoom factor: 1.23. (A) positive control, (B) representative picture of a distal 
colon stained with the same set of probes. Resolution:1944px x 1944px, zoom factor: 1. No positive signal was 
present for Aca 652 Cy3 and Gam42a Cy5+ Bet42acompetitor.  
 
 
Goblet cells quantification and thickness of the mucus layer 
Goblet cells were stained with alcian blue, the biovolume fraction and the thickness of the 
mucus layer were calculated. The biovolume fraction was more elevated in CON (49.4±12.5; 
mean ± SD) and FF (41.2±5.5) respect to PF (29.6±8.4) (Figure 3.30) (Kruskal Wallis test: 
p<0.0001). The thinnest mucus layer was measured in PF (27.4 µm±6.1; mean ± SD), followed 
by FF (40.3 µm ±9.0) respect to CON (58.5 µm ±9.0) (Kruskal Wallis test: p<0.0001) (Figure 
3.31).  A representative picture of the intestinal mucus layer using methacarn fixation and a 
combination of FISH and MUC2 staining is shown in figure 3.32.   
 
A 
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Figure 3.30. Biovolume fraction of goblet cells: (A) CON, (B) FF and (C) PF, (D). Kruskal Wallis test was used 
to analyzed the differences of the biovolume fraction in the three groups (p<0.0001) and Dunn’s test for multiple 
comparisons. **** p ≤0.001.  
 
 
Figure 3.31. Mucus layer thickness: (A) CON, (B) FF and (C) PF, (D). Kruskal Wallis test was used to analysed 
the differences of the mucus layer thickness in the three groups (p<0.0001) and Dunn’s test for multiple 
comparisons. **** p ≤0.001.  
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Figure 3.32. Representative pictures of the mucus layer in the distal colon of a CON mouse stained with DAPI 
(blue), EUB I-II-III 338 DOPE in Fluos (green) for all Bacteria and Alexa 488 goat anti-rabbit secondary antibody 
Cy3 (red) for the mucus layer. Images were performed with confocal laser scanning microscope with: magnification 
63X, resolution1944x1944, zoom factor 1. 
 
 
3.4.4 DISCUSSION  
 
Complex microbial populations are organized in relation to their environment. The complex 
host-microbe organization exemplify the power and necessity of high-throughput imaging and 
analysis of microbial communities for revealing changes in spatial patterning across multiple 
scales (Earle et al, 2015). Gut mucosa-associated microbes are defined as the microbial 
community that reside in the colonic epithelial cell surface and constitute a biofilm with a 
polysaccharide-rich mucus gel layer. Mucosa-associated microbes are in intimate contact with 
the host, affecting pivotal functions such as immune activation, epithelial growth and 
development and mucus production (Wang et al., 2010). Changes in the diet can disturb the gut 
microbiota composition, for example the elimination of microbiota-accessible carbohydrates 
can have an impact on gut microbiota and mucus layer (Earle et al, 2015).  
In our study the privation of fiber and above all polysaccharides affected the diversity and 
richness in the gut. A significant drop in alpha diversity was present for FF and PF diet. The 
same trend was found for both LCM and stool samples and seemed to be diet and day 
A B 
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dependent. A clear separation within proximal, middle and distal colon was present in CON, 
but the privation of fiber and above all the absence of polysaccharides compromised the beta 
diversity from proximal to distal colon.  
After the weekly dietary treatment in privation of fiber or polysaccharides, we found significant 
shifts in species implicated in the breakdown of cellulose and polysaccharides. Prevotella spp. 
and members of S24-7 (Bacteroidaceae) decreased in FF and PF; in fact members of 
Bacteroides spp. and Prevotella spp. are capable of degrade complex plant polysaccharides 
such as starch, cellulose, xylans, and pectins (Rajilicˊ-Stojanovi et al.,2014; Despres et al., 
2016). Members of Proteobacteria increased in PF diet in particular Desulfovibrionaceae and 
Desulfovibrio spp. In accordance with this data, Desulfovibrio intestinalis and desulfuricans 
were identified as indicator OTUs only in PF. 
The indicators species (OTUs) describe the OTUs whose abundance indicates evidence for the 
community changes within a speficic area or condition. Most of the bacterial species detected 
were implicated in fiber and polysaccharide degradation, meaning that the detection of these 
OTUs is diet dependent. 
Indicators OTUs for FF and PF revealed changes in species implicated in cellulose 
(Ruminococcus obeum, Ruminococcus champanellensis, Bacteroides eggerthii ) (Chassard et 
al., 2012) and xylan (Bacteroides xylanisolvens, Clostridium xylanisolvens) degradation. Plant 
cell wall polysaccharides and especially xylans constitute an important part of human diet. 
Xylans are not degraded by human digestive enzymes in the upper digestive tract, therefore 
reach the colon where they are degraded by the symbiotic microbiota. Xylanolytic bacteria are 
the first degraders of these complex polysaccharides and they release breakdown products that 
can have beneficial effects on human health (Despres et al., 2016).  
16S rRNA gene profiles showed that microbial populations associated with the intestinal 
compartments are distinct from those found in fecal samples, as observed in other studies (Nava 
et al., 2011; Eckburg et al., 2005). The analysis of stool and LCM samples revealed a distinct 
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microbial population. In stool samples, the most abundant phyla were Bacteroidetes, 
Firmicutes, Proteobacteria and Verrucomicrobia, while in LCM sample Firmicutes, 
Bacteroidetes, Actinobacteria and Proteobacteria predominated. 
Comparing the relative abundance in proximal, middle and distal colon, more differences 
between compartments seemed to be present in CON, whereas in FF and PF diets this variability 
seemed to be partially lost in agreement with Beta diversity results. The relative abundance 
changes between the compartments may be diet dependent and the privation of fiber and 
polysaccharides may destroy the normal niche-specific colonization, decreasing richness and 
diversity.  
In the microbial world, spatial patterns of microbial diversity are driven by environmental 
heterogeneity. Microbial ecology studies have shown that microbes exhibit spatially predictable 
and aggregated patterns. Thus, one might expect to find similar microbial communities in 
similar habitats and differentiated microbial communities along an environmental gradient 
(Green and Bohannan, 2006). With the distance-decay analysis, a negative correlation between 
sections similarity and distance across sections was present, meaning that when the distance 
across sections increases the similarity decreases. A similar negative trend was present in the 
three groups but the same behavior already described in beta diversity is reported. The privation 
of fiber and above all the absence of polysaccharides compromises the biogeography structure 
from proximal to distal colon.  
A pipeline for analyzing large imaging datasets is critical for building an understanding of 
microbiota localization in an unbiased way. To gain more insight of the spatial organization of 
gut bacteria, the relative abundance between lumen and epithelium was compared and the 
distance between cells was measured using the spatial arrangements measurement every one 
cell. Therefore, we performed FISH analysis in order to explore the different localization in situ 
of specific bacteria (lumen vs epithelium) and their spatial organization.  
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To explore the role of polysaccharide privation on mucus-degrading bacteria, we investigated 
target bacteria capable of consuming mucin glycans near the mucus like Bacteroides 
acidifaciens, mucus-associated bacteria like Clostridium cluster XIVa group and bacteria 
implicated in polysaccharide degradation like Bacteroidaceae, Prevotellaceae. We quantified 
and measured the cells localization of Desulfovibrio spp. found enriched in PF diet after 
sequencing data analysis. We further quantified bacteria commonly present in the colon like 
Lactobacillus spp. and Enterococcus spp.  
In this study, PF mice had a higher abundance of Bacteroides acidifaciens compared to the 
control, and in particular, the highest abundance was present in the epithelium. B.acidifaciens 
is a mucin-degrading bacterium that use the mucus layer as source of polysaccharides 
(Donaldson et al, 2015) and in a diet free of polysaccharides the mucosal glycans are the only 
carbohydrate source.  
Moreover, in a PF mouse we detected Desulfovibrio spp. in accordance with the increased 
relative abundance previously described in stool samples. Consistent with these observations, 
Rey et al described that liberation of sulfate from sulfated mucins promotes Desulfovibrio spp 
growth. They found that the increased sulfatase gene expression in Bacteroides species 
observed in mice consuming low polysaccharide diet, was accompanied by significantly higher 
levels of Desulfovibrio piger and significantly elevated concentrations of H2S in cecal contents. 
Bacteroides spp. expresses sulfatases that are required for its adaptive foraging on mucosal 
glycans when the diet lacks complex polysaccharides. Consequently, D. piger can benefit from 
diets that provide low levels of complex carbohydrates because Bacteroidets increases the 
utilization of host sulfated glycans thereby providing free sulfate for D.piger (Rey et al, 2013). 
Moreover, the sulfide, produced by certain bacteria, reduces disulfide bonds in the mucus 
network. The resulting breaks in the mucus barrier allow exposure of the epithelium to bacteria 
and toxins, causing inflammation (Ijssennagger et al, 2016). Desulfovibrio spp. may be a 
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potential candidate that can influence mucus structure and may be considered disease-liable 
commensals, mainly due to their tight association with the colonic epithelium (Li et al, 2015).  
In accordance with this observation, we can hypothesize that the increased hydrogen sulfide 
production by the Desulfovibrio spp. under the PF diet may be, at least partly, responsible for 
the reduced mucus layer. We can hypothesize that in a diet without polysaccharides the mucin-
degrading bacteria increase the usage of the mucins as carbon source, consequently the goblet 
cells are not able to produce the same amount of mucus required from these bacteria. This may 
provide a stressful condition for the goblet cells and may be an explaination of the decrease 
biovolume fraction. This effect is much more present in PF diet but in a secondary extent in FF 
diet. Therefore, the privation of polysaccharides as well as cellulose may decrease the 
biovolume fraction of goblet cells and the mucus layer thickness. Interestingly, goblet cells are 
reported to be affected in different pathological conditions. During acute intestinal infections, 
goblet cells are induced to proliferate and consequently mucin synthesis and secretion increase. 
On the contrary, chronic infections result in the depletion of goblet cells and quantitative and 
qualitative alteration in mucus layers due both to altered synthesis and secretion of mucins. 
Goblet cells are also reduced in number and size in ulcerative colitis (Kim and Ho, 2010). 
Whereas the mucus layers play key roles in the establishment of the commensal intestinal 
microbiota and the protection from colonization and invasion by the pathogenic bacteria; the 
defective mucosal barrier, abnormal commensal bacteria and defective host innate and adaptive 
immune response, result in intestinal inflammation and injury (Kim and Ho, 2010).  
The dietary fiber are reported to be able to modulate the balance between secretion/synthesis of 
mucin, the recovery of mucin in the lumen and the composition of mucins. For example, studies 
in rats provide evidence that an increase in luminal mucus erosion observed with some dietary 
fiber is counterbalanced by the synthesis and secretion of mucus by goblet cells (Montagne et 
al., 2003).  
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Some of the gut bacteria able to degrade fiber are Bacteroidaceae and Prevotellaceae. In 
condition of fiber and polysaccharide privation, a decreased abundance of Bacteroideaceae, 
Prevotellaceae and Porphyromonodaceae is detected for FF and PF as shown in gut microbiota 
communities from stool and LCM samples. 
The spatial arrangement of cells seemed to be not affected by diet shift revealing a similar trend 
for the three groups of diet in both lumen and ephiltelium. The lack of changes in FF and PF in 
the spatial arrangement may be explained by the high adaptability of Bacteroides spp. in the 
intestine. Compared with other gut bacteria, Bacteroides spp. have the largest number and 
greatest diversity of genes involved in polysaccharide degradation. Bacteroides spp., are 
sometimes referred to as 'generalists', as they are capable of occupying a variety of metabolic 
niches depending on the availability of diverse polysaccharide nutrients. Many studies of 
Bacteroides spp. glycan metabolism in mice have shown that restricting the polysaccharide 
content of the mouse diet allows selection for species (or strains) that are capable of metabo-
lizing the complex glycans present, such as fructans, fucosylated mucin glycans and mannan. 
Presumably, the variety of starch utilization systems (Sus) present in the genomes of 
Bacteroides spp. provides the metabolic plasticity required to persist in the gut despite short- 
and long-term changes in nutrient availability (Ouwerkerk et al., 2013). 
In our study an increased abundance in the epithelium is observed for Clostridium cluster XIVa 
and b members in accordance with Ouwerkerk et al. (Ouwerkerk et al, 2013). Bacteria 
belonging to Clostridium cluster XIVa have been associated in vitro with the colonization of a 
mucin rich environment, and include butyrate producers like Retortamonas intestinalis and 
Eubacterium rectale (Ouwerkerk et al, 2013; Nava et al., 2011). In our study, a significant 
elevated relative abundance in the ephitelium was present for all groups. Interestingly, in PF 
diet a different bacteria shapes were present: coccoid and long rods. In the spatial arrangement 
analysis, these two bacteria morphologies avoided each other. The spatial distribution of 
bacteria in the murine colon is also shape- and not only taxonomy-dependent, indicating the 
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existence of vertical (surface to lumen) and longitudinal (proximal to distal colon) viscosity 
gradients within the mucus layer. Mobility is shape-dependent: long rods with a spiral and curly 
form prefer a higher viscosity, whereas short coccoid bacteria favour a low viscosity and are 
trapped and immobilized by moderate viscosity (Swidsinski et al, 2007). The difference 
between rods and cocci could therefore result from bacterial preference to a specific viscous 
environment. 
Members of the Lactobacillus genus are a minor part of the intestinal microbiota in the colon 
but a much greater component higher up in the gut (Ahrne et al, 2011). In our study, we could 
detect with FISH a low amount of Lactobacillus spp. and Enterococcus spp. and we observed 
an elevated abundance and clusters in the lumen. In particular, the controls have more elevated 
abundance and clusters, while they seemed to decrease in condition of fiber and polysaccharides 
privation.  
The spatial arrangement of cells revealed different patterns that are diet and/or location 
dependent. A different localization of cells is present comparing lumen with mucosa, even if in 
some cases a high inter-individual variation is present. Taken togheter, our data capture 
dramatic changes in the spatial arrangement of the gut microbiota.  
In summary, this study has established new insights into the spatial organization and diversity 
of microbes across the murine intestine. Using a high-resolution microbial capture system in 
conjunction with current nucleic acid analytic techniques, we showed that the microbial 
communities of distal, middle, proximal colon and stool samples were different in three diverse 
dietary treatments. Furthermore, this high-resolution system suggests a model in which the 
privation of dietary polysaccharides results in an increased bacterial consumption of mucin 
glycans, in a thinner mucus layer and in the alterations of goblet cells improving our 
understanding of host-microbial interactions. 
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Introduction 
4.1 The oral microbiota  
The human mouth is heavily colonised by microorganisms, including viruses, protozoa, fungi, 
archaea and bacteria. In contrast to the commensal microbiota found at other body sites, which 
typically live in harmony with the host, the normal microbiota of the mouth is also responsible 
for the two commonest diseases of man: dental caries and the periodontal diseases. The bacterial 
communities found in the mouth are highly complex with around 1000 species present and has 
been shown to be the second most complex in the body, after the colon (Wade, 2013). 
The use of culture-independent methods of determining the composition of the oral microbiota, 
allied with next generation DNA sequencing methods is providing a far deeper analysis than 
hitherto possible. The human oral microbiota is defined as all the microorganisms that are found 
on or in the human oral cavity and its contiguous extensions (stopping at the distal esophagus), 
though most of the studies and samples have been obtained from within the oral cavity (Wade, 
2013). Studies have shown that different oral structures and tissues are colonized by distinct 
microbial communities (Dewhirst et al., 2010). The oral cavity harbors at least five 
communities: the teeth, which are non-shedding surfaces, the saliva, the dorsal and lateral 
surfaces of the tongue, the gingival sulcus, the periodontal pocket and the remaining epithelial 
surfaces of the oral mucosae (Costalonga and Herzberg, 2014).  
 
4.1.1 Composition of the oral microbiota 
In general, the mouth harbours at least six billion bacteria which are represented by more than 
1000 species as well as other types of microorganisms, including fungi, protozoa and possibly 
even viruses (How et al., 2016) : 
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• Protozoa 
Two protozoan species are found as part of the normal microbiota: Entamoeba gingivalis and 
Trichomonas tenax. The numbers of these organisms is raised in subjects with poor oral 
hygiene. They are currently regarded as harmless saprophytes and the apparent link with disease 
is nutritional, in that poor oral hygiene leads to increased amounts of food debris and bacteria, 
both food sources for protozoa (Wade, 2013).  
• Fungi 
Candida species are carried symptomlessly by around half of individuals with the prevalence 
increasing with age, and even cause a wide range of acute and chronic infections. A culture 
independent survey of the oral mycobiome in healthy individuals found 85 fungal genera in the 
mouths of 20 healthy individuals. The predominant genera were Candida, Cladosporium, 
Aureobasidium, Saccharomycetales, Aspergillus, Fusarium, and Cryptococcus (Wade, 2013).  
• Archaea 
The Archaea make up only a minor component of the oral microbiota and the archaeal 
community is restricted to a small number of species/phylotypes, all of which are methanogens. 
They can be detected in health but their prevalence and numbers are raised in subjects with 
periodontitis. The species found are Methanobrevibacter oralis and two un-named 
Methanobrevibacter phylotypes, Methanobacterium curvum/congolense and Methanosarcina 
mazeii (Wade, 2013).  
• Bacteria  
Generally, oral bacteria are composed of Gram-positive and Gram-negative bacteria, and 
secondarily as either anaerobic or facultatively anaerobic according to their oxygen 
requirements. Despite the diverse community of oral microbiota, the oral cavity is, nonetheless, 
characterized by a stable community known as the “core” community. Therefore, if imbalance 
in the oral resident microbiota occurs, oral diseases such as caries and periodontal diseases seem 
to appear, leading to multiplication of potentially pathogenic microorganisms. Several studies 
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have illustrated that a change in microbial species in the gingival sulcus from Gram-positive, 
facultative, fermentative microorganisms to predominantly Gram-negative, anaerobic, 
chemoorganotrophic, and proteolytic organisms has been highly associated with destruction of 
periodontal tissue (How et al., 2016).  
Complex bacterial communities such as the oral microbiota have been characterised by culture-
independent methods based on the analysis of the sequences of conserved housekeeping genes 
directly isolated from samples of saliva or oral biofilms. The gene most commonly used for this 
purpose has been that encoding the 16S rRNA. The use of this method has allowed the 
comprehensive description of the oral bacterial biota (Wade, 2013).  
Today, one of the most important databases of taxa present in the oral cavity is the Human Oral 
Microbiome Database (HOMD) (http://www.homd.org/). HOMD stores 34,753 filtered cloned 
sequences representing a wide variety of healthy and diseased sites throughout the oral cavity 
such as the dorsum of the tongue, lateral sides of the tongue, buccal fold where the gingiva 
folds into the cheek, surface of the cheeks (buccal mucosa), hard palate, softpalate, labial 
gingiva, tonsils, and supragingival and subgingival plaques from tooth surfaces (Costalonga  
and Herzberg, 2014) (Figure 4.1). As an open system, can potentially include all of the 
microorganisms in the environment.  
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Figure 4.1. Proportions of oral microorganisms in the Human Oral Microbiome Database (HOMD) (Costalonga  
and Herzberg, 2014).  
 
The oral microbiota was well explored by different studies (Zaura et al., 2009; Lazarevic et 
al.,2010). Zaura and co-authors sampled and sequenced microbiota from several intraoral 
niches (dental surfaces, cheek, hard palate, tongue and saliva) in three healthy participants with 
454 pyrosequencing. Interestingly, principal component analysis discriminated the profiles of 
the samples originating from shedding surfaces (mucosa of tongue, cheek and palate) from the 
samples that were obtained from solid surfaces (teeth). Moreover, there was a large overlap in 
the higher taxonomic level (genus level or above), "species-level" phylotypes and unique 
sequences among the three microbiota: 84% of the higher taxonomic level, 75% of the OTUs 
and 65% of the unique sequences were present in at least two of the three microbiota. The three 
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individuals shared 1660 of 6315 unique sequences. These 1660 sequences (the "core 
microbiota") contributed 66% of the reads. The overlapping OTUs contributed to 94% of the 
reads, while nearly all reads (99.8%) belonged to the shared higher taxa showing that the major 
proportion of bacterial sequences of unrelated healthy individuals is identical, supporting the 
concept of a core microbiota at health (Zaura et al., 2009) (Figure 4.2).  
In another study, the salivary microbiota from five adults was analyzed at three time-points 
ranging within a 29-day period and showed subject-specific taxa profiles.  The salivary bacterial 
community comparisons revealed that samples from the same individual were clustered and the 
salivary microbial community appeared to be stable over at least 5 days including samples from 
more distant time points (15-29 days). These results point to the persistence of subject-specific 
taxa whose frequency fluctuates between the time points showing the presence of a relative 
stability (Lazarevic et al.,2010).  
 
 
Figure 4.2. The extent of overlap of oral microbiota between three individuals. The extent of overlap between 
subjects S1 (pink circle), S2 (light blue circle) and S3 (yellow circle) at the level of (A) unique sequences, (B) 
OTUs clustered at 3% difference and (C) higher taxa (genus or more inclusive taxon). The data were obtained by 
combining all samples of the respective individual microbiota. The Venn Diagrams show that 26% of the unique 
sequences, 47% of the OTUs and 72% of the higher taxa were common (area in grey) to the three individuals 
(Zaura et al., 2009). 
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4.1.2 Metabolic pathways of oral bacteria 
• Carbohydrates and sugar alcohols 
Polysaccharides can be hydrolyzed into oligosaccharides, disaccharides, and monosaccharides 
by host and bacterial glycosidases. For example, host α-amylase hydrolyzes cooked starch into 
carbohydrates, which can then be incorporated and metabolized by oral bacteria.  
Oral bacteria are capable of utilizing most dietary carbohydrates and some sugar alcohols. 
Incorporated carbohydrates and sugar alcohols are subjected to glycolysis via metabolic 
reactions catalyzed by constitutive and inducible enzymes. The bacterial sugar metabolism is 
known to be regulated by environmental factors, such as the availability of sugar and oxygen 
that change dynamically in the oral cavity. Saccharolytic bacteria including Streptococcus, 
Actinomyces, and Lactobacillus species degrade carbohydrates into organic acids via the 
Embden-Meyerhof-Parnas pathway resulting in dental caries (Takahashi, 2015).  
• Proteins, peptides, and amino acids 
Proteins can be degraded into peptides and amino acids by bacterial and host proteases and 
peptidases. In general, bacteria utilize amino acids for biosynthesis, but periodontal disease– 
and oral malodor–associated bacteria also ferment amino acids to produce energy. In the latter 
process, amino acids are deaminated and then converted into short-chain fatty acids with the 
production of adenosine triphosphate (ATP). Proteolytic amino acid–degrading bacteria, 
including Prevotella and Porphyromonas species, break down proteins and peptides into amino 
acids and degrade them further via specific pathways to produce short-chain fatty acids, 
ammonia, sulfur compounds, and indole/skatole, which act as virulent and modifying factors in 
periodontitis and oral malodour (Takahashi, 2015). 
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4.1.3 The oral microbiota is modulted by dietary habits and environmental factors 
The organisms of the oral cavity differ among individuals reflecting diet, sampling times of 
day, geographical locations (Costalonga and Herzberg, 2014), age, gender, smoke, oral 
hygiene, use of antibiotics and genetic factors (Lazarevic et al.,2010). The members of the oral 
microbiota in health or disease appear to be selected depending on the dietary habits. Diet of 
the human host appears to shape the symbiosis of the microbiota residing on the mucosae and 
on the non-shedding surfaces of teeth. A simple example is the use of refined carbohydrates in 
the diet of modern humans. Sucrose contributes to increased risk of caries. Shifts in the diet of 
early human ancestors to modern foods have contributed to subtle changes in the oral microbial 
community (Costalonga and Herzberg, 2014).  
Clearly, the environment and perhaps host genetics modify the oral microbiota. In South 
American Amerindians living in a remote village of the Amazon forest, who are less exposed 
to selective pressures of modern diet and are genetically less diverse than multiracial and 
multiethnic urban societies, show a more restricted oral mucosal microbiota than urban people. 
Despite the lower number of genera identified, the Amerindians harbor an increased frequency 
of previously unclassified Proteobacteria (Contreras et al., 2010). Remote Eskimo tribes were 
characterized by a low prevalence of periodontal diseases and caries (Russell et al., 1961) until 
modern diets were introduced (Kristoffersen et al., 1973), whereas Sri Lankans with diets 
essentially identical to early ancestors and in the absence of conventional oral hygiene measures 
had little caries but showed a range of incidence and severity of periodontitis as people aged in 
a landmark longitudinal study (Loe et al.,1986). Since the Sri Lankans employed no oral 
hygiene measures and enjoyed similar diets, host genetic polymorphisms within racially and 
ethnically similar populations may account for differences in acquisition or outgrowth of 
pathogens and the occurrence of disease. During the past few hundred years, the human mouth 
appears to have become a substantially less biodiverse ecosystem. Since higher phylogenetic 
diversity is associated with greater ecosystem resilience, the decreased diversity of the modern 
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oral environment may be associated with less resistance to perturbations and greater 
susceptibility to insertion of pathobionts or even true pathogens in the microbial community. 
Whereas this hypothesis has yet to be tested, the microbiota of different ecological niches within 
the oral cavity may reflect greater or less stability over time (Costalonga and Herzberg, 2014).  
 
4.1.4 Cross-talk between oral microbiota and immunity 
The gingival sulcus is lined by a non-keratinized, stratified squamous epithelium that is in 
constant contact with bacteria and their products. As such, this epithelial barrier is integral to 
the maintenance of oral health and immune homeostasis (Ramage et al., 2016).  
Gingival epithelium works in many ways for the protection of underlying connective tissue. 
First, it provides a physical barrier which does not allow microbes to invade while permitting 
selective transaction with oral environment. Second, upon interaction with microbes, it secretes 
cytokines as well as chemokines to activate the influx of neutrophils and other immune cells 
into the sulcular area. Third, the gingival epithelium has been found to be source of epithelial 
antimicrobial peptides (EAP). These EAPs are considered to be important for the innate 
immunity of the host. These peptides are known to possess a wide spectrum of antimicrobial 
activity acting against Gram-positive and Gram-negative bacterial species as well as yeast and 
some viruses. Thereby, EAPs have the potential to prevent various oral diseases of microbial 
origin such as periodontitis, dental caries, candidiasis, and herpetic gingivo stomatitis (Hans 
and Hans, 2014).  
Several families of antimicrobial peptides have been identified in oral cavity, which includes 
-defensins, -defensins, calprotectin, adrenomedullin, histatins, and cathelicidin. Of these, -
defensins are of non epithelial origin, with their major source being the neutrophils migrating 
into the gingival sulcus as primary host response, whereas histatins are secreted in saliva, 
produced by parotid and submandibular salivary gland duct cells. The EAPs work in tandem 
with the salivary antimicrobial agents such as histatins, immunoglobulins, and lysozyme to 
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strengthen first line of host defence. These antimicrobial peptides are expressed in oral  
epithelium constitutively and are inducible; thus, they have both functions, of surveillance and 
of host defence (Hans and Hans, 2014).  
The outer membrane of Gram-negative bacteria consists of lipopolysaccharide (LPS). This is 
an amphipathic molecule that can be divided structurally in three parts: (a) the O-polysaccharide 
(or O-antigen), (b) the core polysaccharide, and (c) the lipid A. The O-antigen is the outmost 
part of LPS expressed on bacteria and therefore is the major antigen targeted by host antibody 
responses. LPS from Gram-negative bacteria is well known for its ability to induce a wide range 
of proinflammatory responses. Specifically, LPS can stimulate macrophages/ monocytes to 
produce pro-inflammatory cytokines, such as interleukin-1β (IL-1β), tumour necrosis factor-α 
(TNF-α), interleukin-6 (IL-6), interferon- γ (IFN-γ), IL-12, IFN inducible protein-10 (IP-10), 
chemotactic cytokines, like monocyte chemotactic protein-5 (MCP-5), IL-8, macrophage 
inflammatory protein (MIP-1α) and MIP-2, prostaglandin E2 (PGE2), and nitric oxide (NO) 
(Madianos et al., 2005).  
Interleukin (IL)-8 mRNA expression was investigated in human dental pulp fibroblast cultures 
after stimulation with LPS prepared from Prevotella intermedia (Nagaoka et al.,1996),  
Porphyromonas gingivalis (Tamura et al., 1992) and inflammatory cytokines. The expression 
of IL-8 mRNA and the release of IL-8 induced by P. intermedia and P. gingivalis LPS were 
detected in pulpal fibroblast cultures, suggesting that pulpal fibroblasts are immunoresponsive 
cells and can elaborate IL-8 upon stimulation with P. intermedia and P. gingivalis LPS 
(Nagaoka et al.,1996; Tamura et al., 1992).  
Perturbations in the microbial community can be caused by growth of microorganisms such as 
P. gingivalis, which can alter the nutrient foundation of the niche and disrupt the equilibrium 
between symbionts and pathobionts (Costalonga and Herzberg, 2014).  
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Despite considerable recent attention to the composition of the human microbiota and 
microbiome, the mechanisms underlying complex host bacterial and interbacterial interactions 
that lead to polymicrobial inflammatory diseases remain poorly defined. An attractive model to 
address this issue is periodontitis, an oral inflammatory disease induced by a multispecies 
biofilm that is readily accessible for investigation (Hajishengallis et al., 2011).   
 
4.1.5 Future research into the functions of the oral microbiota 
It is difficult to measure bacterial metabolic activity, particularly in the oral microbiota, due to 
the small sample sizes involved; however, recent advances in metabolomic technology have 
made it possible to analyze the levels of various types of metabolites in small samples. 
Comprehensive analyses of metabolites (metabolome analysis or metabolomics) can provide 
insights into the metabolic functions of the oral microbiota. Together with comprehensive 
analyses of the mRNA molecules present within the oral microbiome (metatranscriptome 
analysis), the metabolomic approach might make it possible to obtain an overview of the 
metabolic activity of the oral microbiota and its relationship with oral microbiota-associated 
oral diseases (Takahashi, 2015). 
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4.2 Aim of the project 
 
“An altered oral microbiota is associated with IL-8 
production status of gingival epithelial cells in 
healthy individuals” 
 
Understanding changes in the oral microbiota at the early stages of periodontitis and dental 
caries, the most prevalent chronic oral diseases, would allow diagnosis and treatment before the 
appearance of periodontal pockets or dental hard tissue loss (Zaura et al., 2009).  
This study aimed at establishing associations of nutrition, oral hygiene habits and basal release 
of IL-8 from gum ephitelial cells with the oral bacterial community to identify indicator OTUs 
that might predict onset of oral inflammation related to diseases. For this purpose, we 
investigated IL-8 release from the gum epithelial cells (GECs) and the oral microbiota profiles 
from 21 healthy participants. We measured the basal and endotoxin-induced IL-8 release from 
the GECs over 6 h. Whereas the oral microbiota is influenced by diet and environmental factors 
(Costalonga and Herzberg, 2014), we further evaluated the correlations between nutritional and 
oral hygiene habits in regard to the bacterial community. Finally, in order to identify bio-
markers in the oral microbiota community, we performed an indicator species analysis 
associated with the release of IL-8 in the GECs. These indicators may open the possibility to 
identify bio-markers for the early onset of oral inflammation.  
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4.3 PRELIMINARY DATA  
 
4.3.1 EXPERIMENTAL DESIGN 
 
 
 
Figure 4.3. Gum epithelial cells (GECs) were sampled from 21 healthy participants. Bacterial DNA was extracted 
and sequenced. IL-8 release from GECs over 6 h was measured, as well as IL-8 release after 6 h incubation with 
bacterial endotoxins. Basal and endotoxin-induced IL-8 release over 6 h, as well as nutritional and oral hygiene 
habits were analyzed in regard to the bacterial community.  
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4.3.2 MATERIALS AND METHODS  
 
Study population and questionnaire 
21 healthy participants (13 female, 8 male) between the ages of 22 and 55 were recruited for 
the study. Exclusion criteria were pregnancy, smoking and antibiotic therapy in the last three 
months. Participants signed an informed consent and were asked to complete a questionnaire 
including general information, eating and drinking habits, as well as personal oral hygiene and 
medication prior to enrolling in the study (Table 4.1). All participants self-reported to be free 
of oral diseases. 
 
Table 4.1. Factors considered in the questionnaire 
 
general nutrition oral hygiene medication 
age teaa,b toothpaste hormonesg,* 
height coffeea mouthwashf,* pain killersh,* 
weight meatc flossingf,*  
gender beerc chewing gumf,*  
allergies* red wined   
 white wined   
 fruitse   
 sweetsc   
 
Legend: a) per day [L], b) black, green and herbal tea, c) per week [g] or [L], d) per month [L] ,e) portions 
per week, f) >1 per week, g) oral contraceptives, hormone replacement therapy, h) oral intake in the last 30 
days;  *categories yes/no 
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Collection of GECs and bacteria 
Participants were asked to abstain from brushing their teeth and eating breakfast in the morning 
of GEC collection. Material (cells and bacteria) were collected by the participants themselves 
by thoroughly brushing the upper and lower outer gums using three sterile brushes 
(Praxisdienst, Longuich, Germany). Brushes were then rinsed in 7.2 ml of DMEM containing 
10% fetal bovine serum (FBS, Thermo Scientific, Waltham, MA USA) and 8 mM Glutamine. 
After thoroughly resuspending the collected material, 1 ml of suspension was centrifuged at 
16,000xg for 7 minutes at 4 °C and the supernatant was removed. The pellet was then flash-
frozen in liquid nitrogen and kept at -80 °C until DNA extraction. 
 
Ex vivo incubation of GECs 
Epithelial cells were counted, the cell suspension aliquoted into three 15 ml tubes, centrifuged 
for 5 min at 400xg at room temperature and re-suspended in fresh medium to a final 
concentration of 150,000 living cells/ml, as determined by trypan blue exclusion test. Two 
different LPS (EC-stock 1 mg/ml ddH2O from Sigma-Aldrich and PG-stock 1 mg/ml ddH2O, 
euBio, Vienna, Austria) were added to the respective aliquots for final concentrations of 10 
µg/ml LPS. The third aliquot was left without any addition for determination of basal levels of 
IL-8. Cells were incubated for 6 h in triplicate in 24-well plates in an incubator at 37°C and 5% 
CO2. After incubation, pH measurements of all three incubations were done with pH strips, and 
the mean pH of three measurements was used for analysis (interval 0.5 units).  
 
Measurement of IL-8 
After 6 h incubation, supernatants of the 24-well plates were collected, centrifuged at 16,000 x 
g for 10 min at 4°C and two aliquots per well were stored at -80 °C further analysis. Basal IL-
8 levels after 6 h incubation, IL-8 levels after incubation with 10 µg/ml EC-LPS for 6 h (ecLPS) 
and IL-8 levels after incubation with 10 µg/ml PG-LPS for 6 h (pgLPS) were determined in the 
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supernatant by ELISA (Merck Millipore, Darmstadt, Germany), following the manufacturer’s 
instructions. 
 
DNA extraction, preparation of 16s gene target amplicons libraries and sequence analysis  
DNA was extracted from samples using a phenol–chloroform protocol with bead-beating and 
precipitated with 0.1 volume of 3M Na-Acetate and 0.6 volumes of ice-cold isopropanol 
(Griffiths et al., 2000). DNA was subjected to a two-step PCR amplification targeting the 16S 
rRNA gene using a forward primer S-D-bact-0341-b-S-17 (5’-CCTACGGGNGGCWGCAG-
3’) and a reverse primer S-D-bact-0785-a-A-21 (5’-GACTACHVGGGTATCTAATCC-3’). 
The first PCR reaction was performed in triplicate with 25 cycles. The PCR products were then 
pooled and submitted to a second step PCR of 10 cycles with the addition of 8 nt sample-
specific barcode sequence (Herbold et al., 2015). The barcoded amplicons were purified after 
the second step with ZR-96 DNA Clean-up Kit (Zymo Research, USA) and quantified using 
the Quant-iT PicoGreen dsDNA Assay (Invitrogen, USA). An equimolar library was 
constructed by pooling samples, and the resulting library was sequenced on the Illumina MiSeq 
platform at Microsynth AG (Balgach, Switzerland). Sequence data were sorted into libraries 
using the 8 nt sample-specific barcode and primer using a custom-made in-house script, quality-
filtered according to the Earth Microbiome Project guidelines, and paired-end reads were 
concatenated (Bokulich et al., 2013). Reads were then clustered into species-level operational 
taxonomic units (OTUs) of 97% sequence identity, checked for chimeras using USEARCH, 
and taxonomically classified using the Ribosomal Database Project näive Bayesian classifier 
(Wang et al., 2007). Sequence data has been deposited in the NCBI Sequence Read Archive 
under SRP075956. 
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Data Analysis 
 
IL-8 data analysis 
Data were analyzed using SigmaPlot 11.0 (SystatSoftware, USA). Correlations of basal IL-8 
values and metric questionnaire variables were done with Spearman Rank correlations, 
comparisons of two groups were done using Student’s t-test. In case of not normally distributed 
data, comparisons between two groups were done using Mann-Whitney Rank Sum test. A p-
value ≤0.05 was considered significant. For analysis of the response to stimulation with LPS, 
participants with relative IL-8 values lower than 100% (as determined by LPS-treated over 
basal IL-8 levels) after stimulation were designated as “non-responders”, while participants 
with relative IL-8 values over 100% after stimulation with LPS were designated as 
“responders”. 
 
Microbiota Analysis 
Statistical analysis was performed using the statistical software R (https://www.r-project.org/). 
To avoid biases related to uneven library depth, sequencing libraries were subsampled to a 
number of reads smaller than the smallest library (4,500 reads). Significant factors were 
evaluated using permutational multivariate analysis of variance (perMANOVA) and ordination 
was performed using redundancy analysis (RDA) in the vegan package in R version 1.17-4 
(Oksanen et al., 2010). Alpha diversity metrics were calculated using the vegan package and 
statistical differences in alpha diversity was performed using the Student’s t-test. Variables 
were expressed as mean ± SD and a p-value ≤0.05 was considered significant. Indicator species 
analysis was carried out using the indicspecies package (De Caceres et al., 2009).  
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4.3.3 RESULTS 
 
Basal IL-8 levels 
Ex vivo incubated GECs showed a release of IL-8 into the supernatant of 9.9 to 98.2 pg/ml after 
6 h, with a mean value of 42.4 pg/ml for all participants (n = 21, tr = 3). In order to gain further 
insight into the differences in basal IL-8 release, while maintaining sufficient group sizes for 
indicator OTUs analysis, participants were divided into two groups with n = 12 (designated 
‘low IL-8’) and n = 9 (designated ‘high IL-8’), based on the residuals analysis, as determined 
by positive and negative residual values (Figure 4.4A). Both groups were normally distributed 
as determined by Shapiro-Wilk normality testing (Plow IL-8 = 0.974, Phigh IL-8 = 0.525) and QQ-
plots (Figure 4.4B).  
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Figure 4.4. (A) Scatter plot of residuals of all participants (n = 21). The solid line represents the mean value, the 
medium dashed line the specification level of mean ± 1 SD, the short dashed line the specification level of mean 
± 2 SD. (B) QQ-Plots for low IL-8 group (n = 12) and high IL-8 group (n = 9). 
 
Correlations of basal IL-8 and metric questionnaire data (n = 21) 
Statistical analysis for the questionnaire data was done with all participants (n = 21). The 
correlation of basal IL-8 levels with all metric parameters of the questionnaire (Table 4.2) 
showed a positive correlation (R = 0.477) with the pH of the supernatant (p = 0.029), as well as 
the consumption of red wine (R = 0.457, p = 0.037) and white wine (R = 0.485, p = 0.026). 
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Table 4.2. Spearman rank correlation between basal IL-8 levels and questionnaire parameters. 
                 a p-value ≤ 0.05 was considered significant. 
 
IL-8 vs 
Corr Coeff  
n=21 
p-value  
n=21 
age 0.104 0.649 
BMI -0.0286 0.899 
pH 0.477 0.029* 
tea 0.275 0.223 
coffee -0.109 0.633 
meat -0.0939 0.682 
beer 0.0305 0.895 
red wine 0.457 0.037* 
white wine 0.485 0.026* 
fruits 0.107 0.637 
sweets -0.150 0.509 
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Pairwise comparison of basal IL-8 and nominal questionnaire data 
For pairwise comparison, toothpaste ingredients were differentiated (no/yes) by the addition of 
zinc, film formers (methyl vinyl ether/maleic anhydride copolymer) and plant extracts 
(chamomilla, mentha, salvia, myrrha, krameria triandra). Pairwise comparison of basal IL-8 
levels with nominal data for all participants (n = 21) showed no differences in basal IL-8 levels 
concerning gender, allergies, the use of floss, mouthwash, the consumption of chewing gum, 
the intake of hormones (only women) and pain killers (Table 4.3).  
 
Table 4.3. Analysis of basal IL-8 levels regarding nominal questionnaire data. Additionally, the factors tea, white 
wine, red wine and beer were also categorized with yes/no, and sample sizes of compared groups (Student’s t-test, 
Mann-Whitney Rank Sum test) are stated in parentheses next to calculated p-values; a p-value ≤0.05 was 
considered significant. 
 
 
Factor (no/yes) 
group sizes (p-
value) 
gender (f/m) 13 vs 8 (0.447) 
allergies 13 vs 8 (0.980) 
toothpaste ingredients  
              zinc 12 vs. 9 (0.382) 
plant extracts 17 vs 4 (0.046*) 
     filmformer 15 vs 6 (0.791) 
mouthwash 13 vs 8 (0.262) 
flossing 8 vs 13 (0.753) 
chewing gum 9 vs 12 (0.386) 
tea 13 vs 8 (0.139) 
white wine 10 vs 11 (0.032*) 
red wine 12 vs 9 (0.082) 
beer 9 vs 12 (0.370) 
hormones 5 vs 8 (0.195) 
pain killers 8 vs 13 (0.525) 
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The presence of zinc and film formers in the toothpaste reported by participants did not have 
an influence on basal IL-8 levels, but for plant extracts, pairwise comparison resulted in p = 
0.046, with mean values of 47.6 ± 24.5 pg/ml (n = 17) in the absence, and 20.2 ± 12.6 pg/ml (n 
= 4) in the presence of plant extracts in the toothpaste, respectively. Using a nominal dataset 
for the consumption of tea, beer, white and red wine (no or yes), a difference was found between 
white wine drinkers, and non-white wine drinkers (p = 0.032), with mean values of basal IL-8 
for non-white wine drinkers (n = 10) and white wine drinkers (n = 11) were 29.5 ± 13.7 pg/ml 
and 54.1 ± 27.8 pg/ml, respectively. The observed significant correlation in basal IL-8 levels 
for red wine consumption (Table 4.2) did not occur after nominal categorization of data (p = 
0.082).  
 
The oral microbiota composition  
The predominant bacterial phyla (in % abundance) in gum brushes were Firmicutes (70.5 ± 
17.2; mean ± SD), followed by Proteobacteria (12.2 ± 10.7; mean ± SD), Actinobacteria (6.6 
± 4.5; mean ± SD), Bacteroidetes (6.1 ± 6.5; mean ± SD), Fusobacteria (2.5 ± 3.1; mean ± SD) 
and Candidate division TM7 (1.1 ± 1.9; mean ± SD) (Figure 4.5A). The most dominant family 
detected was Streptococcaceae (59.3 ± 21.3; mean ± SD) (Figure 4.5B), which was represented 
at the genus level by Streptococcus (59.3 ± 21.3; mean ± SD) (Figure 4.5C).  
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Figure 4.5. Abundant bacterial taxa from gum brushes. (A) Phylum, (B) family and (C) genus-level  taxon profiles 
are shown. Abundant taxa, defined as having a mean relative abundance of >1%, are shown.  
 
Alpha diversity 
Oral microbiota richness was not significantly different between low and high basal IL-8 levels 
(observed species: p=0.534; Chao1 estimated richness: p=0.163). Likewise, alpha diversity 
metrics, which take into account both community richness and evenness, were not significantly 
different (Shannon: p=0.449; inverse Simpson p=0.895).   
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Associations of oral microbiota with nutrition and oral hygiene habits  
The composition of the oral microbiota was associated with nutrition and oral hygiene habits at 
the OTU level as well as taxonomic levels from genus to phylum,  with significant associations 
with basal IL-8 levels, gender, BMI, allergies, flossing habits, chewing gum use, and 
consumption of tea, meat, beer, white wine, and sweets (perMANOVA; p<0.05, Table 4.4). We 
performed redundancy analysis (RDA) considering these significant parameters to visualize 
these associations. RDA ordination revealed a strong correlation between basal IL-8 levels and 
meat consumption, but not for tea, floss habits and allergies (Figure 4.6).  
 
Table 4.4. perMANOVA analysis performed at every taxonomical level. Significant nutritional and oral hygiene 
habits are shown.  
 
 
Parameters Taxonomical level p-value 
IL-8 OTU 0.016 
tea OTU 
Phylum 
Family 
0.007 
0.001 
0.041 
meat OTU 
Phylum 
0.005 
0.018 
allergies OTU 0.033 
flossing OTU 
Phylum 
0.010 
0.015 
gender OTU 
Phylum 
0.058 
0.014 
BMI Phylum 
Family 
0.005 
0.050 
beer Phylum 0.007 
white wine Phylum 
Family 
Genus 
0.001 
0.009 
0.022 
sweets Phylum 0.041 
chewing gum Phylum 0.007 
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Figure 4.6. Redundancy analysis of oral microbiota at OTU level. Parameters significant at OTU level in the 
perMANOVA analysis were plotted and are represented by arrows. The direction of the arrows shows the 
association between variables, in this case with meat and IL-8.  
 
Stimulation of oral GECs with 10 µg/ml LPS from EC and PG  
Ex vivo challenge of brushed cells with EC- and PG-LPS did not significantly affect basal IL-
8 levels, with means for IL-8, ecLPS and pgLPS of 42.4 ± 25.0 pg/ml, 39.2 ± 22.3 pg/ml and 
40.7 ± 24.1 pg/ml, respectively (Table 4.5). Also, for the earlier designated low IL-8 (n = 12) 
and high IL-8 (n = 9) groups, no differences in absolute basal IL-8 levels compared to levels 
after treatment with EC- and PG-LPS were found. In the low IL-8 group, the absolute mean 
values for IL-8, ecLPS and pgLPS were 24.4 ± 8.8 pg/ml, 24.1 ± 8.5 pg/ml and 24.2 ± 9.6 
pg/ml, respectively. Absolute means for high IL-8 group were 66.4 ± 18.1 pg/ml, 59.3 ± 18.5 
pg/ml and 62.8 ± 19.2 pg/ml for IL-8, ecLPS and pgLPS, respectively. On relative levels 
(ecLPS/pgLPS over basal IL-8 in percent), differences to control (100%) were found in the high 
level ecLPS group with an unexpected decrease in IL-8 levels of -10.6 ± 16.1 % (p = 0.038) 
whereas no other group showed significant alterations in IL-8 release levels.  
In order to prevent overinterpretation of data, release data after challenge with EC-LPS were 
excluded from indicator species analysis. 
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Table 4.5. p-values for pairwise comparisons of IL-8 on absolute [pg/ml] and relative [LPS/basal IL-8 %] levels 
for all participants (n = 21), low IL-8 (n = 12) and high IL-8 (n = 9) groups after ex vivo stimulation of oral GECs 
with EC LPS (10 µg/ml) or PG LPS (10 µg/ml) for 6 hours. a p-value ≤0.05 was considered significant. 
 
 
 
 
IL-8 absolute  
[pg/ml] 
IL-8 relative  
[LPS/basal IL-8 %] 
 
ecLPS 
p-value 
pgLPS 
p-value 
ecLPS 
p-value 
pgLPS 
p-value 
All participants (n = 21) 0.763 0.860 0.405 0.788 
Low (<40 pg/ml, n = 
12) 0.938 0.981 0.478 0.478 
High(>40 pg/ml, n = 9) 0.425 0.659 0.038* 0.178 
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To analyze whether the response to the ex vivo stimulation of GECs with EC-LPS and PG-LPS 
was dependent on basal IL-8 levels, data within the low and high IL-8 groups were divided into 
two categories (non-responders and responders) and a Fisher’s exact test was done with the 
resulting counts for non-responders and responders (contingency table). This analysis resulted 
in a p-value of 0.065. 
 
Indicator species based on IL-8 levels and PG LPS-induced IL-8 response in GECs 
We used an indicator species analysis to determine the strength of the association between OTU 
abundances and the levels of basal IL-8 release (low IL-8, high IL-8) combined with 
responder/non-responder status from LPS challenge (expressed as LPS-induced IL-8/basal IL-
8 in percent). We considered the abundances of individual OTUs and determined indicator 
species for the following groups: low IL-8, high IL-8 (irrespective of response to LPS 
challenge), as well as low IL-8 non-responders to PG-LPS, low IL-8 responders to PG-LPS, 
high IL-8 non-responders to PG-LPS, high IL-8 responders to PG-LPS. Statistically significant 
indicators for either single groups or combinations of groups were then identified. 
We identified 11 indicator OTUs in total: one for “low IL-8”, two for “high IL-8” and eight for 
“high IL-8” responders. Figure 4.7 shows an elevated abundance of indicator OTUs in the high 
IL-8 group, in particular for high IL-8 responders. OTU_216 (Veillonellaceae) and OTU_60 
(Neisseriaceae) were the most abundant indicators for high IL-8 status. 
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Figure 4.7. Dominant indicator OTUs are presented for pgLPS response with their relative abundance (as percent) for 
each sample. Each OTU is annotated with the closest reference sequence and sequence similarity performed with 
BLAST. The indicator species are grouped according to the condition for which they are an indicator for each 
combination. Each column of the heatmap represents a single sample.  
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4.3.4 DISCUSSION 
 
This study aimed at establishing associations of nutrition, oral hygiene habits and basal release 
of IL-8 from GECs with the oral bacterial community to identify indicator OTUs that might 
predict onset of oral pathologies. Basal IL-8 levels obtained in this study were neither 
comparable to levels found in crevicular fluid of patients with periodontitis (over 90,000-fold 
higher), nor to levels obtained by stimulated salivary measurement (250 pg/ml) in healthy 
individuals, which is to be expected due to impaired oral health and different sampling method 
as compared to our study (Goutoudi et al., 2012; Navazesh et al., 1982). Comparable to our 
study, release levels of about 30-50 pg/ml IL-8 were found in primary sterile cultures of 
fibroblasts and periodontal ligament cells from tooth resections in healthy patients (Scheres et 
al., 2010). The basal levels of IL-8 in this study were found to positively correlate with pH 
(Table 4.2) but no significant association between pH and the bacterial community composition 
were found. Nevertheless, the positive correlation of the pH (values between 5.2 and 8.5) could 
be related to acidic or basic bacterial and cellular products released into the medium. It has to 
be considered that although the incubations were done without addition of antibiotics, the 
culture medium contains buffering salts, thus possibly biasing pH measurements. In our study, 
the bacterial community of the mouth was dominated by the phyla Firmicutes, followed by 
Proteobacteria, Actinobacteria, Bacteroidetes, Fusobacteria and Candidate division TM7, 
which is consistent with the oral “core” microbiota reported in previous studies (Lazarevic et 
al., 2010; Zaura et al., 2009). Nutrition and oral hygiene habits can influence the oral microbiota 
composition. Considering the latter, the presence of plant extracts in toothpaste showed an 
effect on basal IL-8 release (Table 4.3). This is in accordance with literature, as many medicinal 
plants that are used in toothpastes are anti-inflammatory, anti-bacterial, anti-fungal or astringent 
(Hotwani et al., 2014). The present analysis found a positive correlation of white and red wine 
consumption with basal IL-8 levels, and a significant difference between non-white wine 
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drinkers and white wine drinkers (Tables 4.2 and 4.3). Studies on alcohol consumption and the 
risk of periodontitis have reported variable findings. Susin et al. (Susin et al., 2015) reported 
that a higher alcohol intake related to the incidence of periodontitis in women, whereas no such 
correlations could be shown in men (n = 1115). On the other hand, Kongstad et al. (Kongstad 
et al., 2008) found a negative association of alcohol consumption and clinical signs of oral 
disease in men but not in women (n = 1521). In the present study, the separate analysis of gender 
subdivided by alcohol consumption would results in very small number of participants, which 
do not allow for such an analysis (n = 1-3 for some groups). It is surprising that red wine 
consumption was also positively correlated with IL-8 levels, as red wine is especially rich in 
polyphenols, molecules able to attenuate inflammatory markers in gastric inflammation as well 
as colonic epithelial cells (Mayo et al., 2000; Nunes et al., 2012). Considering our results of 
healthy participants, it is possible that moderate consumption of alcohol activates immune 
pathways indirectly exposed oral cells, leading to higher basal release levels of IL-8.  
In our study, associations could be found between the composition of the oral microbiota and 
the use of chewing gum as well as oral hygiene habits like flossing. It is demonstrated that the 
use of xylitol gum decreased Streptococcus mutans, but did not change the salivary microbial 
composition (Söderling et al., 2015) and flossing habits reduce gingival inflammation removing 
some interproximal plaque (Berchier et al., 2008).  
Moreover, we found associations between the composition of the oral microbiota and 
consumption of different foods and drinks such as meat, sweets, white wine, beer and tea.   
Tea polyphenolic catechins, in particular epigallocatechin gallate and epicatechin gallate, can 
inhibit the growth of a wide range of gram positive and gram negative bacterial species with 
moderate potency. These molecules may be useful in the control of common oral infections, 
such as dental caries and periodontal disease (Taylor et al., 2005). In particular, catechin 
gallates inhibit growth and adherence to oral epithelial cells of Porphyromonas gingivalis 
(Sakanaka et al., 1996) and Prevotella spp. (Hirasawa et al., 2002).  
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As oral bacteria possess constitutive glucose transport systems, they are capable of utilizing 
most dietary carbohydrates and some sugar alcohols. Incorporated carbohydrates and sugar 
alcohols are subjected to glycolysis via metabolic reactions catalysed by constitutive and 
inducible enzymes. Polysaccharides can be hydrolysed into oligosaccharides, disaccharides, 
and monosaccharides by host and bacterial glycosidases. For example, host α-amylase 
hydrolyses cooked starch into carbohydrates, which can then be incorporated and metabolized 
by oral bacteria (Takahashi, 2015).  
Interestingly, there was a strong association between oral microbiota, meat consumption and 
basal IL-8 levels (Figure 4.6). The association between oral microbiota and meat can be 
explained by the degradation activity of proteins into peptides and amino acids by bacterial 
proteases and peptidases in the oral cavity (Takahashi, 2015). Moreover, L-carnitine is an 
abundant compound in red meat and contains a trimethylamine structure. Intestinal microbiota 
metabolize choline and phosphatidylcholine to trimethylamine (TMA), which is further 
metabolized to trimethylamine-N-oxide (TMAO). TMAO directly activates inflammatory 
pathways, including nuclear factor-kB (NF-kB) signaling (Seldin et al., 2016) but which 
specific microbial species contribute to TMAO formation, have not been fully clarified (Koeth 
et al., 2013).  
A connection between gut and oral microbiota was shown by Ding and Schloss (Ding et al., 
2014), who demonstrated that stool samples showed a significant association with samples from 
within the oral cavity. The strongest association was with the community observed in saliva. 
Saliva was dominated by members belonging to the genera Prevotella, Streptococcus, 
Pasteurellaceae, Veillonella, and Fusobacterium; among these taxa, only Prevotella spp. were 
abundant in the stool communities. Ding and Schloss (Ding and Schloss, 2014) stated that 
although the oral and stool communities seemingly share little taxonomic resemblance, oral 
bacterial populations could possibly seed the gut. Those populations experience the ecological 
milieu of the gut to give rise to consistent community types by the time they reach the stool 
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(Ding and Schloss, 2014). If a connection between gut and oral bacterial communities is 
present, it might be possible that some similar metabolic activities are shared.  
In established in vitro oral and immune cell lines, levels of inflammatory markers are up-
regulated after stimulation with LPS from various bacterial strains (Ehrnhöfer-Ressler et al., 
2013; Walker et al., 2013; Schueller et al., 2015). This is also true for primary sterile cultures 
of oral fibroblasts (Nagaoka et al., 1996). In our study, however, using freshly sampled 
epithelial cells and not using antibiotics, this kind of up-regulation was not established for IL-
8 after 6 h of stimulation with PG-LPS. Muthukuru et al. (Muthukuru et al., 2005) found that 
in healthy tissues, the expression of TLRs is much lower than in periodontal disease, which 
would account for the absence of stimulation by their agonist LPS. Additionally, Scheres and 
Crielaard (2012) demonstrated that primary sterile gingival fibroblast cultures were 
desensitized to live Prophyromonas gingivalis after repeated contact with the pathogen. In this 
study, cells were cultured directly after sampling from the mouth, with live plaque bacteria still 
present. It is therefore very likely that GECs exhibited tolerance to EC- and PG-LPS, as 
observed in the experiments by Scheres and Crielaard (Scheres and Crielaard, 2012). The 
significant down-regulation of IL-8 release after stimulation of GECs with a non-oral-derived 
bacterium (Escherichia coli) only occurred in the high IL-8 group on relative levels. Muthukuru 
et al. (Muthukuru et al., 2005) demonstrated that a repeated challenge with LPS from 
Escherichia coli results in a significant down-regulation of TLRs on the cell-surface, thus 
impeding or reducing activation of IL-8 transcription and subsequent protein release. No 
association could be found between basal IL-8 levels and response to LPS challenge (p=0.065). 
However, the indicator species analysis yielded very interesting results (Figure 4.7). The 
indicator species that we identified are typical members of the oral cavity according to the 
Human Oral Microbiome Database (HOMD) (http://www.homd.org/) and some have also been 
associated with periodontal disease or other inflammatory pathologies. For example, 
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Capnocytophaga ochracea is present in the dental plaque biofilm of patients with periodontitis 
and it has been reported in several cases of periodontal disease (Hosohama-Saito et al., 2016). 
Propionibacterium propionicum was found in root canal-treated teeth with apical periodontitis 
(Siqueira et al., 2009), Eggherthia catenaformis was recently isolated in a patient with a dental 
abscess (Kordjian et al., 2015) and Actinomyces dentalis was isolated from pus of a human 
dental abscess (Hall et al., 2005). In particular, the genus Actinomyces houses several long-
established human pathogens. Some species cause the inflammatory disease actinomycosis, 
whereas others are associated with various nonspecific inflammatory processes, or may play a 
role in the development of dental plaque and subsequent caries or periodontal diseases (Hall et 
al., 2005). Likewise, Selenomonas species dominated the diseased sites of subjects with 
generalized aggressive periodontitis. Selenomonas sputigena was the most frequently detected 
bacterial species whereas other species of Selenomonas were often present in high levels, 
including Selenomonas noxia, Selenomonas oral clone EW076, Selenomonas oral clone EW084 
and Selenomonas oral clone CS002. Gonçalves et al. (Goncalves et al., 2012) revealed that 
Selenomonas phylotypes were frequently part of the subgingival microbiota of generalized 
aggressive periodontitis patients. Also Drescher et al. (Drescher et al., 2010) analyzed the 
topography of the subgingival biofilm by fluorescence in situ hybridization (FISH) and electron 
microscopy in subjects with generalized aggressive periodontitis, chronic periodontitis and 
periodontitis-resistant subject, revealing that Selenomonas spp. appeared in large numbers in 
all parts of the collected biofilms and seemed to make a relevant contribution to their structural 
organization.  
In our study we found an association between basal IL8 levels and microbiota, suggesting a 
link between oral bacteria and inflammatory state. Moreover, a link was also observed between 
nutrition, personal oral hygiene with oral microbiota and IL8 levels.  
The elevated abundance of some bacterial OTUs in high IL-8 responders indicating a higher 
inflammatory activity GEC, may be causally linked to stimulation by LPS. The indicator OTUs 
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that we identified in healthy subjects may hold promise as biomarkers for inflammatory status 
of the oral cavity as well as for risk of onset of oral pathologies. The validation of these 
biomarkers will require further studies with larger cohorts and designs where cohorts are 
followed until some develop disease so that we can evaluate their prognostic values.  
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Conclusions and perspectives  
 
It is becoming clear that an altered gut microbiota is associated with human pathologies like obesity, 
type 2 diabetes, cardiovascular disease, etc. as well as an altered oral microbiota is implicated in the 
onset of the periodontal disease and in the oral cavity inflammations. In the first study, we investigated 
the human gut microbiota composition in obese and normal-weight children revealing a clear 
alteration in the gut microbiota of obese children. In the third study, we verified an association with 
the oral microbiota communities, diet, hygiene habits and the release of the inflammatory marker IL-
8 from gingival epithelial cells (GEC). 
To move forwards, it will be essential to understand whether the gut microbiota is causally linked to 
host metabolism in humans. Prospective studies should be performed to determine whether the gut 
microbiota is altered before or after the onset of disease. To improve the understanding of how the 
microbiota affects the metabolism in humans, metagenomics, transcriptomics, proteomics and 
metabolomics data from key target tissues and the microbiota during various disease states and 
interventions should be combined to provide a map of co-occurrences. These data enable the 
formation of testable hypotheses that can be pursued in validated animal models, and they will form 
the foundation for specific interventions. 
In the second project, we studied the role of polysaccharide and fiber privation in wild type mice to 
gain more insight into the role of diet on gut microbiota and we found an alteration in gut microbial 
communities and in the large intestine compartments and even in mucus layer and goblet cells 
structure.   
Therefore, it will also be important to gain a more precise understanding of the foundational principles 
of the microbiota, such as the cross-sectional or longitudinal spatial organization of interactions 
between the host and its microbes in the intestine. The majority of studies in humans and mice rely 
on faecal samples, which provide some representation of what is occurring throughout the digestive 
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tract; however, aspects of microbial communities and host responses that are specific to the large 
intestine might be obscured by faecal sampling (Sonnenburg and Bäckhed, 2016).  
Microbial metabolites probably act as mediators for the host metabolism and can be either beneficial 
(for example, butyrate) or detrimental like the Trimethylamine N-oxide (TMAO). Such molecules 
might therefore provide therapeutic approaches in which beneficial metabolites could be 
supplemented pharmacologically or the bacteria that produce them are developed into probiotics and 
receptor antagonists could be developed from detrimental metabolites (Sonnenburg and Bäckhed, 
2016).  
Controlled dietary interventions that document the utility of various supplements, probiotics, 
nutrients and foods in modulating aspects of the gut microbiota and human health are required. 
Prebiotics and probiotics have physiologic functions that contribute to gut microbiota’s homeostasis, 
maintenance of a healthy body weight and control of factors associated with metabolic disorders 
through their effects on mechanisms controlling food intake, body weight and gut microbiota 
(Sanchez et al.,2015). Future treatments for human pathologies may be possible through the 
modulation of the gut microbiota using probiotics, prebiotics, and microbiota transplants. A better 
understanding of dietary effects on the microbiota may allow individualized nutritional 
recommendations and guide food production and distribution. The microbiota may change the future 
of health care, providing new diagnostic biomarkers of health and new pharmacologic agents derived 
from members of the human microbiota or their chemical products. The ability to accurately profile 
each individual’s microbiota may open the possibility of personalized medical treatments and 
prevention strategies.  
Clearly, there are still more questions than answers. However, the potential implications of this 
exciting and rapidly advancing field are staggering. The measurement of multiple aspects of 
individuality, including the microbiota, will provide insight into the characteristics of people who 
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respond beneficially to a given intervention and will pave the way for microbiota-focused precision 
nutrition.  
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